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Candidate's statement on research contributions 
 
1.1 Application of Multiple Correspondence Analysis for assessing the relationship 
between malaria infection and socioeconomic status  
The first new idea in this thesis was the application of Multiple Correspondence Analysis 
(MCA) to classify households in socioeconomic status. I came up with this idea after reading 
a lot of literature about the methodological challenges applied by other scholars which led to 
uncertain conclusions. The approach was recommended already in other domains that this 
model is better and the results are more reliable. So, I developed the application for the 
health field.   
 
1.2 Publication of manuscript entitled: Socioeconomic health inequality in malaria 
indicators in rural western Kenya: evidence from a household malaria survey on the burden 
and care-seeking behaviour 
I participated in the development of the protocol, development of tools, training of research 
assistants, data management. I personally analyzed the data based on the objective of my 
study, I drafted the first manuscript, presented it as the KEMRI centre scientific committee 
and to the national scientific and ethics committee for approval. After the input from co-
authors and approvals, I submitted it to the malaria journal. I was the corresponding author 
with the primary responsibility to address all reviewer comments until the paper was 
published by the malaria journal. I got guidance from my supervisors and inputs from my co-
authors who shared with me some of the ideas on the content of the paper which I integrated. 
The paper can be found in the link below 
https://malariajournal.biomedcentral.com/articles/10.1186/s12936-018-2319-0   
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1.3 The reclassification of wealth quintiles into ‘poorest ‘or less-poor” 
 
After applying the MCA model to classify households in five socioeconomic strata, I later 
decided to classify them into two distinct groups, poorest and less poor where the poorest 
were a merge of lowest three quintiles (60%) and less poor was a merge of the highest two 
quintiles (40%). This made it easier to compare the prevalence rates between the two groups 
and for modelling purposes. This was my decision following a study by the World Bank that 
showed that about 60% of the population in the study area were living below the poverty 
line. This approach can be adopted by other researchers who wish to collapse some groups 
into two. The use of localised data can help in this classifications  
 
1.4 The study on the trends in socioeconomic health inequalities in malaria-related 
health events from 2006 to 2013, using repeated routine cross-sectional data 
There was no previous study that had assessed trends in socioeconomic inequalities in 
malaria-related health events as part of efforts to monitor the process in achieving the targets 
of sustainable development goals and universal health coverage. This was my idea and was 
supported by my supervisors. The analysis revealed that the poorest individuals have borne 
the heaviest burden of malaria over time. This has implications in the sense that efforts on 
malaria reduction must also focus on the poorest populations to ensure universal health is 
equitable besides being cost-effective  
I developed a manuscript, personally analyzed eight years of data, took the manuscript 
through scientific and ethics committees at KEMRI and CDC, addressed all queries as the 
corresponding author, ensured the paper was published by a peer review journal (BMJ Open) 
The publication can be accessed using the link below;  
https://bmjopen.bmj.com/content/9/9/e033883 
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1.5 Publication of LLIN study protocol to document methods and study procedures  
 
Title: Large-scale implementation of disease control programmes: a cost-effectiveness 
analysis of long-lasting insecticide-treated bed net distribution channels in a malaria-
endemic area of western Kenya—a study protocol 
My next contribution was the publication of the research protocol for evaluating the cost and 
equity effects of LLIN distribution channels in western Kenya. This effort was to document 
methods and procedures other scholars may want to refer to when conducting this kind of 
evaluation. There was no previous publication of similar work.  
I developed the original proposal as the principal investigator. I took the proposal through 
institutional review boards, received approvals and together with co-investigators we secured 
funds to conduct the study. 
The idea of publishing this proposal was floated by Dr. Elvis Gama, a health economist who 
was working at LSTM. We discussed and agreed that he takes lead in formatting the proposal 
as a manuscript and he became the first author and I was the second author. The ideas in this 
paper are largely from the proposal of which I was the PI. Although Dr. Elvis was the 
leading author, I responded to most questions being the person who was the PI. This joint 
effort led to the publication of the protocol at the BMJ Open. The paper can be accessed 
through the link: https://bmjopen.bmj.com/content/6/11/e012776.short 
 
1.6 The evaluation of MTAT in a cluster-randomized trial in terms of reducing 
socioeconomic inequalities. The manuscript title is: Equity effect of intermittent mass test-
and-treat on the household burden of malaria and quality of life: Results from a cluster-
randomized trial in western Kenya 
Most clinical trials are focused on epidemiological outcomes and there has been little 
evidence on un-intended economic benefits of such a large scale mass drug administration to 
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the community. The initial design of MTAT was to reduce the prevalence of malaria with no 
intention of assessing any economic outcomes. I came up with the idea of assessing potential 
equity gains for the poorest individuals. There was no previous study that had assessed the 
equity effects of a large drug administration would be to households.  
Previous studies had only focused on general assessment at the population level but no 
studies have considered the potential economic benefit to the poorest individuals, in terms of 
free access to medicines, ITN and less cost to seek care. The use of data from a clinical trial 
was best suited to assess the unintended economic benefits and contribute to promoting such 
mass campaigns through economic perspectives.  
Dr. Meghan Desai was the PI of the main protocol and I was a co-investigator whose roles 
included developing methods sections of economic evaluations, training staff, statistical 
analysis, data collection. I developed the manuscript, analyzed the data and presented the 
results in this chapter. The paper is undergoing review and publication processes   
1.7 Socioeconomic inequalities in population burden of malaria: analyses of disability-
adjusted life years in a health and demographic surveillance, 2006-2014, western Kenya 
My other research contribution presented in Chapter 5. Previously global disease burden had 
presented disease burden for the general population and no studies had assessed the total 
disease burden in terms of DALYs (mortality and morbidity) between socioeconomic groups 
and showing trends over time. I came up with this idea to provide evidence on the existence 
of socioeconomic inequalities for total disease burden at population using data from Health 
and Demographic surveillance targeting a population of 220,000 and about 65,000 
households.  I conducted further assessment of the economic effect of malaria infection and 
mortality by estimation of DALYs averted by socioeconomic groups and gender. This is also 
an original contribution from my side. I personally assembled data sets from surveys, HDSS, 
and grey literature, developed and set-up a model framework for analysis, conducted the 
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analysis, developed the manuscript and presented the results in the paper. The manuscript is 
to be published but is in the review process. I am the first author and other authors have 
provided input and their ideas have been incorporated. 
 
1.8 Universal household coverage with insecticide-treated bed nets - efficiency and 
equity outcomes in malaria-endemic western Kenya. 
Lastly, it was observed that there was a lack of data on the cost-effectiveness and efficiency 
in combination with the equity effect of LLIN distribution channels in endemic areas. The 
gap in knowledge was that most studies had only assessed the cost-effectiveness of LLIN, 
but no previous studies had evaluated the unit cost of each distribution, compared unit costs 
or even cost-effectiveness or equity effects of the distribution methods. I came up with the 
idea of bringing in an equity perspective, using local reference standards. This had not been 
done before. The results have shown that none of the distribution channels was pro-poor yet 
probably contributed to a reduction of inequities in achieving universal coverage. The cost of 
distribution one LLIN to achieve universal coverage was the least for mass distribution, 
compared to other channels. We concluded that the use of community health volunteers was 
closest to achieving equity in UC between the poorest and less poor households.  
I developed the proposal, conducted data collections and data analysis on equity effect and 
cost analysis, and developed the first draft of the manuscript. Dr. Eva Worrell is the lead 
author and I am the second authour. I have continued to respond to reviewer comments given 
my experience taking lead in being the principal investigator. Dr. Ann Buff contributed 
information on net distribution numbers and Dr. Meghna also provided insights into the 
distribution approaches being used. My supervisors provided guidance throughout the 
process. The manuscript is under the internal publication review process at the CDC for 
possible publication in the Lancet Global Health. 
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The finding from this specific study contributes to news ideas of reducing socioeconomic 
inequalities in LLIN distributions through a mixture of approaches to achieve universal 
coverage and sustainable development goals.  
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Glossary in alphabetical order 
ACTS    Aartemisinin-based combination therapies 
AL    Artemetherisinin -lumefantrine 
ANC    Antenatal care   
CHV    Community health volunteer 
CO    Commercial outlet 
DALYs   Disability adjusted life years 
HDSS    Health demographic surveillance system 
IPT    Intermittent preventive treatment 
ITNs    Insecticide treated mosquito nets 
LLIN    Long lasting insecticide nets 
MCA    Multiple component analysis 
MD    Mass distribution 
MTAT    Mass testing and treatment 
PCA    Principal component analysis 
RDT    Rapid diagnostic test 
SDG    Sustainable development goals 
SES    Socioeconomic Status  
SM    Social marketing 
WHO    World health organization 
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Chapter 1: General introduction  
 
Abstract  
Background  
Malaria control in endemic areas still faces the challenge of ensuring that scale-up of 
interventions is sustainable, cost-effective and equitable. However, there have not been 
adequate studies monitoring equity effects or changes in socioeconomic inequalities of these  
Interventions over time even. The existence of socioeconomic health inequalities is a barrier 
to achieve universal health coverage and sustainable development goals.  
 
Methods: Secondary datasets have been used in these microeconomic evaluations including 
eight years of repeated annual cross-sectional surveys from 2006 to 2013 involving 19,000 
individuals in Siaya County, western Kenya. Data from a two-year cluster randomized Mass 
Test and Treat (MTAT) study conducted between 2013 and 2015 were also used. Further, 
malaria-related mortality and morbidity data from health and demographic surveillance 
system (HDSS) surveys from 2006 to 2014 have been used. Lastly, data on costs and effects 
of Long-Lasting Insecticide Nets (LLIN) distribution channels were collected from national 
to local levels in Busia County, western Kenya to assess the cost-effectiveness of LLIN 
distribution channels from a provider and household perspectives. Household socioeconomic 
status (SES) was established using multiple correspondence analysis (MCA), socioeconomic 
inequalities were assessed using concentration indices, and multi-level mixed-effects 
generalized linear regression models (GLM) were used to compare prevalence ratios with 
95% confidence intervals. Disability-adjusted life years and cost-effectiveness ratios were 
calculated to answer research questions. Data were compared between the poorest and less 
poor individuals at the household and population level. 
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Results: The poorest individuals, children, and women, bore the greatest burden of malaria 
measured in terms of morbidity, mortalities and disability-adjusted life years but the health 
inequality gap between the poor and less poor has reduced over time. There were no 
significant inequalities in medication use and care-seeking for fever between the poorest and 
less poor which represents equity gains for the poorest individuals. The MTAT intervention 
resulted in equity gains amongst the socio-economic groups in terms of access to medication, 
care-seeking, use of LLINs and averting malaria deaths in the participating communities. 
Mass distribution of LLINs combined with the use of community health volunteers remains 
the most cost-effective and equitable method of achieving universal coverage.   
 
Discussion. Malaria remains a disease of poor individuals across age groups and gender but 
is mostly concentrated amongst children and women. While intensification of malaria control 
activities has resulted in a reduction of socioeconomic inequalities in rates of infections, 
mortality, care seeking and medication for fever, pro-poor and mass campaigns for control 
interventions should be to be integrated to reduce inequalities and inequities. The results from 
these studies are vital for monitoring socioeconomic inequalities and equity trends towards 
achieving universal health coverage and sustainable development goals.  
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Introduction 
 
Malaria burden over time 
Malaria is a global health problem, with 3.2 million people at the risk of malaria infections 
[1]. World Health Organization (WHO) estimated that between 2010 - 2016, 216 million 
(95% confidence interval CI=196-263 million) malaria cases occurred globally, incidence 
rates fell by 18% globally and by 20% in Africa, malaria mortality rates fell by 25% globally 
and by 66% in the African region [1]. Sub-Saharan Africa has been disproportionally affected 
by the burden of malaria despite the falling mortality with over 90% of the estimated 445,000 
malaria deaths worldwide occurring in the region in 2016 [1]. Similarly, in sub-Saharan 
Africa, 3.1% of all disability-adjusted life-years (DALYs) were lost to malaria in 2002[2]. In 
Kenya, despite remarkable achievements in malaria prevention and control over the last 10 
years, malaria remains a leading cause of morbidity and mortality with more than 70 per cent 
of the population at risk [3]. In 2015, while the prevalence of microscopically-confirmed 
malaria was 8% amongst children less than 15 years (13% by malaria rapid diagnostic test 
[RDT]s) nationally, it was 27% (43% by malaria RDT) in the lake-endemic region of western 
Kenya [4].  
 
Scale-up of malaria control interventions over time  
There have been intensified scale-up of malaria control interventions in Kenya over time 
including use of long-lasting insecticide nets (LLINs), indoor residual spraying (IRS), 
improved case management with rapid diagnostic tests (RDTs), use of effective artemisinin-
based combination therapy (ACT) and intermittent preventive treatment (IPT) for high-risk 
groups [1] and recently the use of mass test and treat (MTAT) has been suggested for 
evaluations [5]. Empirical studies om who profits from the distribution of public goods 
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(whether drugs or bed nets) suggest that such programs tend to favour those who are better-
off [6], and this results in socioeconomic inequalities in access and utilization of these 
interventions. There have not been adequate studies evaluating equity effects or monitoring 
socioeconomic inequalities of these interventions on malaria indices in endemic areas despite 
recent studies assessing their effects on reducing malaria burden.  
 
Relationship between malaria infection and socioeconomic status  
The relationship between malaria disease and poverty has often been described as a vicious 
cycle, and whether malaria infection is a consequence of or a cause for, low household 
socioeconomic status (SES) has been debated for decades [7, 8]. Malaria imposes substantial 
costs on governments, households, and individuals.  Globally in 2015, the total funding for 
malaria control and elimination efforts was estimated at US$2.9 billion; governments in 
malaria-endemic countries provided 32% of the total funding, of which 65% or US$612 
million was the expenditure incurred by national malaria control programs for program 
implementation and 35% or US$332 million was the cost of health service delivery[9]. The 
results of analyses assessing the relationship between malaria burden and socioeconomic 
status have been mixed and contradictory [6, 7, 10-12]. In a systematic review of nine studies 
to establish the relationship between malaria and poverty, two studies found a significant 
relationship between poverty and malaria, four studies found no significant relationship and 
three studies demonstrated mixed results[7]. Lack of consistency in these findings have been 
partly been attributed to inconsistency in the application of methods for measuring household 
SES, variations in population subgroups studied, and objective measurement for malaria 
infection [7, 13-15]. Different methods of establishing household or individual SES 
employing quantitative and qualitative aspects of poverty have been suggested by various 
researchers [10, 16-22]. For instance, a study in rural western Kenya compared three methods 
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of ranking households into SES Multiple Correspondence Analysis, Polychoric Principal 
Analysis, and principal component analysis and found that there were no significant 
variations in their results but MCA gave the highest percentage of the total variation in the 
outcome variable [22]. Recent studies have also established that the MCA model is more 
flexible as it allows for both quantitative and qualitative variables to be included in the 
model, it produces larger factor weights hence allowing larger values to distinguish cut-offs 
for classification of households into wealth quintiles [22, 23]. Despite this advantage, there 
were no studies to the best of our knowledge that had applied MCA to investigate the 
relationship between socioeconomic status and malaria-related indices including 
socioeconomic inequalities in malaria infection, use of malaria prevention, treatment 
interventions and expenditures.  
 
Effectiveness of interventions to control malaria and their effects on equity 
Equitable distribution of health services or interventions is a principle advocated for in most 
national policy documents aimed at achieving universal health coverage [24]. Monitoring 
socioeconomic inequalities and equity effect is part of Sustainable Development Goals 
(SDGs) related to poverty reduction, health, and wellbeing for all, equitable education, 
gender equality, and reduction of inequalities within and between countries [25, 26]. 
However, the lack of longitudinal data on SES and malaria-related indices have hampered 
these analyses. In some cases, health inequality variables have been collected but have not 
been assessed through economic perspectives to establish the effectiveness of control 
interventions in achieving equity between socioeconomic groups over time. Mass Test and 
Treat (MTAT) is a community-based intervention that has been evaluated in some countries 
and has been showed to be effective in the control of malaria in addition to known 
interventions such as the use of ITNs, ACTs, IPTp and IRS. Yet there are limited analyses 
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which have evaluated the effects of these interventions in reducing socioeconomic 
inequalities and equity effect.  
Cost-effectiveness of interventions to control malaria 
Studies from various parts of Africa indicate that the use of LLINs has a beneficial effect on 
malaria transmission, severe malaria and mortality [27, 28]. Similarly, there are numerous 
studies demonstrating the cost-effectiveness of LLINs in different parts of the world and in 
various contexts [29]. However, while various LLIN distribution methods have been used 
before, there is limited evidence on the actual costs of parallel distribution channels in the 
same context and coverage results that can realistically be achieved from each channel based 
on financial inputs [30]. Similarly, there are no studies that have evaluated the cost-
effectiveness of various ITN distribution channels, and equity effects in a malaria-endemic 
area in sub-Saharan Africa.  
Figure 1 below shows the conceptual relationship between malaria and poverty, illustrating 
and their inter-relationship.  The framework depicts a dual relationship whereby the effects of 
malaria disease can result in households falling into poverty, due to factors such as treatment 
costs, death or disability of household breadwinners. At the same time, low socioeconomic 
status has been shown to be a risk factor for malaria infection, as those in low SES live in 
impoverished conditions, with residence in poor houses or environments, poor access to 
information, low education and lack of proper care-seeking behaviours, and lack of resources 
to buy effective preventive and treatment options. Malaria transmission and poverty are also 
influenced by geographical conditions, macro-economic factors, household and individual 
factors of which poor individuals may be disproportionately affected [8]  
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Figure 1: Conceptual framework of the relationship between malaria burden and socio-
economic status. Source: de Castro and Fisher (2012) [8] 
 
The rationale for the Study  
Despite the intensification of malaria control programs in recent years, the burden of malaria 
remains high in western Kenya yet factors leading to a lack of significant reduction in burden, 
remains unclear and there are few studies looking at economic perspectives of malaria control 
in endemic areas. The existence of socioeconomic inequalities between the poor and less poor 
individuals are known to be a barrier to achieving universal health coverage and SDGs. 
Monitoring socioeconomic inequalities and equity effects of such programs contribute to 
global, regional and local efforts towards malaria reduction strategies. The results of studies 
presented in this thesis have implications on monitoring five key SDGs related to the 
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reduction of health inequalities at both national and global levels including poverty reduction, 
health and wellbeing for all, equitable education, gender equality, and reduction of 
inequalities within and between countries [26] The results of these studies also contribute to 
the objectives of Kenya National Malaria Strategy 2009-2017, which aimed to reduce 
mortality for children less than five years of age by two-thirds by 2015 and to eradicate 
malaria in Kenya by 2017, although these aims were not attained [31]. The success of the 
Kenyan strategy required monitoring of the epidemiological and economic benefits of 
malaria control programs. In the context of intensified malaria control efforts and due to the 
competing uses of the scarce resources in the health sector, policymakers are increasingly 
requesting that economic impact evaluation of interventions be conducted before decisions 
are taken to adopt new interventions.  
 
The effects of malaria interventions on the burden may have economic benefits or losses to 
households which may promote inequities or inequalities between the socioeconomic classes. 
The strategies and methods for monitoring inequalities or inequities in health outcomes have 
been outlined by both the World Bank and WHO. However, there is still a need for 
continuous assessment of these methods and strategies to advance knowledge in monitoring 
socioeconomic inequalities and equity gains due to interventions. The use of longitudinal data 
or clinical trial data will provide an opportunity to measure the existence of socioeconomic 
inequalities or equity effects and cost-effectiveness of malaria control programs. The findings 
from these studies provide evidence on the relationship between malaria and poverty status, 
equity patterns of malaria indices between the poor and less poor. The findings also provide 
evidence on equity effects of community-based mass test-and-treat interventions, and the 
compilation and measurement of health loss due to malaria morbidity and mortality. The 
results presented in this thesis further provides evidence about the effects of LLIN 
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distribution channels on equitable universal coverage and the costs associated with each 
distribution channel. 
Aim, themes, objectives, and hypotheses of the thesis 
 
Aim of this thesis 
The aim of this thesis was to assess socioeconomic inequalities in the malaria burden, 
treatment, and prevention, effectiveness of interventions to control malaria and their effects 
on equity and lastly to assess the cost-effectiveness of interventions to control malaria an 
endemic area of western Kenya. 
The thesis is organized around the following themes 
 Establish the socioeconomic inequalities in the burden, treatment, and 
prevention of malaria 
 Assess the effectiveness of interventions to control malaria and their effects on 
equity 
 Conduct studies to determine the cost-effectiveness of interventions to control 
malaria 
 Make recommendations for policy, practice and future research to reduce 
socioeconomic inequalities and achieving universal health coverage  
 
Specific Objectives and Hypotheses  
 
1. To establish socioeconomic inequalities in malaria burden, treatment, and prevention 
in the malaria-endemic area of western Kenya  
1.1 Hypothesis 1: Risk of malaria disproportionally occurs among individuals in 
lower socio-economic status   
1.2 Hypothesis 2: Seeking care for fever, medication use, and expenditure of 
treatment disproportionally occurs amongst individuals in lower household 
socio-economic status 
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1.3 Hypothesis 3: Over time, socioeconomic inequalities in malaria burden, ITN use, 
drug use, and related expenditure have occurred disproportionally amongst 
individuals in the lowest socioeconomic status strata 
2. To assess the effectiveness of interventions to control malaria and their effects on 
equity for malaria-related events at the household level 
 2.1 Hypothesis 1: Mass testing and treatment had no effect on socioeconomic 
inequalities in malaria burden and related expenditure among households in 
western Kenya 
3.2. Hypothesis 2: Cumulative malaria occurrence and related expenditure 
disproportionally occurs amongst a cohort of households in the lowest 
socioeconomic strata over time 
3.3. Hypothesis 3:  Cumulative malaria exposure, household expenditures, medication 
use, and health-seeking shows benefits to the poorest households in the 
intervention sites  
4. To establish socioeconomic inequalities in the population burden of malaria in terms 
of disability-adjusted life years in a health and demographic surveillance, 2006-2014, 
western Kenya 
4.1. Hypothesis 1: Due to malaria interventions, there would be a decline in years of 
life lost (YLL) from morbidity and mortality among households in western 
Kenya over time 
4.2. Hypothesis 2:  The reduced Disability Adjusted Life Years (DALYs) burden 
disproportionately occurred among households in lower economic strata in the 
population 
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5. Evaluating the costs and effects of long-lasting insecticide-treated bed net distribution 
channels in a malaria-endemic area of western Kenya 
 5.1. Hypothesis 1: Costs, cost-effectiveness, and equity outcomes are not significantly 
different between various channels of LLIN distributions.   
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Abstract  
 
Background: Health inequality is a recognized barrier to achieving health-related 
development goals. Health-equality data are essential for evidence-based planning and 
assessing the effectiveness of initiatives to promote equity. Such data have been captured but 
have not always been analyzed or used to manage the programming. Health data were 
examined for microeconomic differences in malaria indices and associated malaria control 
initiatives in western Kenya. 
 
Methods: Data were analyzed from a malaria cross-sectional survey conducted in July 2012 
among 2,719 people in 1,063 households in Siaya County, Kenya. Demographic factors, 
history of fever, malaria parasitaemia, malaria medication usage, insecticide-treated net (ITN) 
use and expenditure on malaria medications were collected. A composite socioeconomic 
status (SES) score was created using multiple correspondence analyses (MCA) of household 
assets; households were classified into wealth quintiles and dichotomized into the poorest 
(lowest 3 quintiles; 60%) or less-poor (highest 2 quintiles; 40%). Prevalence rates were 
calculated using generalized linear modelling. 
 
Results: Overall prevalence of malaria infection was 34.1%, with significantly higher 
prevalence in the poorest compared to less-poor households (37.5% versus 29.2%, adjusted 
prevalence ratio [aPR] 1.23; 95% CI=1.08–1.41, p=0.002). Care seeking (aPR=0.95; 95% CI: 
0.87–1.04, p=0.229), medication use (aPR=0.94; 95% CI: 0.87–1.00, p=0.087) and ITN use 
(aPR=0.96; 95% CI=0.87–1.05, p=0.397) were similar between households. Among 
participants with malaria infection, 36.4% reported taking malaria medicines in the prior 2 
weeks; 92% took artemether-lumefantrine, the recommended first-line malaria medication. In 
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the poorest households, 4.9% used non-recommended medicines compared to 3.5% in less-
poor (p=0.332). Mean and standard deviation [SD] for expenditure on all malaria medications 
per person was US$0.38 [US$0.50]; the mean was US$0.35 [US$0.52] amongst the poorest 
households and US$0.40 [US$0.55] in less-poor households (p=0.076). Expenditure on non-
recommended malaria medicine was significantly higher in the poorest (mean US$1.36 
[US$0.91]) compared to less-poor households (mean US$0.98 [US$0.80]; p=0.039).  
 
Conclusions: Inequalities in malaria infection and expenditures on potentially ineffective 
malaria medication between the poorest and less-poor households were evident in rural 
western Kenya. Findings highlight the benefits of using MCA to assess and monitor the 
health-equity impact of malaria prevention and control efforts at the microeconomic level. 
 
Keywords   Socioeconomic, malaria, medication, inequalities, Kenya 
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Background 
Malaria is one of the most important diseases in many low- and middle-income countries, 
primarily affecting children and pregnant women in sub-Saharan Africa. In 1999, 
approximately 60% of global malaria deaths were concentrated among the poorest 20% of the 
global population[32]. In sub-Saharan Africa, 3.1% of all disability-adjusted life-years 
(DALYs) were lost to malaria in 2002[2]. Although preventable and treatable, the number of 
deaths due to malaria remains high. In 2015, there were an estimated 429,000 malaria deaths 
(range: 235,000–639,000) worldwide, and most (92%) of these deaths occurred in Africa 
[33].In Kenya, despite remarkable achievements in malaria prevention and control over the 
last 10 years, malaria remains a leading cause of morbidity and mortality[3]. In 2015, while 
the prevalence of microscopically-confirmed malaria was 8% amongst children less than 15 
years (13% by malaria rapid diagnostic test [RDT]) nationally, it was 27% (43% by malaria 
RDT) in the lake-endemic region of western Kenya [4].  
 
The relationship between malaria disease and poverty has often been described as a vicious 
cycle and whether malaria infection is a consequence of or a cause for low household 
socioeconomic status (SES) has been debated for decades [8]. In a systematic review of nine 
studies to establish the relationship between malaria and poverty, two studies found a 
significant relationship between poverty and malaria, four studies found no significant 
relationship and three studies demonstrated mixed results [7]. Malaria also imposes 
substantial costs to individuals, households, and governments. Globally in 2015, total funding 
for malaria control and elimination efforts was estimated at US$2.9 billion; governments in 
malaria-endemic countries provided 32% of the total funding, of which 65% or US$612 
million was expenditure by national malaria control programmes for programme 
implementation and 35% or US$332 million was expenditure on health service delivery [33]. 
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In high malaria-transmission settings in Kenya where the average annual household 
expenditure was less than US$800[34], households spent an average of US$10 (range: US$9–
12) monthly and approximately US$120( range: US$108-144) annually on malaria treatment 
in 2010[35].  
 
The microeconomic relationship between malaria burden and composite wealth indices is 
also mixed and contradictory [7]. A study among Tanzanian children, using principal 
component analysis (PCA) to rank households, established that malaria was associated with 
household SES when SES was the dependent variable, but an individual’s SES was not 
associated with malaria risk when malaria was the dependent variable [8]. Another study in 
Tanzania, which investigated causality between malaria and SES, established that the higher 
the household wealth quintile the lower the prevalence of malaria in individuals in the 
household [10]. The lack of consistent findings may partly reflect the inherent difficulty in 
measuring SES and differences in the populations studied, methods used to measure malaria 
infection and malaria intensity in the study areas [7, 13, 14, 36]. 
 
Various methodologies for assessing SES employing broad quantitative and qualitative 
aspects of poverty have been recommended including PCA, Polychoric PCA, and multiple 
component analysis (MCA) [16-18, 20, 21, 37]. A study from rural western Kenya compared 
the three methods of ranking households into SES quintiles and established that although the 
methods produced similar results, MCA gave the highest percentage of the total variation for 
the household asset variables and thus the largest weights for the variables. The study 
concluded that MCA was a better model for generating asset weights than PCA or Polychoric 
PCA [22]. The study further conducted comparison between ordinary PCA and MCA and 
established that 93% of households were placed in the same quintile by both methods, 87% of 
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the households by ordinary PCA and Polychoric, and 91% by Polychoric and MCA and that 
ordinary PCA asset index was statistically significantly correlated with the index based on 
MCA (r = 0.997, p<0.01) [22]. The MCA model also allows both quantitative and qualitative 
variables, which is not possible with traditional PCA methods [22, 23, 38]. However, studies 
using MCA methods to investigate socioeconomic inequalities related to malaria indicators 
are lacking.  
 
Multiple correspondence analysis descriptions  
MCA can be used for both nominal, continuous and categorical data. It applies a 
correspondence analysis algorithm to an indicator matrix, where the rows represent 
individuals and columns are dummy variables representing categories of the variables in a 
geometric frame. Association between variables is uncovered by calculating the chi-square 
distance between individual categories of the variables and between individual observations.  
In the MCA approach, quantitative variables are recorded as bib taking value taking a 0 or 1. 
In contract, PCA uses orthogonal transformation to convert a set of observations correlated 
asset variables of linearly uncorrelated variables called principal components [22, 23, 38] 
 
The main difference between MCA and PCA is that PCA decomposes relations between 
columns only ( covariance matric) treating rows as ‘case’, while MCA decomposes both rows 
and columns of a matrix simultaneously, treating them symmetrically as cross-tabulations of 
‘categories’. The MCA model considers the number of variables used and the number of 
observations in a dataset and hence its ability to get better factors weights than PCA [22, 23, 
38]. 
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Health inequality data, including malaria parasitaemia prevalence, use of malaria prevention 
and treatment interventions and expenditures on malaria medication, are often collected but 
not analyzed from an economic or equity perspective. Yet, such data and analysis are 
important for monitoring health inequalities and the impact of malaria control interventions at 
the microeconomic level. The aim of this study was to establish the relationship between 
household SES and inequalities in malaria-related health indicators including morbidity, use 
of insecticide-treated nets (ITNs), care-seeking, and expenditure on malaria medications in a  
malaria-endemic area of rural western Kenya.  
 
Methods 
Study site  
A community-based cross-sectional survey was conducted in mid-2012, a year after a mass 
ITN distribution in Siaya County. The survey was conducted within the Kenya Medical 
Research Institute (KEMRI) and the Centers for Disease Control and Prevention (CDC) 
health and demographic surveillance system (HDSS) in Siaya County, western Kenya. The 
HDSS has been described in detail elsewhere [22, 39-41]. Briefly, the HDSS area covers a 
population of approximately 223,000 people residing in 393 villages in three sub-counties of 
Siaya County, spread over approximately 700 km2 along the shores of Lake Victoria. The 
vast majority of the population earns their living through subsistence farming and fishing. 
Residents of the HDSS were visited in their homes every 4 months to record births, deaths, 
pregnancies, immigration, and out-migration. Health indicators in Siaya county, formerly part 
of Nyanza Province, are poor compared to the national averages [42, 43]. Nyanza Province 
had the highest rate of child mortality at 72 deaths per 1,000 live births in 2008–2009, and an 
estimated 60% of the population lived below the poverty line during the study period [26, 
27].  
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Population, sampling strategy, and sample size  
The sampling frame obtained from the HDSS included all households with children <5 years 
of age because many malaria interventions target this age group. Households were selected 
for participation by systematic random sampling, stratified by sub-county (i.e., Rarieda, Gem 
or Siaya). The sampling interval was calculated by dividing the total number of selected 
compounds by the target sample size. A random start number was selected from the ordered 
compound listing. Households were selected based on systematically adding the sampling 
interval to the random start number until the required sample size had been achieved. In total, 
998 compounds comprising 1,063 households were sampled. A sub-sample of all household 
members were surveyed (5-14 years and 15+ years), except for children <5 years, who for 
ethical reasons were all included. If an individual of any age group (<5 years, 5-14 years and 
≥15 years) was sampled in a household, then all children <5 in that household were also 
included in the survey. 
 
Data collection  
Study participants were interviewed face-to-face by trained field staff using a structured 
questionnaire, programmed into a personal digital assistant, to collect data on demographic 
factors, socioeconomic factors including asset ownership and utilities, ITN ownership and 
usage night before the survey, history of fever in the past 14 days, care-seeking behaviors and 
medication use in the past 14 days. A finger prick blood specimen was obtained from all 
individuals in the sampled households; haemoglobin was measured by HemoCue® 
(Ängelholm, Sweden) and the presence of malaria parasitaemia was evaluated using RDT 
(Carestart™ Malaria HRP-2/pLDH (Pf/PAN) Combo, Somerset, NJ, USA). Individuals with 
a positive malaria RDT were treated in accordance with the 2010 Kenya national malaria 
treatment guidelines for uncomplicated malaria while complicated cases were referred to 
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nearby health facilities for treatment [44]. Additionally, thick and thin blood smears were 
taken for screening, malaria species’ identification and enumeration of parasite density.   
Medication prices used to estimate expenditures were obtained from a separate survey in the 
same area, which assessed the availability and cost of antimalarial medications in September 
2013 [45]. Medication prices were estimated using the local prices in Kenya shillings and 
converted to U.S. dollars using the October 2013 exchange rate of 85 Kenya shillings to 
US$1.00 [45]. Non-recommended medications for uncomplicated malaria included 
Amodiaquine, chloroquine, Sulphadoxine-Pyremethamine, and quinine (not recommended 
for use by non-pregnant women). In Kenya, quinine is only recommended as a first-line 
malaria medication for women in the first trimester of pregnancy [28]. The variables used to 
generate household SES index included the occupation of household head (doing business, 
commercial ,farming, housewife, salaried worker, Skilled labour, unskilled labour and 
subsistence farming) primary source of drinking water, type of cooking fuel, ownership of 
household assets (e.g., lantern lamp, radio, television, bicycle) and ownership of livestock 
(e.g., cattle, chicken, pigs, donkey) [22].  
Data management and analysis 
Data were downloaded into a Microsoft Access (Version 2010, Microsoft, and Seattle, WA, 
USA) database for management. Laboratory analyses of microscopy results were recorded in 
an Excel (Version 2010, Microsoft, Seattle, WA, USA) spreadsheet. All the datasets 
underwent validation and consistency checks to identify and resolve errors before they were 
merged using the HDSS unique identifiers or sample codes as appropriate.  
Using the MCA model, households were characterized into five socio-economic quintiles 
with the first quintile as the poorest and the fifth quintile as the least-poor based. Household 
SES index included the occupation of household head (which included; doing business, 
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commercial, farming, housewife, salaried worker, skilled labour , unskilled labour and 
subsistence farming) primary source of drinking water, type of cooking fuel, ownership of 
household assets (e.g., lantern lamp, radio, television, bicycle) and ownership of livestock 
(e.g., cattle, chicken, pigs, donkey) [22, 23]. A generalized linear model, customized with a 
log-link function, was used to estimate and compare adjusted prevalence ratios (aPR). 
Dependent variables included malaria infection, care-seeking, medication, and ITN use, while 
SES, study areas (i.e., sub-counties), sex and age groups (<5, 5–14 and ≥15 years) were 
included as independent variables. As described in detail elsewhere, SES quintiles were 
aggregated into dichotomous groups [9]. A binary variable was created with the first three 
SES quintiles (i.e., poorest, second and third poorest) grouped as the ‘poorest’ category and 
the fourth and fifth quintiles grouped into the ‘less-poor’ category, with the latter as the 
reference category in the models. Proportions and 95% confidence intervals were generated, 
and p-values <0.05 were considered statistically significant. Proportions were compared 
using Fisher’s exact test, and the costs of medications compared using a generalized linear 
model. Medians and interquartile ranges were generated if data were not normally 
distributed; medication expenditures were compared using Wilcoxon rank-sum test because 
price data were not normally distributed.   
Ethics, consent, and permissions 
The HDSS protocol and consent procedures, including surveillance, were approved by 
KEMRI (SSC#1801) and CDC (#3308) institutional review boards (IRB) annually. The 
malaria-specific survey, including the collection of blood samples, received approval from 
the KEMRI scientific steering committee (#2031) and CDC IRB (#6012). Written consent 
was obtained in the local language prior to the administration of the questionnaires. 
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Results 
Characteristics of study participants  
A total of 1,063 households and 2,719 individuals were surveyed in July 2012, approximately 
1 year after a mass ITN distribution in the study area. Participants ages were categorized into 
<5 years (56.8%; n=1,545), 5–14 (17.4%; n=437), and ≥15 years (25.8%; n=701) (Table 1).  
 
  Table 1 Socio-demographic characteristics of the study population in Siaya 
County, Kenya, 2012 
 Categories na Per cent 
Age groups <5 years 1,545 56.8 
 5–14 years 437 17.4 
 ≥15 years 701 25.8 
    
Sex Female 1,494 54.9 
 Male 1,225 45.1 
Wealth quintiles (SES)    
 1 (Poorest) 458 20.6 
 2 434 19.5 
 3 459 20.6 
 4 436 19.6 
 5 (Least poor) 441 19.8 
Sub-counties     
 Rarieda 834 30.7 
 Gem 872 32.0 
  Siaya 1,013 37.3 
a N=2,719 total population surveyed.  
 
 
Descriptive epidemiology  
The prevalence of malaria parasitaemia by microscopy was 34.1% overall, 34.4% among 
children <5 years, 54.8% in 5–14 year olds and 19.3% in persons aged ≥15 years (Table 2). 
Fever in the 14 days prior to the survey was self-reported by 53.9% (n=1,463) of the survey 
population; this was highest (60.6%) among children aged <5 years (Table 2).  Of those 
reporting fever, 70.4% (n=1,032) had sought care. Of those who sought care, 51.8% sought 
 36 
 
care from health facilities, 30.4% from pharmacies, and 15.4% from shops. Use of any 
medication among those who reported having fever was 77.3% overall, with the highest 
proportion among young children (81.9%), and lowest (65.2%) among persons aged ≥15 
years. Overall, 64.9% of the population reported that they used ITN the night prior to the 
survey (Table 2).  
 
Table 2 Descriptive epidemiology of malaria-related indicators in Siaya County, Kenya, 
2012 
   
<5 years  
n (%)  
5–14 years 
n (%) 
≥15 years 
n (%) 
Total  
n (%) 
 Fever in prior 2 weeksa  935 (60.6)  209 (44.2) 319 (45.5) 1,463 (53.9) 
 Malaria parasitaemia  532 (34.4) 259 (54.8) 135 (19.3) 926 (34.1) 
 Care seeking  708 (75.6) 134 (64.1) 190 (59.6) 1,032 (70.4) 
 Medication usageb  766 (81.9)  157 (75.1) 208 (65.2) 1,131 (77.3) 
 ITN use  1,033 (66.9)  251 (53.1)  481 (68.6) 1,765 (64.9) 
a Self-reported fever. 
bOf the 1,463 persons who reported that they had a history of fever, 1,131 took 
medication. 
ITN insecticide-treated net 
 
Multivariable analysis 
Overall, 37.6% of persons from the poorest households had malaria infection compared to 
29.2% of persons from less-poor households (adjusted prevalence ratio [aPR] =1.23; 95% 
CI=1.08-1.41, p=0.002), when adjusting for age, geographic area, gender and ITN use (Table 
3).  
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In multivariate analysis of care-seeking (n=1,182), children <5 years were significantly more 
likely to seek care (aPR=1.27; 95% CI=1.14-1.41, p<0.001) compared to adults ≥15 years. 
There were no significant differences in care-seeking by SES, gender or geographic area 
(Table 4). Among persons who reported fever in the prior 14 days, the prevalence of 
medication use was significantly higher in children <5 years (aPR=1.27; 95% CI=1.15-1.40, 
p<0.001) compared to adults ≥15 years. The poorest persons reported less medication use, but 
it was not significantly different compared to the less-poor (aPR 0.94, 95% CI=0.88-1.0; 
p=0.05) (Table 4).  
 
 
 
Table 3 Multivariate analysis of socioeconomic status and association with malaria 
infection in Siaya, Kenya, 2012.  
Characteristic 
Malaria  
parasitaemia 
n        (N)        percent 
Adjusted 
prevalence 
ratio 
95%  
confidence 
interval 
 
 
p-value 
Overall 926    2,228 34.1     
SES       
Pooresta 401    1,070 37.5 1.23 1.08 1.41 0.002 
Less poorb 338    1,158  29.2 Ref    
Age group       
<5 years 395    1,177  33.6 1.76 1.46 2.14 <0.001 
5–14 years 227       427 53.2 2.74 2.27 3.31 <0.001 
≥15 years 117       624   18.8 Ref    
Sub-county       
Gem 278       685  40.6 1.38 1.14 1.65 0.001 
Siaya 268       842  31.8 1.12 0.93 1.35 0.241 
Rarieda 193       701  27.5 Ref    
ITN usage       
Yes 429    1,449 29.6 0.84 0.73 0.96 0.010 
No 310       779 39.8 Ref      
a ‘Poorest’ was constituted by collapsing the poorest three quintiles.  
b ‘Less-poor’ was constituted by collapsing the wealthiest two quintiles. 
ITN insecticide-treated net; SES socioeconomic status 
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  Table 4 Association of socioeconomic status with care-seeking and medication usage in Siaya County, Kenya, 
2012 
 Care seekinga (n=1,182) Medication usea (n=1,180) 
  
n N 
% aPR 95% CI 
p-
value 
n N % 
aPR 95% CI 
p-
value 
SES               
Poorest 411 598 68.7 0.95 0.87 1.04 0.229 447 598 74.8 0.94 0.87 1.00 0.087 
Less-poor 414 584 70.9 Ref    457 582 78.5 Ref    
Age 
group 
  
     
  
     
<5 years 535 716 74.7 1.27 1.14 1.40 <0.001 582 714 81.5 1.27 1.15 1.40 <0.001 
5–14 
years 
124 188 
66.0 1.11 0.97 1.29 0.120 
142 188 
75.5 1.17 1.04 1.32 0.008 
≥15 years 166 278 59.7 Ref    180 278 64.8 Ref    
Sub-
county 
  
     
  
     
Gem 301 407 74.0 1.05 0.94 1.17 0.391 326 406 80.3 1.10 1.01 1.20 0.037 
Siaya 301 459 66.8 0.91 0.82 1.02 0.110 347 458 75.8 1.02 0.94 1.10 0.657 
Rarieda 223 316 70.6 Ref    231 216 73.1 Ref    
Sex               
Female 460 656 70.1 1.03 0.96 1.11 0.350 500 655 76.3 1.02 0.95 1.08 0.617 
Male 365 526 69.4 Ref    404 525 77.0 Ref    
aAmong the surveyed population who self-reported fever in the prior 2 weeks. 
SES socioeconomic status; aPR adjusted prevalence ratio; CI confidence interval 
 
Ownership of at least one ITN per household overall was very high at 93.9%; ITN ownership 
was not different between the poorest and less-poor households (93.5% versus 94.3, p=0.72). 
Use of ITNs was also common; overall, 65.0% of persons reported using nets the night before 
the survey. In multivariate analysis of the association between SES and ITN usage, 63.2% of 
persons in the poorest group used ITNs compared with 66.8% amongst the less-poor, but the 
difference was not statistically significant (aPR=0.96; 95% CI=0.90–1.02, p=0.18). 
Significant differences were observed in reported ITN use by sub-county, with a significantly 
higher proportion of persons from Rarieda (80.5%) using ITNs compared to Gem (56.5%) or 
Siaya (59.1%) (p<0.001 for both) (Table 5). 
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Of the 1,180 individuals with a reported history of fever in the 14 days prior to the survey 
who had malaria infection and had SES data available, 34.5% (n=505) took the recommended 
first-line malaria medication, artemether-lumefantrine (AL) (Table 6). Among those who 
took AL, 30.9% were from the poorest households compared to 36.2% from less-poor 
households (p=0.43). Amongst individuals who used any malaria medicines, the use of non-
recommended medicines was 4.9% in the poorest households compared to 3.5% in less-poor 
households (p=0.32). The expenditure on any type of malaria medications in the 14 days 
prior to the survey was not statistically different between the poorest and less-poor household 
members (mean US$0.35, standard deviation [19] US$0.52 versus mean US$0.40 [US$0.55]; 
p=0.076, respectively). However, persons in the poorest households spent significantly more 
purchasing non-recommended malaria medicines compared to persons from less-poor 
households (mean=US$1.36 [US$0.91] versus mean US$0.98 [US$0.80]; p=0.039).  
 
 
Table 5  Association between household socioeconomic status and insecticide-treated net use 
in Siaya County, Kenya, 2012 
 
 
n 
 
N ITN use 
percent aPR 
95% 
confidence 
interval 
 
p-value 
SES        
Poorest 676 1,070 63.2 0.96 0.87 1.05 0.397 
Less-poor 773 1,158 66.8 Ref    
Age group        
<5 years 790 1,117 67.1 1.00 0.94 1.07 0.976 
5-14 years 231 427 54.1 0.79 0.71 0.89 <0.001 
≥15 years 428 624 68.6 Ref    
Sub-county        
Gem 387 685 56.5 0.70 0.63 0.79 <0.001 
Siaya 498 842 59.1 0.73 0.65 0.81 <0.001 
Rarieda 564 701 80.5 Ref    
Sex        
Female 802 1,225 65.5 1.00 0.95 1.07 0.811 
Male 647 1,003 64.5 Ref    
SES socioeconomic status; ITN insecticide-treated net; aPR adjusted prevalence ratio 
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Discussion 
The study evaluated the relationship between the burden of malaria infection and household 
SES within a rural of western Kenya. This is the first published paper to assess the 
relationship between malaria indicators and SES using the MCA model to generate household 
wealth quintiles based on continuous and categorical variables. The findings show that 
individuals in the poorest households had a higher burden of malaria infection compared to 
those from less-poor households. Persons from the poorest households also spent 
significantly more money to purchase medications that are not recommended for malaria 
Table 6 Use of and expenditure on malaria medication in the surveyed population who reported fever 
in prior 2 weeks in Siaya County, Kenya, 2012 
Utilization of medication 
(N=1,180)  
All 
Poorest 
households  
Less-poor 
households  
n (%) n (%) n (%) p-valuec 
Artemether-lumefantrine  396 (33.6) 185 (30.9) 211 (36.2) 0.434 
Sulphadoxine-Pyremethamine  8   (0.7) 6   (1.0) 2   (0.3) 0.119 
Amodiaquine  11   (0.9) 7   (1.2) 4   (0.7) 0.284 
Quinine  14   (1.2) 6   (1.0) 8   (1.4) 0.721 
Chloroquine  5   (0.4) 3   (0.3) 2   (0.3) 0.557 
Overall (any malaria medicine) 429 (36.4) 205 (34.3) 224 (38.4) 0.133 
Non-recommended medicine a 
 
38   (4.2) 22   (4.9) 16   (3.5) 0.332 
 
Mean (SD)  
in USD 
Mean (SD)  
in USD 
Mean (SD) 
 in USD  
Expenditure on all malaria 
medications per person  
 
0.38 (0.50) 0.35 (0.52) 0. 40 (0.55) 0.076 
 
Mean (SD) 
Median (IQR) 
in USD 
Mean (SD) 
Median (IQR) 
in USD 
Mean (SD) 
Median (IQR) 
in USD p-valued 
Expenditure on all medications per 
person among only those who paid 
for drugs (n=424) b 
 
1.04 (0.32) 
1.01 (1.01-1.01) 
1.02 (0.32) 
1.01 (1.01-
1.01) 
1.05 (0.33)                            
1.01 (1.01-
1.01) 
0.345 
0.926 
Expenditure on non-recommended 
malaria medicines per person 
(n=38) 
1.14 (0.86) 
0.62 (0.42-2.24) 
1.36 (0.91) 
1.43 (0.45-
2.24)  
0.98 (0.80) 
0.62 (0.42-
2.24) 
0.039 
0.018  
aNon-recommended medicine for malaria treatment included Sulphadoxine-Pyremethamine, 
Amodiaquine, quinine used by non-pregnant women and chloroquine. 
b Mean prices of adult formulation were artemether-lumefantrine=USD 1.01; Sulphadoxine-
Pyremethamine= USD 0.62; Amodiaquine=USD 0.42; quinine=USD 2.24; chloroquine=USD 0.40. 
c Fisher’s exact test 
d Wilcoxon rank-sum test to compare medians and t-test to compare means; excludes children who 
received medicine for free from public health facilities. 
USD United States dollars; SD standard deviation; IQR interquartile range 
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treatment, which are likely to have less clinical efficacy and lead to unnecessary risk of 
adverse effects and complications of taking inappropriate medications. No significant 
associations between care-seeking and SES or medication use and SES were observed, and 
the study found high access to and use of ITNs, irrespective of household SES. The 
prevalence of malaria infection was significantly higher in Gem sub-county compared to 
Rarieda sub-county. This could be due to high vegetation coverage and the presence of River 
Yala which cuts across the sub-county. These findings contribute to the scarce published 
literature on malaria and socioeconomic inequalities. Although there is extensive literature on 
health inequalities and health outcomes more generally, no previous study has evaluated the 
relationships between malaria indicators and SES using MCA to analyse microeconomic 
data.  
The study results are similar to findings by Somi and colleagues who reported a large 
variation in parasitaemia rates between socioeconomic groups, where individuals with the 
lowest SES were significantly more likely to have malaria parasites than less-poor individuals 
[8]. Findings from this analysis, however, contrast with those of de Castro and Fisher who 
found that SES had no association with malaria infection [8]. The de Castro study, however, 
was limited to children aged 6–59 months whereas a study by Somi et al, in which the 
analysis was not restricted to a specific age group [5, 8]. Both cross-sectional studies used 
household assets and proxies to measure SES using the PCA model [8, 10, 20]. This study 
addressed some of the limitations of these previous studies by using malaria confirmed by 
microscopy, as the main outcome of interest controlling for age group, and using generalized 
linear models instead of traditional concentration indices and Lorenz curves to estimate the 
risk of health indicators as a measure of inequity as recommended by World Bank and World 
Health Organization [13, 17, 19]. 
Previous studies on health outcomes, including malaria, and SES have traditionally used the 
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PCA model to generate a household SES index. The PCA model relies heavily on 
dichotomous socioeconomic variables to achieve a composite household SES index [16, 17, 
20]. The benefits of using the MCA model are the inclusion of both continuous and 
categorical variables and larger weights for assets, which increases statistical power [23, 38]. 
Using PCA models to generate household SES indices was anticipated to facilitate a more 
robust evidence base for assessing the associations between health outcomes and poverty, 
especially at the household and community levels [16, 17, 20, 38]. However, recent literature 
has demonstrated the weaknesses of PCA models including the inability to accommodate 
continuous variables such as number of assets owned and generation of low asset weights, 
which makes it difficult to determine clear wealth quintile cut-offs particularly in settings 
where most households have the same assets and therefore the same or very similar SES 
scores [23, 38]. Based on evidence already published elsewhere [22] that MCA is a better 
model than PCA. The study has applied MCA to establish the socioeconomic related 
inequalities in malaria outcomes.  
The study determined that nearly two-thirds of persons had a fever in the past 2 weeks, and 
the majority (81%) of them took the medication with an equal proportion of individuals 
among the poorest and less-poor households. Nearly half of those who sought care went to 
health facilities, but the other half sought care from pharmacies and informal drug shops. 
Research from Kenya shows that people who seek care from health facilities are more likely 
to get tested for malaria and receive the first-line recommended medications for treatment 
compared to those who go to pharmacies and informal drug shops [45-48]. There were no 
differences observed in the expenditure on all malaria medications per person between SES 
groups, and less than 5% of persons purchased non-recommended malaria medicines overall, 
which is a positive finding. However, the poorest households spent more to purchase 
potentially ineffective medicines compared to less-poor households; ineffective treatments 
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potentially prolong parasitaemia or fail to clear parasitaemia, which can lead to recrudescence 
or severe malaria and increased expenditures on additional treatments or hospitalizations. The 
findings of this study suggest that there is a need to encourage healthcare seeking in the 
formal health sector, especially among the poorest households. 
No significant differences in ITN ownership or usage between the poorest and less-poor 
households were observed in this rural western Kenya community in 2012, which was less 
than a year after the first universal coverage ITN distribution in Siaya County. Ownership of 
at least one ITN per household overall reached near full coverage (94%) and was well above 
the national target of 80% [31]. Subsequent national household surveys have consistently 
demonstrated significant differences in ITN ownership, access and use between the lowest 
and highest wealth quintiles [4, 26]. Because this cross-sectional study was conducted in a 
relatively small geographic area (i.e., three sub-counties) of rural Siaya County, there is 
probably much less socioeconomic variation compared to the national population and more 
uniformity in programmatic distribution within a single county. 
 A key principle of the Kenya Health Policy 2014–2030 is to achieve equity in the 
distribution of health services and interventions by 2030 [49]. Findings from this study 
illustrate existing socioeconomic inequalities in the burden of malaria infection and 
expenditures on non-recommended malaria medication in this rural western Kenya setting. 
However, the lack of differences between SES groups in care-seeking, overall medication 
use, and expenditures, and ITN ownership and use demonstrate the progress toward achieving 
equitable access to health services and distribution of free malaria commodities, including 
first-line medicines for treatment and ITNs, in western Kenya. Analysis of malaria indicators 
in relation to household SES using MCA methodology can be used to monitor progress 
towards achieving health equity goals in line with the Kenya Health Policy 2014–2030 and 
global sustainable development goals [50].  
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The study has a number of limitations. Findings were based on one cross-sectional survey 
preventing any evaluation of cause-and-effect of SES on malaria indicators over time. A 
longitudinal or trend analysis of repeated surveys would have provided an opportunity to 
study changes in SES and monitor the gap in malaria indicators between the poorest and less-
poor households over time as malaria control interventions, including free first-line malaria 
treatment at health facilities and ITNs, were implemented. The other limitation was the 
inclusion of only households with children <5 years of age based on protocol-specific 
objectives. While this study advances the knowledge related to the association between 
malaria, control interventions, and microeconomics, under these limitations, it reduces 
generalizability. Additionally, expenditures were calculated per person rather than per 
household because not all persons in the household were interviewed or tested for malaria. 
Although all children <5 years of age were surveyed, only a small proportion of persons ≥5 
years of age were included in the survey sample. Finally, the use of assets as proxies for SES 
also has limitations including, most importantly, that the monetary value of assets was not 
collected, and hence the net worth of the household might be over- or under-estimated. Asset-
based proxies, however, have been shown as a reasonable way to measure wealth status in the 
absence of household income or expenditure data, which is not commonly available in 
informal economies [19].  The study did not compare the current results with any other 
results which could have been analyzed using other methods besides MCA because there is 
already evidence that MCA is a better model compared to PCA. Such comparison would not 
be statistically different in assigning households into the quintiles[22]  
 
Conclusion 
In rural western Kenya, individuals in the poorest households had a higher burden of malaria 
prevalence compared to those in the less-poor households. However, no significant 
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differences were observed in care-seeking, overall medication use and expenditure, or ITN 
ownership and use between households based on SES. This study demonstrates that the MCA 
model can be a useful tool for assessing malaria-related health inequalities at the 
microeconomic level and to monitor progress towards achieving equitable access to health 
services and distribution of malaria interventions in line with national and global health and 
development goals.  
 
  
 46 
 
Declarations 
Ethics approval and consent to participate 
The HDSS protocol and consent procedures were approved by the KEMRI scientific steering 
committee (SSC) (#1801) and CDC institutional review board (IRB) (#3308) annually. The 
malaria-specific survey, including the collection of blood samples, received approval from 
the KEMRI SSC (#2031) and CDC IRB (#6012).  
 
Abbreviations 
AL: artemether-lumefantrine; aPR: adjusted prevalence ratio; CDC: Centers for Disease 
Control and Prevention; DALY: disability-adjusted life year; HDSS: health and demographic 
surveillance system; IRB: institutional review board; ITN: insecticide-treated net; KEMRI: 
Kenya Medical Research Institute; MCA: multiple correspondence analysis; PCA: principal 
correspondence analysis; RDT: rapid diagnostic test; SES: socioeconomic status; SSC: 
scientific steering committee. 
 
Conflicts of interest 
The authors declare that they have no competing interests. 
 
Authors' contributions 
MD, VW, SK conceived and designed the study. MD, VW, SK coordinated and performed 
the study. VW analyzed the data. VW, MD, SK, AMB, AS, SPK, FtK, PPH and LN drafted 
the manuscript. All authors read and approved the final manuscript. 
 
 
 
 47 
 
Disclaimer 
The findings and conclusions presented in this manuscript are those of the authors and do not 
necessarily reflect the official position of KEMRI, Liverpool School of Tropical Medicine, 
U.S. President’s Malaria Initiative, U.S. Agency for International Development or CDC. The 
corresponding author had full access to the study data and had final responsibility for the 
decision to submit for publication.  
 
Acknowledgments 
We are grateful to the communities of the KEMRI and CDC HDSS for their participation in 
and support of the HDSS. We also thank the numerous field, clinical, data and administrative 
staff, without whom, this work would not have been possible; the KEMRI and CDC Research 
and Public Health Collaboration is a member of the IN-DEPTH Network. This paper was 
published with the permission of the Director, KEMRI. 
Availability of data 
Requests for the data may be made to the KEMRI data manager, Vincent Were, 
vwere@kemricdc.org. 
Financial support  
Partial support for VW was made possible by the U.S. President’s Malaria Initiative under the 
terms of a cooperative agreement between the U.S. Agency for International Development 
and Liverpool School of Tropical Medicine. The sponsor of the study had no role in study 
design, data collection, data analysis, data interpretation, or writing of the manuscript.  
 
 
 
 
 48 
 
References 
1. World_Health_Organization: World malaria report 2016. Geneva: WHO; 2016. 
2. Lopez AD, Mathers CD: Measuring the global burden of disease and 
epidemiological transitions: 2002–2030. Annals of Tropical Medicine & 
Parasitology 2006, 100:481-499. 
3. Mohajan HK: Improvement of Health Sector in Kenya. American Journal of Public 
Health Research 2014, 2:159-169. 
4. National Malaria Control Programme N: Kenya Malaria Indicator survey 2015. 
Nairobi, Kenya, and Rockville, Maryland, USA: NMCP, KNBS, and ICF 
International.; 2016. 
5. Samuels AM, Awino N, Odongo W, Abong’o B, Gimnig J, Otieno K, Shi YP, Were 
V, Allen DR, Were F: Community-based intermittent mass testing and treatment 
for malaria in an area of high transmission intensity, western Kenya: study 
design and methodology for a cluster randomized controlled trial. Malaria 
journal 2017, 16:240. 
6. Abdel-Wahab A, Abdel-Muhsin A-MA, Ali E, Suleiman S, Ahmed S, Walliker D, 
Babiker HA: Dynamics of gametocytes among Plasmodium falciparum clones in 
natural infections in an area of highly seasonal transmission. The Journal of 
infectious diseases 2002, 185:1838-1842. 
7. Kern SE, Tiono AB, Makanga M, Gbadoé AD, Premji Z, Gaye O, Sagara I, Ubben D, 
Cousin M, Oladiran F: Community screening and treatment of asymptomatic 
carriers of Plasmodium falciparum with artemether-lumefantrine to reduce 
malaria disease burden: a modelling and simulation analysis. Malaria journal 
2011, 10:210. 
 49 
 
8. Linn AM, Ndiaye Y, Hennessee I, Gaye S, Linn P, Nordstrom K, McLaughlin M: 
Reduction in symptomatic malaria prevalence through proactive community 
treatment in rural Senegal. Tropical Medicine & International Health 2015, 
20:1438-1446. 
9. Tiono AB, Ouédraogo A, Ogutu B, Diarra A, Coulibaly S, Gansané A, Sirima SB, 
O’Neil G, Mukhopadhyay A, Hamed K: A controlled, parallel, cluster-randomized 
trial of community-wide screening and treatment of asymptomatic carriers of 
Plasmodium falciparum in Burkina Faso. Malaria journal 2013, 12:79. 
10. de Castro MC, Fisher MG: Is malaria illness among young children a cause or a 
consequence of low socioeconomic status? evidence from the United Republic of 
Tanzania. Malaria journal 2012, 11:161. 
11. Somi MF, Butler JR, Vahid F, Njau J, Kachur SP, Abdulla S: Is there evidence for 
dual causation between malaria and socioeconomic status? Findings from rural 
Tanzania. The American journal of tropical medicine and hygiene 2007, 77:1020-
1027. 
12. Chima RI, Goodman CA, Mills A: The economic impact of malaria in Africa: a 
critical review of the evidence. Health policy 2003, 63:17-36. 
13. Goodman C, Kara H, Anne M, Virginia W, Worrall E: The Economics of Malaria 
and Its Control. Scientific Working Group on Malaria (WHO/TDR ed) 2003. 
14. Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M, 
Nahlen BL, Gimnig JE, Kariuki SK, Kolczak MS: Community-wide effects of 
permethrin-treated bed nets on child mortality and malaria morbidity in western 
Kenya. The American journal of tropical medicine and hygiene 2003, 68:121-127. 
15. Worrall E, Basu S, Hanson K: Is malaria a disease of poverty? A review of the 
literature. Tropical Medicine & International Health 2005, 10:1047-1059. 
 50 
 
16. Kolenikov S, Angeles G: The use of discrete data in PCA: theory, simulations, 
and applications to socioeconomic indices. Chapel Hill: Carolina Population 
Center, University of North Carolina 2004:1-59. 
17. Kolenikov S, Angeles G: The use of discrete data in principal component analysis 
for socio-economic status evaluation. University of North Carolina at Chapel Hill, 
Carolina, NC[Online] February 2005. 
18. McKenzie DJ: Measuring inequality with asset indicators. Journal of Population 
Economics 2005, 18:229-260. 
19. Vyas S, Kumaranayake L: Constructing socio-economic status indices: how to use 
principal components analysis. Health policy and planning 2006, 21:459-468. 
20. Somi MF, Butler JR, Vahid F, Njau JD, Kachur SP, Abdulla S: Use of proxy 
measures in estimating socioeconomic inequalities in malaria prevalence. 
Tropical Medicine & International Health 2008, 13:354-364. 
21. World_Health_Organization(WHO): Handbook on health inequality monitoring with 
a special focus on low-and middle-income countries. WHO; 2013. 
22. Amek N, Vounatsou P, Obonyo B, Hamel M, Odhiambo F, Slutsker L, Laserson K: 
Using health and demographic surveillance system (HDSS) data to analyze the 
geographical distribution of socio-economic status; an experience from 
KEMRI/CDC HDSS. Acta tropica 2015, 144:24-30. 
23. Su-Myat KK, de Tibeiro JJ, Kumar P: An Integrated Approach to Regression 
Analysis in Multiple Correspondence Analysis and Copula Based Models. 
Journal of Statistics Applications & Probability 2012, 1:1. 
24. Niessen LW, Mohan D, Akuoku JK, Mirelman AJ, Ahmed S, Koehlmoos TP, Trujillo 
A, Khan J, Peters DH: Tackling socio-economic inequalities and non-
 51 
 
communicable diseases in low-income and middle-income countries under the 
Sustainable Development agenda. The Lancet 2018. 
25. Were V, Buff AM, Desai M, Kariuki S, Samuels A, Kuile FO, Phillips-Howard PA, 
Kachur SP, Niessen L: Socioeconomic health inequality in malaria indicators in 
rural western Kenya: evidence from a household malaria survey on burden and 
care-seeking behaviour. Malaria journal 2018, 17:166. 
26. Guillot M, Gwatkin DR: The burden of disease among the global poor: current 
situation, future trends, and implications for strategy. 1999. 
27. Household final consumption expenditure per capita in Kenya 
[https://data.worldbank.org/indicator/NE.CON.PRVT.PC.KD] 
28. Chuma J, Okungu V, Molyneux C: The economic costs of malaria in four Kenyan 
districts: do household costs differ by disease endemicity? Malaria Journal 2010, 
9:149. 
29. Houweling TA, Kunst AE, Mackenbach JP: Measuring health inequality among 
children in developing countries: does the choice of the indicator of economic 
status matter? International journal for equity in health 2003, 2:8. 
30. Sherraden M, Gilbert N: Assets and the Poor: New American Welfare Policy. 
Routledge; 2016. 
31. Abdi H, Valentin D: Multiple correspondence analysis. Encyclopedia of 
measurement and statistics 2007:651-657. 
32. Adazu K, Lindblade KA, Rosen DH, Odhiambo F, Ofware P, Kwach J, Van Eijk AM, 
Decock KM, Amornkul P, Karanja D: Health and demographic surveillance in 
rural western Kenya: a platform for evaluating interventions to reduce 
morbidity and mortality from infectious diseases. The American journal of tropical 
medicine and hygiene 2005, 73:1151-1158. 
 52 
 
33. Hamel MJ, Adazu K, Obor D, Sewe M, Vulule J, Williamson JM, Slutsker L, Feikin 
DR, Laserson KF: A reversal in reductions of child mortality in western Kenya, 
2003–2009. The American journal of tropical medicine and hygiene 2011, 85:597-
605. 
34. Odhiambo FO, Laserson KF, Sewe M, Hamel MJ, Feikin DR, Adazu K, Ogwang S, 
Obor D, Amek N, Bayoh N: Profile: the KEMRI/CDC health and demographic 
surveillance system—Western Kenya. International journal of epidemiology 2012, 
41:977-987. 
35. Kenya_National_Bureau_of_Statistics_(KNBS)_and_ICF_Macro: Kenya 
Demographic and Health Survey 2008–09. Calverton, Maryland, USA.2010. 
36. Kenya_National_Bureau_of_Statistics_(KNBS)_and_ICF_Macro K: Kenya 
Demographic and Health Survey 2014. Calverton, Maryland, USA.2015. 
37. Division of Malaria Control: National guidelines for the diagnosis, treatment, and 
prevention of malaria in Kenya. Kenya Ministry of Public Health and Sanitation, 
Nairobi Kenya; 2012. 
38. Kioko U, Riley C, Dellicour S, Were V, Ouma P, Gutman J, Kariuki S, Omar A, 
Desai M, Buff AM: A cross-sectional study of the availability and price of anti-
malarial medicines and malaria rapid diagnostic tests in private sector retail 
drug outlets in rural Western Kenya, 2013. Malaria Journal 2016, 15:359. 
39. Machini B, Nyandigisi A, Kigen S, Memusi D, Kimbui R, Mulinga J: Monitoring 
outpatient malaria case management under the 2010 diagnostic and treatment 
policy in Kenya: progress 2010–2014. Nairobi: Ministry of Health 2014. 
40. Cohen J, Dupas P, Schaner S: Price subsidies, diagnostic tests, and targeting of 
malaria treatment: evidence from a randomized controlled trial. The American 
Economic Review 2015, 105:609-645. 
 53 
 
41. Riley C, Dellicour S, Ouma P, Kioko U, ter Kuile FO, Omar A, Kariuki S, Buff AM, 
Desai M, Gutman J: Knowledge and adherence to the national guidelines for 
malaria case management in pregnancy among healthcare providers and drug 
outlet dispensers in rural, western Kenya. PloS one 2016, 11:e0145616. 
42. Ministry_of_Public_Health_and_Sanitation_(MOPHS): National Malaria Strategy 
2009-2017.  (Control DoM ed. Nairobi, Kenya: Division of Malaria Control; 2009. 
43. Kenya_Ministry_of_Health_(MOH): Kenya Health Policy 2014-2030—Towards 
attaining the highest standard of health.  (health Mo ed. Nairobi, Kenya: Kenya 
Ministry of Health; 2014. 
44. Nam UV: Transforming our world: the 2030 Agenda for Sustainable 
Development. 2015. 
 
 
 
 
 
 
 
 
 
 
 
 54 
 
Chapter 3: Trends in socioeconomic-related health inequality in rural western Kenya: 
data from repeated household malaria surveys 2006–2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 55 
 
Trends in socioeconomic-related health inequality in rural western Kenya: data from 
repeated household malaria cross-sectional surveys from 2006–2013 
Vincent Were1,4$, Ann M. Buff 2, Meghna Desai2, Simon Kariuki1, Aaron Samuels2, Penelope 
A. Phillips-Howard3, Feiko O. ter Kuile3, S. Patrick Kachur2, and Louis Niessen4 
 
1. Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya 
    (vwere@kemricdc.org; skariuki@kemricdc.org) 
2. Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, 
Centers for Disease Control and Prevention, Atlanta, USA 
 (ali3@cdc.gov;mud8@cdc.gov; iyp2@cdc.gov; spk0@cdc.gov )  
3. Liverpool School of Tropical Medicine, Liverpool, United Kingdom (Penelope.Phillips-
Howard@lstmed.ac.uk; Feiko.terKuile@lstmed.ac.uk; Louis.Niessen@lstmed.ac.uk) 
$ Corresponding Author 
Vincent Were 
Kenya Medical Research Institute, Centre for Global Health Research  
P O Box 1578-40100 
Kisumu Kenya 
Email: vincentwere@gmail.com;vwere@kemricdc.org 
Published by BMJ Open 
https://bmjopen.bmj.com/content/bmjopen/9/9/e033883.full.pdf 
 
 56 
 
Abstract 
 
Objective: The objective of this analysis was to examine socioeconomic inequalities in 
malaria indicators from 2006 to 2013 during a period of intensified malaria control 
interventions in Siaya County, western Kenya. 
 
Methods: Data were analyzed from eight independent annual cross-sectional surveys and 
participants were 19, 315 individuals in 7,253 households. The study setting was a health and 
demographic surveillance area of western Kenya. Data collected included demographic 
factors, household assets, and characteristics, a recent history of fever. The primary outcome 
was malaria parasitaemia by microscopy and secondary outcomes were medication usage, 
insecticide-treated bed net (ITN) use, and care-seeking behaviour. A composite 
socioeconomic status (SES) score was created using multiple correspondence analysis of 
household assets. Households were classified into wealth quintiles and dichotomized into 
poorest households (poorest 60%) and less poor households (richest 40%). Adjusted 
prevalence ratios (aPR) were calculated using a multivariate generalized linear model, which 
accounted for household clustering for each year and for the pooled data. 
 
Results: Overall, malaria infection prevalence was 36.5%and higher among poorest persons 
compared to those in less poor (39.9% versus 33.5%, aPR=1.17; 95%CI=1.11-1.23). Care-
seeking (61.1% versus 62.5%, aPR=0.99; 95%CI=0.95-1.03) and use of any medication 
(73.2% versus 76.2%, aPR=0.95; 95% CI=0.92-1.00) was similar among the poor and less 
poor. However, the poorest were less likely to use Artemether-Lumefantrine or quinine for 
pregnant women (18.8% versus 22.1%, aPR=0.81, 95%CI=0.72-0.91). Use of ITNs was 
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lower among the poor compared to less poor (54.8% versus 57.9%; aPR=0.95; 95%CI=0.91-
0.99). 
 
Conclusions: Despite similar ITN use by SES, malaria parasitaemia prevalence was higher 
among the poorest individuals, which might be due in part to a lower likelihood of treatment 
with an effective antimalarial. Although equity was achieved in ITN use, a key malaria 
control intervention, the burden of malaria remains greater among the poor in rural western 
Kenya suggesting additional strategies are necessary to achieve equitable population health 
outcomes. 
Keywords: Socioeconomic, equity, inequalities, malaria, medication, Kenya 
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Article Summary 
Strengths and limitations of the study  
 Eight years of repeated annual cross-sectional pooled data provided more power to 
assess socioeconomic inequalities and equity 
 Equity assessment has used multivariate regression models accounting for clustering 
 Longitudinal monitoring provided an opportunity to monitor the effectiveness of 
policy intervention over time 
 The main limitations include; Use of cross-sectional surveys prevented any evaluation 
of cause-and-effect of SES on malaria indicators over time and  
  Only households with children <5 years and a portion of persons ≥5 years were 
included in the surveys based on protocol-specific objectives due to logistics reasons.  
The transition from chapter 2 to chapter 3 
Results presented in chapter 2 are from a single cross-sectional study conducted in mid-2012. 
However, the results presented in chapter 3 is a pooled analyses of repeated cross-sectional 
surveys from 2006 to 2013.  
 
Background 
Malaria is a global health problem with 3.2 billion people at risk of malaria infection.1 The 
World Health Organization (WHO) estimated that between 2010- 2016, 216 million (95% 
CI=196-263 million) malaria cases occurred globally and incidence rates fell by 18% globally 
and by 20% in Africa, while malaria mortality rates fell by 25% globally and by 66% in the 
African region1. Sub-Saharan Africa is disproportionally affected, and despite falling 
mortality, over 90% of the estimated 445,000 malaria deaths worldwide occurred in Africa in 
2016.[33] In Kenya, malaria remains a major cause of morbidity and mortality with more 
than 70 per cent of the population at risk[4]. In 2015, the prevalence of microscopically-
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confirmed malaria among children <15 years of age was eight per cent nationally and 27% in 
the lake-endemic region of western Kenya[4]. 
Government of Kenya (GoK) and international partners spent approximated USD 810million 
on malaria preventions and treatment programmes[51] which included distribution of long-
lasting insecticide-treated bed nets (ITNs), indoor residual spraying (IRS) in selected areas, 
intermittent preventive treatment during pregnancy (IPTp) in malaria-endemic areas, and 
prompt and effective malaria case management [4, 52, 53]. Since 2014, there have been key 
policy changes in Kenya. First-line treatment for malaria changed to artemisinin-based 
combination therapies (ACT) [54-56]. By 2006, Artemether-Lumefantrine (AL), the first-line 
ACT, started becoming available in the public sector at no cost to patients, and the first free 
mass net distribution campaign targeting children <5 years and pregnant women were 
conducted in malaria-endemic and epidemic-prone areas [40, 56, 57]. The second free mass 
net distribution campaign, with a goal of universal coverage (i.e., one net per two people per 
household), was conducted in a phased approach from 2011 to 2012, with households in 
western Kenya receiving LLINs in 2011[58]. Equitable distribution of health services or 
interventions is a principle advocated for in most national policy documents to achieve 
universal health coverage [24]. A recent paper outlined the five Sustainable Development 
Goals (SDGs) set of targets that relate to the reduction of health inequalities nationally and 
worldwide [26]. The study listed the SDG targets as poverty reduction, health, and wellbeing 
for all, equitable education, gender equality, and reduction of inequalities within and between 
countries[26].  
However, despite a  national policy of free antimalarial medications for children <5 years in 
the public sector in Kenya, access, and utilization of health services has been shown to vary 
substantially across socioeconomic groups, which undermines achieving health equity[59].  
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A key pillar of the Kenya Health Policy 2014–2030 is to improve health indicators through 
equitable distribution of health services and interventions in line with the Sustainable 
Development Goal (SDG) to achieve universal access to safe, effective, quality and 
affordable health care services for all [15].  
Health inequality and equity data on malaria indicators are often collected but not analyzed 
from an economic or equity perspective. Yet, such data and analyses are important for 
monitoring health inequalities and assessing the impact of malaria control interventions at the 
microeconomic level[60]. However, analysis of longitudinal data and multiple repeated 
survey data has not been done especially in malaria-endemic areas to assess the potential 
effect of the intensified control program of equity at the household over time.  The specific 
objectives of this analysis were to evaluate the existence of socioeconomic inequalities and 
vertical equity patterns in relation to malaria indices using data from annual malaria surveys 
conducted in a malaria-endemic region of western Kenya between 2006–2013. 
 
Methods 
Study design and site 
Independent annual community-based, cross-sectional surveys were conducted between 2006 
and 2013, between the months of April to July within the Kenya Medical Research Institute 
(KEMRI) and Centers for Disease Control and Prevention (CDC) Health and Demographic 
Surveillance System (HDSS) in Siaya County in western Kenya. The HDSS has been 
described in detail elsewhere.[39, 41]Briefly, HDSS covers a population of approximately 
223,000 people residing in 393 villages located in three of six sub-counties of Siaya County, 
an area of approximately 700 km2 along the shores of Lake Victoria. The vast majority of the 
population are subsistence farmers and fishermen. Health indicators in Siaya County, part of 
the former Nyanza Province, are poor compared to national standards[42, 43]. Nyanza 
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Province had the highest rates of child mortality and an estimated 60% of the population 
lived below the poverty level during the survey period.[61] 
 
Population and sampling strategies  
For each year from 2006-2013, different sampling strategies were selected for logistical 
purposes. A systematic sampling technique was used from a sample frame of eligible 
households and individuals enrolled in HDSS except in 2009 when a cluster sampling was 
used. Households were selected for participation if they had children <5years because of 
many malaria control interventions that targeted this age group. Surveys were conducted in 
Rarieda, Gem and Alego-Usonga sub-counties in Siaya County except in 2006 when Alego-
Usonga sub-county was not included. The sample size for each year is shown in Table 1.  
 
Data collection 
During the surveys, study participants were interviewed by trained staff using personal digital 
assistants (PDA) and tablets. Data collected included demographic factors, socioeconomic 
factors including asset ownership, characteristics and utilities, care-seeking behaviours, 
history of fever in the 2 weeks before the survey, ITN use and antimalarial medication use 
both recommended and non-recommended by polices.  
During each survey, a blood specimen was obtained from all individuals providing consent in 
the sampled households using a finger prick and used for measurement of haemoglobin 
(HemoCue®; Ängelholm, Sweden) and to measure malaria parasitaemia by rapid diagnostic 
test(RDT) (Carestart™ Malaria HRP-2/pLDH (Pf/PAN) Combo, Somerset, NJ, USA). 
Individuals with a positive malaria RDT were treated in accordance with the Kenya national 
malaria treatment guidelines[44, 55, 57]. Thick and thin blood smears were obtained for 
malaria species’ identification and parasite density.  
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Data management and analysis 
Data coding, recoding, merging and analysis were conducted in Stata 14 (StataCorp, College 
Station, TX). A generalized linear model (GLM), using a Poisson distribution with a log-link 
function, was used to estimate adjusted prevalence ratios (aPR) accounting for clustering at 
the household level in multivariate analysis for pooled data which addresses selection bias. 
Study outcomes included malaria parasitaemia infection, care-seeking, medication, and ITN 
use. The independent variables were SES, study areas (sub-counties), sex and age groups (<5, 
5–14 and ≥15 years. SES indices were generated using MCA using the following variables; 
Occupation of household head, the primary source of drinking water, and type of cooking 
fuel, ownership of household assets and ownership of livestock. The households were 
categorized into five socioeconomic quintiles and then classified into two groups for ease of 
comparisons. The first three poor quintiles were classified as the ‘poorest’ and the fourth and 
fifth quintiles classified as the ‘less-poor’ [22, 23, 62].  
  
Results 
Characteristics of study participants  
A total of 19,315 individuals in 7,253 households were surveyed between 2006 and 
2013.Overall, 33.9% were children aged <5 years, 26.6% were children aged 5-14 years and 
the remaining 39.5% were 15 years old adults. Sample size in 2006 to 2013 were (2006 
n=1,113; 2007 n =1,270; 2008 n=1,830; 2009 n=2,508; 2010 n=5,334; 2011 n=2,129; 2012 
n=2,719; 2013 n=2,412 and the mean annual sample was 2414 (Table 1). 
 
Descriptive epidemiology 
The prevalence of parasitaemia microscopy was 36.5% overall with substantial variation by 
age group (38.4% in children <5 years; 56.9% in children 5–14 years; 20.9% for adults ≥15 
 63 
 
years). The prevalence of malaria parasitaemia was relatively stable between 2006 (38.3%) 
and 2011 (39.8 %) but reduced from 36.3% in 2012 to 34.5% in 2013. The proportion of 
individuals who received the first-line antimalarial medication, AL, in the two weeks prior to 
the survey increased from 0% in 2006to 44.0 %in 2013(Table 1). 
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Table 1 Socio-demographic characteristics of study populations in Siaya County, Kenya, 2006-2013  
Year 2006 2007 2008 2009 2010 2011 2012 2013 Total 
Total a 
 
1,113 
 
1,270 1,830 2,508 5,334 2,129 2,719 2,412 19,315 
Age in years 
Mean (SD)b 
18.7 
 (20.1) 
16.2 
(18.2) 
22.0 
(31.4) 
20.4 
(20.8) 
18.5 
(19.2) 
16.7 
(18.9) 
13.5 
(17.3) 
13.9 
(17.6) 
18.2 
(21.3) 
Percent % % % % % % % % % 
Malaria infection           
(Overall) 38.3 29.6 27.5 39.0 39.7 39.2 34.1 34.5 
 
36.5 
<5 years 40.6 35.0 32.9 43.6 42.6 42.4 35.5 34.9 38.4 
5–14 years 62.7 50.8 47.4 60.7 60.2 55.2 60.3 50.8 56.9 
≥15 years 21.9 15.7 14.9 23.3 21.6 26.2 21.2 22.2 20.9 
Fever in last 2 weeks 33.8 50.6 39.3 46.3 50.9 50.8 53.9 51.9 49.3 
Sought care  61.0 50.0 68.8 40.6 66.9 70.6 70.4 69.6 47.6 
Medications for fever 88.7 76.8 75.3 33.6 42.3 46.9 46.3 43.5 46.8 
AL/Coartem c 0.0 4.7 6.0 9.0 14.7 21.4 25.3 44.0 18.3 
Chloroquine 2.1 1.3 2.1 2.9 0.6 0.2 0.4 0 0.93 
Amodiaquine 3.4 8.1 7.7 5.8 3.4 2.2 1.2 0.8 3.4 
Fansidar/SP d 5.6 9.8 3.2 11.8 - 0 0 0 2.5 
Panadol 58.4 54.5 41.1 42.9 48.6 58.2 34.4 28.7 46.0 
Quinine 2.6 1.6 1.8 5.4 3.6 1.9 0.82 0.75 2.5 
Septrin - - - 1.9 5.4 7.7 6.0 6.1 3.4 
ITN use 41.4 25.5 37.1 37.6 56.5 62.2 65.0 77.4 55.5 
Wealth quintiles (SES) e          
Poorest 1 20.6 20.1 21.1 20.2 20.3 20.3 20.3 20.6 20.4 
2 20.0 21.1 19.2 19.9 19.8 19.7 19.7 19.5 19.9 
3 20.2 19.0 19.7 19.9 20.4 19.9 19.9 20.6 20.0 
4 19.5 20.1 20.0 20.0 19.6 20.8 20.8 19.6 20.1 
Least Poor 5 19.6 19.8 19.9 20.0 20.0 19.1 19.1 19.8 19.7 
a  <5 year: n=6,523 (33.9%); 5-14 years: n=5,116 (26.6%); ≥15 years: n=7,584 (39.5%); missing age: n=92  
b SD=standard deviation  c AL=artemether-lumefantrine d SP=Sulphadoxine-Pyremethamine  e SES=socioeconomic status 
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Association of malaria infection, care-seeking, medication use, and ITN use with socioeconomic status 
The prevalence of malaria infection was significantly higher among poor individuals compared to less-poor overall (39.9% versus 33.5%; 
aPR=1.17; 95%CI=1.11-1.23). The prevalence of malaria infection was also significantly higher in poor individuals in each age group (children 
<5years: aPR=1.20[95%CI=1.11-1.31]; children 5-14 years: aPR=1.13[95%CI=1.06-1.21]); adults≥15years: aPR=1.18[95%CI=1.05-1.33]). There 
was no clear trend in malaria prevalence by SES either overall or stratified by age group over time for the pooled analysis (Figure 1 and Table 2).  
 
Figure 1. Patterns of adjusted prevalence ratios for malaria infections in western Kenya: 2006-2013 
aPR =adjusted prevalence ratio for the poorest compared to the less poor; CI =confidence interval; aPR=1 is the reference category for less poor 
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Table 2 Prevalence of malaria infection by household socioeconomic status and age group in Siaya County, western Kenya from 2006 to 2013 
  Year 2006 2007 2008 2009 2010 2011 2012 2013 Total 
Overall N 690 707 677 1629 2681 991 2228 1778 11383 
Poorest  % 183/435(42.1) 103/353(29.3) 106/361(29.4) 350/870(40.2) 619/1363(45.4) 240/536(44.8) 401/1070(37.5) 319/825(38.7) 2321/5813(39.9) 
Less Poor % 90/255(35.3) 99/354(28.0) 72/316(22.8) 286/761(37.6) 498/1318(37.8) 183/455(40.2) 338/1158(29.2) 300/953(31.5) 1866/5570(33.5) 
 aPRⱡ 1.05 1.1 1.32 1.02 1.17 1.05 1.23 1.21 1.17 
 (95%CI) (0.83-1.32) (0.83-1.46) (1.01-1.72) (0.90-1.17) (1.06-1.29) (0.90-1.23) (1.08-1.41) (1.06-1.39) (1.11-1.23) 
           
<5 years N 169 162 127 393 695 407 1177 801 3931 
Poorest % 54/121(44.6) 34/93(36.6) 27/73(37.0) 100/225(44.4) 189/392(48.2) 107/224(47.8) 218/586(37.2) 150/393(38.2) 879/2107(41.7) 
Less Poor % 17/48(35.2) 21/69(30.4) 12/54(22.2) 69/168(41.1) 123/303(40.6) 73/183(39.9) 177/591(30.0) 137/408(33.6) 629/1824(34.5) 
 aPRⱡ 1.1 1.17 1.79 1.06 1.17 1.18 1.22 1.13 1.2 
 (95%CI) (0.69-1.17) (0.72-1.89) 1.03-3.09) (0.82-1.36) (0.98-1.39) (0.94-1.48) (1.03-1.45) (0.93-1.37) (1.11-1.31) 
           
5-14 years N 201 228 200 487 911 257 427 403 3114 
Poorest % 83/131(63.4) 53/99(53.5) 49/102(48.0) 152/268(56.7) 303/457(66.3) 91/145(62.8) 126/203(62.1) 105/189(55.6) 962/1594(60.4) 
Less Poor % 46/70(65.7) 55/129(42.6) 43/98(43.9) 138/219(63.0) 258/454(56.8) 67/112(59.8) 101/224(45.1) 102/214(47.7) 810/1520(53.3)* 
 aPRⱡ 0.92 1.26 1.1 0.91 1.16 0.99 1.8 1.2 1.13 
 (95%CI) (0.73-1.17) (0.91-1.73) (0.80-1.52) (0.78-1.07) (1.04-1.30) (0.79-1.24) (1.31-2.74) (0.98-1.47) (1.06-1.21) 
           
≥15 years N 320 316 345 751 1075 327 624 574 4315 
Poorest % 46/183(25.1) 16/160(10.0) 15.8 98/377(26.0) 127/514(24.7) 42/167(25.2) 57/281(20.3) 64/243(26.3) 479/426(22.7) 
Less Poor % 27/137(19.7) 23/156(14.7) 9.9 79/374(21.1) 117/561(20.9) 43/160(26.9) 60/343(17.5) 61/331(18.4) 426/2223(19.2) 
 aPRⱡ 1.27 0.7 1.57 1.22 1.16 0.87 1.1 1.43 1.18 
  (95%CI) (0.83-1.95) (0.37-1.34) (0.89-2.77) (0.94-1.60) (0.93-1.46) (0.60-1.27) (0.77-1.57) (1.07-1.94) (1.05-1.33) 
ⱡ aPR  adjusted prevalence ratio; CI confidence l interval; covariates in regression model included socioeconomic status, age group, sub-county, sex and 
insecticide-treated bed net use 
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For the pooled data, there was no significant difference in the proportion of individuals who sought care for 
illness between poor and less-poor households (61.1% versus 62.5%, aPR=0.99 [0.95-1.03]) overall or by 
age group and year (Table 3). Overall, medication use was similar among the poorest individuals and less 
poor (73.2% versus 76.2%, aPR=0.95 [0.92-1.00]). However, the poorest individuals were less likely to use a 
recommended first-line antimalarial medication (i.e., AL or quinine for pregnant women) among those who 
reported fever in the 2 weeks prior to the survey (18.8% versus 22.1%, aPR=0.81 [0.72-0.91]). Poorest 
households were slightly less likely to report ITN usage the night prior to the survey(55.2% versus 57.8%, 
aPR=0.95 [0.91-0.99]).  
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Table 3  Care seeking, medication and ITN use by household socioeconomic status in Siaya County, western Kenya from 2006 to 2013   
  Year 2006 2007 2008 2009 2010 2011 2012 2013 Total 
Care Seeking           
 n 1044 707 1145 1631 1343 498 1182 893 8443 
Poorest % 401/647(62.0) 164/354(46.3) 416/772(53.9) 357/652(54.8) 470/886(53.1) 189/350(54.0) 411/825(49.8) 277/617(44.9) 2685/5103(52.6) 
Less Poor % 249/397(63.0) 189/353(53.5) 174/373(46.7) 513/979(52.4) 250/457(54.7) 94/148(63.5) 187/357(52.4) 134/276(48.6) 1790/3340(53.6)* 
 aPRⱡ 0.97 0.84 1.11 1.04 0.96 0.9 0.95 0.91 0.99 
 (95%CI) (0.86-1.11) (0.70-1.00) (1.00-1.23) (0.90-1.20) (0.88-1.05) (0.80-1.01) (0.87-1.04) (0.85-1.04) (0.95-1.03) 
Took any 
medications for 
fever           
 n 138 111 176 736 1343 497 1180 834 5441 
Poorest % 77/118(65.3) 31/73(42.5) 60/127(47.2) 288/536(53.7) 501/944(53.1) 205/374(54.8) 447/904(49.6) 307/665(46.2) 2588/5018(51.6)* 
Less Poor % 10/20(50.0) 15/38(39.5) 32/49(65.3) 116/200(58.0) 218/399(54.6) 78/123(63.4) 151/276(54.7) 83/169(49.1) 2853/5651(50.5)* 
 aPRⱡ 1.03 0.74 0.72 0.91 0.94 0.85 0.94 0.99 0.95 
 (95%CI) (0.80-1.33) (0.43-1.27) (0.51-1.02) (0.78-1.06) (0.84-1.05) (0.75-0.97) (0.87-1.00) (0.74-1.11) (0.92-1.00) 
Took AL or Quinine          
 n 138 111 176 647 1343 374 904 665 4358 
Poorest % 4/5(80.0) 1/4(25.0) 6/12(50.0) 49/88(55.7) 105/235(44.7) 44/85(51.8) 189/404(46.8) 133/297(44.8) 531/1130(46.9)* 
Less Poor % 83/133(62.4) 45/107(42.1) 86/164(52.4) 292/559(52.2) 614/1108(55.4) 161/289(55.7) 258/500(51.6) 174/368(47.3) 
        
1713/3228(53.1)* 
 aPR 1.29 1.03 0.78 1.13 0.66 0.95 0.95 0.92 0.81 
 (95%CI) (0.30-5.5) (0.37-2.89) (0.29-2.09) (0.74-1.72) (0.51-0.85) (0.66-1.38) (0.76-1.20) (0.77-1.09) (0.72-0.91) 
           
ITN Use n 1044 707 1145 1631 2726 1003 2228 1811 12295 
Poor % 256/425(60.2) 110/198(55.6) 232/455(50.9) 455/844(53.9) 795/1580(50.3) 306/611(50.1) 676/1449(46.7) 625/1355(46.1) 3455/6313(54.7)* 
Less Poor % 394/619(63.7) 243/509(47.7) 358/690(51.9) 415/787(52.7) 598/1146(52.2) 236/392(60.2) 394/779(50.6) 220/456(48.3)   3462/5982 (57.9)* 
 aPRⱡ 0.91 1.25 0.97 1.02 0.96 0.85 0.96 0.98 0.95 
  (95%CI) (0.71-1.16) (0.83-1.87) (0.80-1.18) (0.90-1.18) (0.87-1.05) (0.75-0.96) (0.87-1.05) (0.91-1.05 (0.91-0.99) 
ⱡ aPR  adjusted prevalence ratio; CI confidence l interval; covariates in regression model included socioeconomic status, age group, sub-county, sex 
and insecticide-treated bed net use; *  Cochran Armitage trend, significant result at p<0.05 
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Discussion  
A key principle of the Kenya Health Policy 2014–2030 is to achieve equity in the distribution of health 
services and interventions by 2030 [49]. Monitoring socioeconomic trends in the uptake and utilization of 
malaria interventions are important to identify gaps in equity at the microeconomic level.  
Individuals in the poorest households had a higher burden of malaria infection compared to those from less-
poor households; this was consistent across age groups and over time. No significant differences were 
observed in care-seeking behaviour between socioeconomic groups. However, persons from poor households 
were less likely to use the most effective antimalarial medications, AL and quinine, which have been the 
recommended first-line therapies in Kenya since 2006[44, 57]. Although differences in ITN use between the 
poor and less poor were statistically significant, they were very small which suggests that ITNs are equitably 
distributed and used among these relatively poor rural communities.  
 
The results are comparable to findings from the Kenya malaria indicator surveys, which showed that 
increased care-seeking behaviour for fever, use of first-line antimalarial medications and ITN ownership and 
use between 2007 and 2015as well as higher malaria prevalence in the lower wealth quintiles [4, 52, 53]. In 
2011, the national malaria control program launched the first nationwide mass distribution of free ITNs with 
the goal of universal coverage[58] and as a result, this study showed an increase in the use of ITNs across the 
study period and near equity in ITN use across SES. Results are also comparable with a multi-country study 
which showed that household ownership of insecticide-treated mosquito nets (ITNs) varied from 5% to 
greater than 60%, and was equitable by urban/rural and wealth quintile status among 13 (52%) of 25 
countries[17].  
Although there were no significant differences in care-seeking behaviour for fever between individuals from 
poor compared to less-poor households, poor individuals were less likely to use the recommended first-line 
antimalarial medications, AL and quinine for pregnant women[44, 55, 57]. A previous study has suggested 
that the use of AL was higher in children from the lowest wealth quintile compared to the highest wealth 
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quintile because of policies that systematically affected access to malaria treatment for children[31]. Prior to 
the 2010 introduction of the Affordable Medicine Facility– malaria (AMFm) in Kenya, AL was significantly 
more expensive than other non-recommended antimalarial medicines in the private sector[63]. Evidence from 
a study from rural western Kenya showed that when adults are uncertain that fever is due to malaria, they 
tend to choose the lowest-priced antimalarial medicine from private-sector pharmacies and retail outlets[47]. 
Therefore, when antimalarial medications were not available in public health facilities during the study 
period, individuals from poor households might have preferentially purchased non-recommended 
antimalarial medications in the private sector due to lower prices[40]. But despite equity, universal coverage 
or use does not appear to have been attained. Therefore, even perfectly equitable access to interventions 
could have an inequitable impact since the risk is so strongly linked to poverty.  
Strengths and limitations 
The main strength is the use of eight years of pooled data which provided more power to assess 
socioeconomic inequalities and equity. Equity assessment had used multivariate regression models 
accounting for clustering and lastly longitudinal monitoring provides an opportunity to monitor the 
effectiveness of policy intervention over time. The study has three main limitations. First, the findings were 
based on data from cross-sectional surveys preventing any evaluation of cause-and-effect of SES on malaria 
indicators over time. Second, only households with children <5 years were included in the surveys based on 
protocol-specific objectives. Although all children <5 years in a household were surveyed every year, only a 
small proportion of persons ≥5 years were included in the survey samples and lastly these results are 
generalizable to study area and not nationally.  
Conclusion 
Despite equity ITN use and care-seeking for fevers, malaria parasitaemia prevalence remains highest 
amongst poorest individuals in all age groups, which might be due in part to a lower likelihood of treatment 
with effective antimalarial medications when compared to less-poor individuals. Although equity has been 
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achieved in ITN use, the level of usage still falls short of universal expectations, suggesting that additional 
strategies are necessary to achieve equity in malaria controls or pro-poor population health outcomes. 
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Abstract 
Background: Mathematical simulations have shown that mass testing and treatment (MTAT) can have a 
significant impact on malaria transmission, particularly in areas with the hypo-endemic transmission or low 
to moderate transmission. However, there is limited data on the equity impact of MTAT on malaria indices in 
households. The aim of this study was to asses the equity effect of MTAT on the prevalence of malaria 
infection, care-seeking, use of medications, and expenditure on treatment and on disability-adjusted life years 
(DALYs) between the poor and less poor households in a malaria-endemic region of western Kenya.  
 
Methods: MTAT was a community-based cluster-randomized trial consisting of three cross-sectional 
surveys done at baseline in mid-2013 and endline in 2015 targeting persons in 400 compounds who lived 
within 3 km of 10 selected health facilities within the health and demographic surveillance system (HDSS) in 
Siaya County, western Kenya.  It was implemented in 10 intervention clusters which received mass testing 
and treatment in 3 rounds per year. Both primary data on morbidity and secondary data on malaria-related 
mortality were used to estimate outcomes. We used multiple correspondence analyses (MCA) to establish 
wealth quintiles (Q1- Q5) of households, which were collapsed into poor (Q1-Q3) and less poor (Q4-Q5). A 
difference in difference (DID) approach was integrated into a generalized linear model (GLM), with a poison 
distribution and a log link function, to account for clustering when modelling net equity effect. Adjusted 
prevalence ratios (aPR) are reported. The concentration index was used to measure inequalities. DALYs were 
calculated as a sum of years of life lost (YLL) and years lived with disability (YLD) adjusted, for each age  
group and sex. Reference life-table for Kenya has been used to estimate life expectancies. The cost of 
treatment was converted into US Dollars. 
 
Results: Parasitemia malaria prevalence was not different between 2013 and 2015 (35.9% versus 35.3%, 
respectively p=0.829). Uptake of anti-malarial drugs declined by 26% amongst individuals in poorer 
households and by 30% in less poor households. Overall net uptake of drugs declined by 28%.  Overall 
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parasitemia reduced by 0.5% but the reduction was not significant in the regression model. Children <5 years 
of age had the highest malaria burden and more DALYs were lost by females than males. However, no SES 
group dominated DALYs lost, representing equity gains for the poorest.  
 
Conclusion: After two years of implementation, MTAT resulted in no change in the malaria burden in the 
overall population. However, there was no difference in access to medication and no change in DALYs lost 
between SES groups.   Despite not being effective in reducing overall prevalence, the poorest and less poor 
individuals benefited from access to ITN and medication use.  
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Introduction 
Malaria is one of the most important diseases in many low- and middle-income countries, primarily affecting 
children and pregnant women in sub-Saharan Africa. In 1999, approximately 60% of global malaria deaths 
were concentrated among the poorest 20% of the global population[64]. In sub-Saharan Africa, 3.1% of all 
disability-adjusted life-years (DALYs) were lost to malaria in 2002[2]. Although preventable and treatable, 
the number of deaths due to malaria remains high. In 2015, there were an estimated 429,000 malaria deaths 
(range: 235,000–639,000) worldwide, and most (92%) of these deaths occurred in Africa[33]. Malaria is a 
huge economic burden to households and to economies [13, 65]. It has been described as a disease of poverty 
and current control and elimination efforts are considered a contribution to effective and sustained poverty 
alleviation[66]. In Kenya, malaria remains a major cause of morbidity and mortality with more than 70% of 
the population at risk[67]. In 2015, the prevalence of microscopically-confirmed malaria among children <15 
years of age was 8% nationally and 27% in the lake-endemic region of western Kenya.[68]. There has been 
scale-up of malaria control interventions including long-lasting insecticide-treated nets (LLINs), indoor 
residual spraying (IRS), improved case management with rapid diagnostic tests (RDTs), Artemisinin-based 
combination therapy (ACT) and intermittent preventive treatment (IPT) for high-risk groups [33]. These 
efforts are predicted to have had an effect on the burden resulting in an estimated 40% decline in the malaria 
case burden in Africa from the year 2000 to 2015[5, 56, 69].  
Despite the scale-up of these malaria control interventions, the prevalence of malaria has remained relatively 
high since 2009 in western Kenya[68]. It is known that individuals with asymptomatic parasitemia play an 
important role in sustaining malaria transmission during the dry season when the population of Anopheles 
mosquitoes has decreased, and provide a parasite reservoir at the beginning of the wet season when 
anopheles populations rebound[70]. Asymptomatic Plasmodium infections may occur in between 12% and 
39% of the population and systematic identification and treatment of individuals with asymptomatic 
infections could reduce transmission of malaria.[71, 72].  One strategy under evaluation is the community-
based mass testing and treatment (MTAT)[5], in which individuals are tested and those who test positive but 
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have not shown any symptom of malaria are given ant- malarial drugs to clear the parasitaemia in their blood 
system. Mathematical simulations have shown that MTAT can have a significant impact on malaria 
transmission, particularly in areas with the hypoendemic transmission or low to moderate transmission 
achieved through vector control [71, 73].  
Having identified a range of interventions with proven efficacy, the challenge remains to scale-up their 
implementation in a sustainable, cost-effective and equitable manner[74]. Empirical studies of who profits 
from the distribution of public goods (whether drugs or bed nets) suggest that, even though such programs 
are always intended for the poor, they more often than not tend to benefit the rich more than the poor[75]. 
Socioeconomic inequalities are known barriers to successful malaria elimination and control of other 
diseases.[76, 77]. Complete elimination of malaria will clearly achieve equity, however, an inadvertent 
unequal distribution of benefits needs to be avoided to ensure that the situations of those most disadvantaged 
are not compromised further[78]. Most equity gains from the receipt of goods would result in a successful 
universal coverage, which is already part of many control strategies however, this is not unique to 
elimination. However, the overall, appraisal of these strategies has provided limited information [78]. A 
recent systematic review on costs and cost-effectiveness of malaria control intervention had established that 
from a health system perspective,  the median financial cost of protecting one person for one year was $2.20 
(range $0.88-$9.54) for LLTNs, $6.70 (range $2.22- $12.85) for IRS, $0.60 (range $0.48-$1.08) for IPT in 
infants, $4.03 (range $1.25-$11.80) for IPT in children, and $2.06 (range $0.47-$3.36) for IPT in pregnant 
women[74]. The median financial cost of diagnosing a case of malaria was $4.32 (range $0.34-$9.34). The 
study also established that the median financial cost of treating an episode of uncomplicated malaria was 
$5.84 (range $2.36-$23.65) and the median financial cost of treating an episode of severe malaria was $30.26 
(range $15.64-$137.87) [74]. However, there is a need for the establishment of an equity effect of control 
interventions to assess progress towards achieving sustainable development goals aimed at ensuring equity 
gaps are reduced [21]. Current costs and cost-effectiveness analyses have not taken socioeconomic 
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differences in access and utilization of malaria control interventions into account and still remain an area of 
further research [6, 77-80]. 
The disability-adjusted life year (DALY) is a summary measure of public health widely used to quantify the 
burden of disease[81]. In the DALY philosophy, every person is born with a certain number of life-years 
potentially lived in optimal health. People may lose these healthy life years through living with illness and/or 
through dying before a reference life expectancy [81]. DALY estimates are a sum of morbidity and mortality 
and measure the total health status of populations rather than the effects of either morbidity or mortality 
separately [82]. 
The concentration index is defined as twice the area between the concentration curve and the line of equality 
(the 45-degree line)[83]. The concentration index in this paper has been used to measure the socioeconomic 
difference in malaria-related outcomes between the poor and the least poor households. The concentration 
index varies from +1 to -1. The negative sign indicates that the health variable is concentrated among the 
poor while the positive sign shows that it is concentrated among the rich. The larger the magnitude of the 
concentration index, the greater is the inequality in the health variable A concentration index of 0 shows that 
there is no socioeconomic-related inequality in the health variable while a concentration index of either +1 or 
-1 indicates a perfect inequality in favour of the rich and the poor groups respectively. A value of zero 
implies a complete lack of inequalities and hence the health variable is equitable.  
While previous studies have focused on the cost-effectiveness of malaria control interventions, the data on 
the assessment of the equity impact of malaria control interventions at the microeconomic level is still 
lacking. The current analysis was aimed at assessing the equity effect of MTAT as malaria control 
intervention on prevalence of infection,  care-seeking, medication use, DALYs lost or gained, expenditure on 
medication, comparing differences between the poor and less poor at the household level. 
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Methods and materials 
Study site and population  
The methodology for this study has been described elsewhere [5]. In brief, this study was conducted within 
the Health and Demographic Surveillance System (HDSS) of KEMRI/CDC in Siaya County, western Kenya. 
Communities surrounding a sub-sample of 10 health facilities were selected for inclusion. The selected 
villages were within 3km of each health facility. All households within the study area were enumerated and 
GPS-mapped.  
Residents are mainly of the Luo ethnic group who earn their living through subsistence farming and small 
businesses. Malaria transmission in the area is high and perennial, with peak transmission in May–July and in 
October-November. Plasmodium falciparum is the dominant malaria species, and the estimated EIR in this 
area, where household ITN ownership is over 80%, and use among children under 5 years old is over 60%, is 
<20 infectious bites per person per year (Bayoh, unpublished data). ACTs (artemether-lumefantrine) were 
introduced as the first-line treatment of uncomplicated malaria provided in government and mission health 
facilities in July 2006 [44].  
 
Study design 
MTAT was a community-based cluster-randomized trial consisting of three cross-sectional surveys done at 
baseline in mid-2013 and endline in 2015 targeting persons in 400 compounds who lived within 3 km of 10 
selected health facilities within the health and demographic surveillance system (HDSS) in Siaya County, 
western Kenya.  It was implemented in 10 intervention clusters which received mass testing and treatment in 
3 rounds per year. 
After appropriate sensitization, all households within the selected communities were invited to participate in 
the trial. Around each of the 10 health facilities, approximately one-third of the communities were randomly 
allocated to the intermittent community test and treat (MTAT) and the other two-thirds to the control arm. To 
avoid potential contamination between the intervention and control arms, a buffer was designated within each 
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study area so that only individuals/houses living in the core area are to be included in evaluation activities. 
To evaluate the equity effects of MTAT intervention data from three rounds of cross-sectional surveys was 
analyzed between the baseline, midline, and endline of the intervention. The collected data were subjected to 
equity analysis to compare the level of disparity in malaria-related outcomes between the baseline and end 
line. 
 
Data collection methods  
The cross-sectional surveys were conducted at baseline in 2013 and at endline 2015 in communities that were 
selected for MTAT. During each cross-sectional survey, selected participants were tested for malaria 
parasitemia using the Kenya Ministry of Health recommended rapid diagnostic tests, or RDTs (currently, 
CareStart Malaria HRP2/ pLDH Pf). Women of childbearing age who were not visibly pregnant were tested 
with either a urine pregnancy test or malaria and pregnancy combo RDT test depending on its availability. 
Residents who tested positive for malaria by RDT were provided with ACTs, excluding women in their first 
trimester of pregnancy who received quinine as per national guidelines. Because pregnant women and young 
infants are at higher risk of infectious febrile diseases, all pregnant women, regardless of gestational age, and 
all children <3 months of age with a history of fever or a positive RDT test, were referred to a health facility 
for full assessment and treatment, even if treatment has been provided. Likewise, anyone who had a fever 
and was RDT negative was referred to a health facility for care.  All participants in the intervention arm were 
screened and treated with an ACT for malaria; at two to three-time points in the subsequent years, 2014 and 
2015, ideally occurring during the low transmission season. The non-intervention arm received standard of 
care, which is the treatment of symptomatic malaria cases presenting at local health facilities [5].  
Following informed consent/assent cross-sectional surveys were conducted in all communities within the 
core area surrounding the selected health facilities.  A total of 400 compounds were randomly selected in the 
study area, 200 from intervention and 200 from control arms. All residents of the compounds who have been 
resident in the HDSS for at least 4 months were included in the study. Questionnaires were programmed for 
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use on PDA and tablets using ODK programming software and administered to the participants. The 
variables collected included socio-demographics, history of pregnancy, a recent history of fever (prior 2 
weeks and 48 hours) and antimalarial treatment, use of and opinions about preventive interventions such as 
LLITNs, IPTp, residual spray, and repellent use. Data was also collected on all concurrent medications that 
may have an impact on malaria parasitemia within 14 days prior to the survey. Data socioeconomic variables 
were also collected. All individuals included in the cross-sectional survey were tested for malaria by RDT 
and treated if positive. Blood samples were collected for detection of P. falciparum (both asexual and sexual 
stage parasites) by microscopy [5].  
 
Definition of equity effect 
Equity effect is used in this context to refer to ‘lack of statistically significant difference in health events 
between poorest and less poor individuals’. When the estimate of concentration index and 95% confidence 
intervals range from negative to positive, we have reported lack of socioeconomic inequalities and used this 
interpretation as a proxy to refer to equity effect from a provider perspective”. Differences that exist between 
socioeconomic groups may be considered inequities if they are unfair to the poorest individuals and creates a 
barrier to achieving universal health coverage. MTAT intervention was delivered by the program to the 
community and the effect was ease in access of medicines and ITNs to the individuals. In this analysis, when 
socioeconomic differences in the prevalence of health events are not evident, we have reported an equity 
effect. 
 
Data management and analysis 
Data recorded on the personal digital assistants and tablets were downloaded each evening into a secured 
access database by the data team. The collected data was thoroughly checked by the data team for 
inconsistent and inaccurate entries. The inconsistencies were resolved by sending queries forms to be 
responded to by the field teams. SAS codes and Microsoft Access queries were used to clean the data. 
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Descriptive statistics and frequency distributions were used to describe the prevalence and socio-
demographic factors.  
Using the MCA model, households were categorized into five socio-economic quintiles with the first quintile 
as the poorest and the fifth quintile as the least-poor, based on asset ownership, utilities and occupation[22, 
23]. As described in detail elsewhere, SES quintiles were aggregated into dichotomous groups [33]; creating 
a binary variable from the poorest three SES quintiles (i.e., poorest, second and third poorest) and the fourth 
and fifth quintiles grouped into the ‘less-poor’ category, with the latter as the reference category in the 
models. Proportions and 95% confidence intervals were generated, and p-values <0.05 were considered 
statistically significant. Proportions were compared using generalized linear model (GLM) Poisson 
distribution with a log link and to compare adjusted prevalence ratios (aPR), which allowed for robust 
standard error correction accounting for clustering at the household level [84]. Dependent variables included 
malaria infection, care-seeking, medication, and ITN use.  SES, study areas (i.e., sub-counties), sex and 
categorized age groups (<5, 5–14 and ≥15 years) were included as independent variables. Medians and 
interquartile ranges were generated if data were not normally distributed; medication expenditures were 
compared using Wilcoxon rank-sum test because price data were not normally distributed.  
 
Description and interpretation of interaction term 
The net effect of the intervention is the net change represented by the interaction term (a product of study 
arm by study period). A prevalence ratio of the interaction term greater than one in the regression model 
represents a higher prevalence of the health events in the intervention arm compared to the control arm and 
between the study periods. In this analysis, A PR greater than 1 with 95% confidence intervals above 1 
represents the increased prevalence in the poorest individuals compared to less poor. Conversely, PR less 
than 1 with 95% confidence intervals below one represents lower prevalence rates amongst the poorest. 
 The theoretical framework describing the interaction term in the regression model is as below 
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P(Y=1|y=0)= β1Studyarm(
𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛=1
𝐶𝑜𝑛𝑡𝑟𝑜𝑙=0
)+ β2Period(
𝐸𝑛𝑑𝑙𝑖𝑛𝑒=1
𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒=0
)+ β3Interaction[ Studyarm*Period]+ β4ᵡ1 + 
β5ᵡ2+…+ β6ᵡn +ε  
Where Y is a binary outcome,( ᵡ1 +ᵡ2+…+ ᵡn)  are other independent variables included in the model, β1, β2 to βn 
are the marginal effects measured using prevalence ratios in this study (PR). 
Hence Interaction term={
1 𝑖𝑓 𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛 = 1 𝑎𝑛𝑑 𝑒𝑛𝑑𝑙𝑖𝑛𝑒 = 1
0 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
  
Overall intervention effect [interaction term] =(𝑰𝒏𝒕𝒆𝒓𝒗𝒆𝒏𝒕𝒊𝒐𝒏 𝒔𝒊𝒕𝒆: %𝑒𝑛𝑑𝑙𝑖𝑛𝑒 − %𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒)-
(𝒄𝒐𝒏𝒕𝒓𝒐𝒍 𝒔𝒊𝒕𝒆: % 𝑒𝑛𝑑𝑙𝑖𝑛𝑒 − %𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒) 
If the measure of effect (PR of β3) is >1 then the intervention has a higher PR compared to control 
If the measure of effect (PR of β3) is <1 then the control sites have higher PR than intervention 
DALYs represent the number of years lost due to premature death plus years lived with disability due to 
malaria infection. DALYs were calculated by summing up YLD and YLL. Computation of YLD was done 
by multiplying prevalence of malaria in each age group and sex by a disability weight for malaria of 0.191 
[81]. YLL was calculated as a product of the total number of malaria deaths in each age group and the mean 
life expectancy using the local standard life table at an average age of death. DALYs were estimated for each 
age group by sex and socioeconomic status. DALYs estimate and 95% Confidence intervals are reported 
[82]. Socioeconomic related inequalities in DALYs lost were measured using the concentration index (Cind).  
The concentration index also indicates the level of dominance by SES groups.  
 
Calculation of 95% Confidence Interval of the concentration index  
The 95% confidence interval of the concentration index was estimated using Stata software through 
Simulation (repeated resampling) methods. The simulated confidence intervals for the concentration index 
was calculated from a Lorenz plot of the cumulative share of health event in the population (on the 𝑦-axis; eg 
DALYs or years lived with a disabilities etc.) against the cumulative proportion of the population ranked by a 
socioeconomic variable (on the 𝑥-axis; e.g wealth quintile). If health event or outcome is distributed perfectly 
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equally across the socioeconomic groups, the Lorenz curve coincides with the diagonal – the equality line. 
The further the curve is away from the diagonal equality line, the greater the degree of inequality. The 
concentration index is the area between the Lorenz curve and the line of equality, measured and reported as a 
proportion of the total area beneath (or above) the line of equality. The concentration index shows how 
unevenly health events or outcomes are distributed according to population share. It takes a value between 
zero and 1 (or 100%), where zero indicates perfect equality and 1 indicates ‘ultimate inequality’ (ie the 
hypothetical situation where all the ‘good health’ is in the least deprived group). A negative value represents 
the concentration of the health event amongst the poorest individuals and a positive value represents the 
concentration of the events amongst the wealthier individuals. When 95% confidence intervals overlap with 
zero, there are no inequalities, the event is fairly distributed  
The 95% confidence interval formula is: CI±1.96*(SD/√𝑛) where the CI is the concentration index, SD is the 
standard deviation associated with a mean estimate of the Concentration index and n is the number of 
samples. However (SD/√𝑛) represents the standard error of the estimate. 
CInd was calculated as twice the covariance of the health variable and the fractional household or groups 
ranking variable divided by sample mean of the health variable. It can also be described as twice the area 
between the concentration curve and the line of equality. A value of 0 indicated that there were no 
socioeconomic inequalities and a value of 1 indicated perfect equality. A negative value show health 
outcome in concentrated amongst the poor and a positive value represents the dominance of the health 
outcome by the less poor.  The exchange rate of USD in 2013 (Present Value PV was USD1=Ksh 85) was 
discounted at a rate of 3% to estimate the true value of a dollar in 2014 and 2015 [85].  
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Results 
Socio-demographic characteristics of the study population 
A total of 1970 individuals participated in the pre-intervention baseline survey in mid-2013. Of these 17.3% 
were persons aged <5 years, 50.5% persons aged 5-14 years and the rest 32.1% were aged ≥15 years. In the 
2015 post-intervention endline survey, a total of 1844 persons participated in the survey and out of these, 
14.4% were persons aged <5 years, 53.2% were aged 5-14 years and the rest 32.7% were aged  ≥ 15 years.  
For equity analysis, 1181 (60%) persons were classified as poor at baseline in 2013 and 1062 were poor 
57.6% in the 2015 endline survey. Similarly, 789 (40%) of individuals were classified as less poor at baseline 
surveys (2013) and 38.0% (n=700) in the 2015 endline survey (table 1).  
 
Descriptive analysis of equity effect of MTAT on malaria infection, health-seeking, ITN use and 
expenditure on treatment 
The differences in proportions of indicators at baseline (2013) were compared to the differences in 
proportions at endline 2015, irrespective of the study arms (table 1). The results showed that overall, the 
prevalence of malaria amongst children <5 years was 17.3% at the baseline survey and 14.1% at endline. 
Amongst children <5 years from poor households, the net change in the prevalence of malaria was a 
reduction of 2.6% (baseline 14.6%   vs endline 12.0%). The overall prevalence reduction of malaria infection 
amongst 5-14 years was similar (baseline 50.5% vs 53.2% endline).  Prevalence of malaria infection amongst 
children aged 5-14 years from poor households increased by 3.2% (baseline 52.1% vs 55.3% endline), while 
there was a 0.8% increase amongst those from less poor households (baseline 48.4% vs endline 49.2%).The 
net change in prevalence amongst the adults aged ≥15 years from poor households was a reduction of 0.3% 
compared to a 3.5% reduction amongst the less poor.  
Differences between poor and less poor over time were more marked for uptake and use of interventions. The 
proportion of individuals who sought care for fever increased by 10.2% amongst the poor compared to 22.9% 
amongst the less poor, a net change of 12.6% in favour of the less poor. Uptake AL (recommended first-line 
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treatment for malaria) increased by 0.48% amongst the poor (baseline 13.7% vs endline 14.2%) compared to 
reduction of  1.15% amongst the  less poor households (baseline 14.7% vs endline 13.6%). The overall net 
effect was a reduction of 1.63% in the use of AL for malaria treatment in favour of the poor.  Overall, ITN 
usage increased by 42.0%. However, the use of ITN reduced amongst poor households from 61.2% at 
baseline to 39.0% at the endline of the survey. This represents a similar margin of reduction (22.2%) in ITN 
use by the least poor households. (Table 1) 
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Table 1  Socio-demographic characteristics of the study population and malaria indices between poor and less Poor in Siaya County, Kenya 
   Poor  households  Less Poor  households 
  Overall 
 Baseline 2013 
 n(%) 
 
Baseline 
(A) 
n (%) 
Endline  
(B) 
n(%) 
% 
Change 
(B-A) 
Overall Endline 
n(%) 
Baseline 
(C)  
n  (%) 
Endline 
 (D) 
n (%) 
%change 
(D-C) 
Net Change 
(B-A)-(D-C) 
Number of 
Participants   
N 1893 726d 1018e  1844 482 d 678 e   
 <5 years 300 (15.85) 107(53.23) 131(12.87) NA 229(12.42) 94 (46.77) 91(13.42) NA NA 
 5-14 years 599(31.64) 235(61.04) 277(27.21) NA 459(24.89) 150(38.96) 165(24.34) NA NA 
 ≥15 years 994(52.51) 384(61.74) 610(59.92) NA 1156(62.69) 238(38.26) 422(62.24) NA NA 
Malaria 
infection 
<5 years 89(19.69) 48(18.46) 32(12.03) -6.43 67(14.14) 41(21.35) 35(18.13) -3.22 -3.21 
 5-14 years 221(48.89) 126(48.46) 147(55.26) 6.8 252(53.16) 95(49.48) 95(49.22) -0.26 7.06 
 ≥15 years 142(31.42) 86(33.08) 87(32.71) -0.37 155(32.7) 56(29.17) 63(32.64) 3.47 -3.84 
Fever last 2 
weeks 
Yes 878(46.38) 337(46.42) 324(41.01) -5.41 600(43.26) 222(46.06) 251(45.64) -0.42 -4.99 
 No 1015(53.62) 389(53.58) 465(58.86) 5.48 786(56.67) 260(53.94) 299(54.36) 0.42 5.06 
Sought 
Care 
Yes 542(61.73) 206(61.31) 226(69.75) 8.44 400(66.67) 122(54.71) 159(63.35) 8.64 -0.20 
 No 336(38.27) 130(38.69) 98(30.25) -8.44 200(33.33) 101(45.29) 92(36.65) -8.64 0.20 
Medications 
Use 
ALc 
264(30.07) 122(36.20) 46(14.20) -22.0 83(13.83) 61(27.48) 34(13.55) -13.93 -8.07 
 SPb 12(1.37) 7(2.08) 0(0.00) -2.08 - 1(0.45) 0(0.00) -0.45 -1.63 
 Quinine 9(1.03) 5(1.48) 1(0.31) -1.17 2(0.33) 2(0.90) 1(0.40) -0.50 -0.67 
 Ibuprofen 49(5.58) 22(6.53) 5(1.54) -4.99 8(1.33) 10(4.50) 3(1.20) -3.30 -1.69 
 Acetominophen 452(51.48) 180(53.41) 68(20.99) -32.42 136(22.67) 115(51.80) 62(24.70) -27.1 -5.32 
 Septrin 54(6.15) 18(5.34) 6(1.85) -3.49 6(1.00) 13(5.86) 0(0.00) -5.86 1.87 
ITN Use Yes 1200(63.39) 446(61.43) 422(41.00) -20.43 719(38.99) 288(59.75) 596(59.00) -0.75 -19.68 
 No 693(36.61) 280(38.57) 297(43.81) 5.24 1125(61.01) 194(40.25) 381(56.19) 15.94 -10.70 
a Net change is the Difference-in-Difference (DID) in proportions between surveys and studies arms; bSP= Sulphadoxine-Pyrimethamine;  cAL=Artemether-Lumefantrine; cNA = Not 
Applicable; d In 2013, n=1208  individuals had complete SES data out of 1893; e in 2015, n=1696 individuals had SES data of 1844 
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Multivariate regression analysis of the equity effect of MTAT on malaria-related indices  
MTAT resulted in a reduced prevalence of malaria by 10% overall but the reduction was not 
statistically significant [aPR=0.90; 95%CI=0.74-1.07]. Amongst the poorest individuals, malaria 
prevalence was lowered but not significantly [aPR=0.9; 95%CI= (0.70-1.21), p=0.548]. However 
there was no significant change in risk of prevalence amongst the less poor individuals 
[aPR=1.0; 95%CI= (0.76-1.41), p=0.837]. Proportion of poor individuals who sought care for 
fever increased by 30% (aPR=1.30; 95%CI=1.06-1.65, p=0.014) compared to non-significant 
change amongst the less poor (aPR=1.00; 95%CI=0.72-1.31, p=0.851). Overall use of 
medication for treatment declined significantly (aPR= 0.80; 95%CI=0.74-0.98, p=0.022). 
However there was no significant change in use of medications amongst poorest (aPR=0.80; 
95%CI=0.67-1.01, p=0.063) and similarly no significance change amongst less poor (aPR=0.9; 
95%CI=0.72-1.25, p=0.698). There was a significant change in the use of ITN overall and 
between the SES groups (Table2)
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Table 2. Descriptive Analysis of equity Effect of MTAT on malaria infection, care-seeking, and  expenditure on treatment, Siaya County, western Kenya 
  Baseline (2013) 
Baseline   
Differencea 
Endline (2015) 
Endline 
Differenceb 
Net-
Change[b-a] 
Interaction termc 
(Net effect) 
  Intervention % Control  % Change %  Intervention % Control % Change %  DIDb % aPR(95%CI) P value 
Malaria Infection 
Overall 47.73 52.27 -4.54 45.46 54.54 -9.08 -4.54 0.9(0.74-1.07) 0.223 
Poor 35.05 36.55 -1.50 31.46 38.21 -6.75 -5.25 0.9(0.70-1.21) 0.548 
Less poor 33.47 46.75 -13.28 28.75 41.47 -12.72 0.56 1.0(0.76-1.41) 0.837 
Care seeking 
Overall 48.63 51.37 -2.37 46.67 53.33 -6.66 -4.29 1.1(0.92-1.24) 0.415 
Poor 58.13 64.20 -6.07 75.63 64.02 11.61 17.68 1.3(1.06-1.65) 0.014 
Less poor 53.98 55.45 -1.47 60.36 65.71 -5.35 -3.88 1.0(0.72-1.31) 0.851 
Medication  
Overall 47.50 52.50 -5.00 46.67 53.33 -6.66 -1.66 0.8(0.74-0.98) 0.022 
Poor 41.82 36.29 5.53 80.00 85.37 -5.37 -10.9 0.8(0.67-1.01) 0.063 
Less poor 35.1 37.99 -2.89 71.17 82.14 -10.97 -8.08 0.9(0.72-1.25) 0.698 
Affordability of health care services  
Overall 48.01 51.99 -3.98 48.00 52.00 -4.00 -0.02 0.9(0.82-1.08) 0.376 
Poor 75.29 81.82 -6.53 71.90 84.76 -12.86 -6.33 0.9(0.77-1.10) 0.352 
Less poor 75.70 75.34 0.36 74.63 79.35 -4.72 -5.08 0.9(0.75-1.14) 0.476 
ITN use          
Overall 47.70 52.30 -4.6 46.53 53.47 -6.94 -2.34 1.2(1.04-1.35) 0.011 
Poor 62.15 57.14 5.01 46.30 41.69 4.61 -0.40 1.0 0.999 
Less poor 59.21 63.29 -4.08 45.32 37.99 7.33 11.41 1.0 0.999 
b-a DID implies Difference in Difference between study periods and the study arms. c The interaction term is defined as the product of study arm (intervention=1, control=0) and 
study period (endline=1; Baseline=0). If PR is significant and greater, the intervention arm has resulted in increased cases of the health event and vice versa).  
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Equity effect of MTAT on Disability-Adjusted Life Years (DALYs) amongst males 
Amongst the poorest males, there was a net reduction of 107.5 (95% CI=16.5-198.5) DALYs 
overall, a net reduction of 124 (95% CI=33-215) DALYs amongst children <5 years, 1.5 (95% 
CI=-89.5 -92.4) DALYs reduction in those 5-14 years old and 18.1 (95% CI=-72-105) DALYs 
amongst adults aged at least 15 years. Overall, the least poor male individuals had a net equity 
gain of 205 DALYs; 307 amongst the children under 5 years, 4.3 amongst 5-14 years and 105.5 
amongst the adult at least 15 years. The DALYs were concentrated amongst the poor males' 
individuals overall represented by a negative concentration index (CInd) = (-0.4599); However, 
the concentration amongst the poor does not show statistically significant dominance (95%CI= 
{-2.9-1.96]). DALYs were concentrated amongst the least poor male children under 5 years 
(CInd=0.1). However there no significant dominance of DALYs lost by the least poor compared 
to the poor (95%CI=-29-0.5) and DALYs lost were more concentrated amongst the poor male 
children aged 5-14 years old (Table 3) 
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Table 3: Equity effect of MTAT on the disability adjusted-life years amongst the male population in Siaya County, Kenya. 
  Control Sites Intervention Sites  
SES Quintiles Age groups Baseline (2013) Endline (2015)  Baseline (2013) Endline (2015)   
  DALYs 95%CI DALYs 95%CI   Change DALYs 95%CI DALYs 95%CI Change Net 
Change 
Poorest <5years 181.3 90 -272 183.9 137 -231 2.6 121.7 56.5-187 0.2 -19-19.4 -121.6 -124.2 
 5-14years 1.1 -89-92 3.2 -44 -50 2.1 1.7 -63.5-67 2.3 -17-22 0.6 -1.5 
 ≥15years 21.7 -61-113 17.3 -30 -64 -4.4 20.4 -44.9-86 34.1 15-53 13.8 18.2 
 All ages 204.1 113-294 204.5 158 -251 0.3 143.8 79-209 36.6 16.3-55.3 -107.2 -107.5 
2rd poor <5yrs 61.4 -29-152 122.2 75 -169 60.8 247.8 183-313 0.6 -18.6-19.8 -247.2 -308.0 
 5-14years 120.7 29-211 3.1 -44 -50 -117.6 1.5 -64-66.7 1.5 -18-21 0.0 117.6 
 ≥15yrs 40.7 -50-131 47.0 .0237 -94 6.3 16.3 -49-81.5 1.0 -18-20 -15.3 -21.6 
 All ages 222.8 132-312 172.2 125 -219 -50.6 265.6 200-331 3.1 -16-22 -262.6 -212 
3rd Poor <5yrs 242.0 151-333 250 203 -297 8.0 63 -2.2-128 62.7 44.4-82 -0.4 -8.4 
 5-14years 60.8 -30-152 59.5 13 -106 -1.3 3.2 -62-68.4 1.3 -17-21 -1.9 -0.6 
 ≥15years 94.3 3-185 0.0 -47 -47 -94.3 1.0 -64-66 1.1 -18-20 0.2 94.5 
 All ages 397.1 306-488 309.5 263 -356 -87.6 67.2 1.95-132 65.2 46-84 -2.1 85.5 
4th poor <5yrs 664.8 574-756 0.8 -47 -48 -664.1 424 358-489 125.6 106-145 -298.4 365.6 
 5-14years 60.8 -30 -152 3.2 -44 -50 -57.8 1.7 -64 -67 1.9 -17-21 0.2 57.9 
 ≥15years 70.9 -20 -162 1.3 -46 -48 -69.6 27.2 -38-92 1.1 -18-20 -26.0 43.6 
 All ages 796.6 706 -887 5.2 -42 -52 -791.4 452.9 387-518 128.6 109-148 -324.3 467.1 
Least poor <5yrs 1.3 -90 -92 188.3 141 -235 186.9 121.2 56-186 1.0 -18-20 -120.2 -307.1 
 5-14years 58.4 -32 -149 2.5 -44 -49 -55.9 61.4 -3.8-127 1.1 -18-20 -60.2 -4.3 
 ≥15years 117.7 27 -209 1.3 -46 -48 -116.4 24.3 -41-90 13.5 -5.8-35 -10.9 105.5 
 All ages 177.5 87 -268 192.1 145 -239 14.6 206.9  15.6 -3.7-34.9 -191.3 -205.9 
Concentration 
Index 
<5 years -0.0295 -0.034-0.29 0.0207 -0.05-0.09  -0.0490 -0.20-0.10 0.1000 -0.29-0.50   
 5-14 years -0.0772 -0.40-0.29 0.1710 -0.38-0.73  0.6842 0.54-0.80 -0.2210 -1.00-0.60   
 ≥15 years 0.1657 -0.35-0.70 -0.4120 0.93-0.11  0.0001 -0.30-0.30 -0.3390 -1.58-0.90   
 All ages 
 
0.0590 -1.45-1.50 -0.2203 
 
-1.36-0.93  0.6356 
 
0.02-1.20 -0.4599 -2.90-1.96   
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Equity effect of MTAT on Disability-Adjusted Life Years (DALYs) amongst females 
There was a concentration of DALYs amongst the males at the intervention sites during the 
endline (Cind. -0.46; 95%CI=-2.9-1.96).  Amongst the female adults aged at least 15 years, there 
was equally no dominance of DALYs by either SES groups (CInd -0.339; 95%CI=-1.58-0.9). 
(Table 3). Amongst the poorest females, there was an increase of 135 DALYs overall, with the 
largest net increase of 127 DALYs observed amongst children <5 years. A very small increase of 
0.2 was observed among the 5-14 years old and an increase of 7.6 DALYs amongst adults aged 
at least 15 years. However, when the first three quintiles are combined into one quintile (‘Poor’) 
and the last two quintiles are combined into one quintile (‘Less poor’), the net equity gain among 
the poor female individuals was 32.8 DALYs overall; net equity gain of 66.8 DALYs was 
observed among the 2nd poor females, net equity gain of 101.1 among the 3rd poor females while 
a net equity loss of 135 DALYs was observed among the poorest female individuals. Amongst 
the least poor female individuals, a net equity loss of 457 DALYs was observed overall. The 
DALYs were concentrated amongst the poor female individuals <5 years overall in the 
intervention sites represented by a negative concentration index (CInd) = (-0.131); 95%CI=-
0.32-0.054); However there was no dominance of concentration (Cind 0.029; 95%CI= {-0.686-
0.74]) at endline in the intervention sites. However, there was no significant concentration of 
DALYs lost by the 5-14 years (Cind=0.216; 95%CI -0.094-0.53) (table 4).  
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Table 4: Equity effect of MTAT on the Disability Adjusted Life Years amongst the female population in Siaya County, Kenya 
  Control Sites Intervention Sites   
SES Age groups Baseline  (2013) Endline (2015)  Baseline (2013) Endline (2015)   
  Estimate 95%CI Estimate 95%CI Change Estimate 95%CI Estimate 95%CI Change Net Change 
Poorest <5yrs 260.4 165.5 -355.2 134.2 83.6-184.8 -126.2 65.6 16.5-114.6 66.6 51.5-81.7 1.0 127.2 
 5-14yrs 2.483 -92.4- 97.3 2.483 -48.1- 53.1 0.0 1.1 -47.9- 50.1 1.3 -13.9-16.4 0.2 0.2 
 ≥15yrs 23.3 -71.5-118.1 26.2 -24.4-76.8 2.9 12.0 -37-61 22.6 7.5-37.7 10.5 7.6 
 All ages 286.2 191.3-381 162.9 112.3-214 -123.3 78.8 29.8-127.8 90.5 75.4-105.6 11.7 135 
2rd poor <5yrs 391.1 296.2-485.9 131.6 80.9-182.2 -259.5 325.2 276.1-
374.2 
67.5 52.4-82.6 -257.7 1.8 
 5-14yrs 61.6 -33.2-156.4 65.6 14.9-116.2 4.0 191.8 142.7-
240.8 
60.9 45.8-76 -130.9 -134.9 
 ≥15yrs 71.5 -22.3-166.3 23.2 -27.4-73.8 -48.3 0.6 -48.4-49.6 18.6 3.5-33.7 18.0 66.3 
 All ages 524.3 429.4-619.1 220.4 169.7-271 -303.8 517.6 468.5-
566.6 
147 131.9-
162.1 
-370.6 -66.8 
3rd Poor <5yrs 326.5 231.6-421.3 264.3 213.6-315 -62.2 65.6 16.5-114.6 66.8 51.7-81.9 1.2 63.4 
 5-14yrs 64.3 -30.5-151.1 63.4 12.7-114 -0.8 129.3 80.2-178.3 2.9 -12.2-18 -126.4 -125.6 
 >=15yrs 27.0 -67.8-121.8 2.7 -47.9-53.3 -24.3 90.5 41.4-139.5 27.2 12.1-42.3 -63.3 -38.9 
 All ages 417.8 322.9-512.6 330.4 279.7-381 -87.4 285.3 236.2-
334.3 
96.8 81.7-111.9 -188.5 -101.1 
4th poor <5yrs 531.2 436.4- 626 268.7 218.1-319 -262.4 130.6 81.5-179.6 0.6 -14.5-15.7 -130.0 132.4 
 5-14yrs 65.2 -29.6-160 2.9 -47.7-53.5 -62.3 2.3 -46.7-51.3 61.3 46.2-76.4 59.0 121.4 
 >=15yrs 1.7 -93.1-96.5 2.3 -48.3-52.9 0.6 89.7 40.6-138.7 26.6 11.5-41.7 -63.1 -63.7 
 All ages 598.1 503.3-692.9 273.9 223.3-325 -324.2 222.6 173.5-
271.6 
88.5 73.4-103.6 -134.1 190.1 
Least poor <5yrs 325.6 230.8-420.4 1.1 -49.5-51.7 -324.4 130.6 81.5-179.6 66.4 51.3-81.5 -64.2 260.2 
 5-14yrs 3.1 -91.7-97.9 68.1 17.5-118.7 65.0 64.4 15.4-113.4 64.9 49.8-80 0.4 -64.6 
 >=15yrs 59.9 -34.9-154.7 2.1 -48.5- 52.7 -57.8 1.7 -47.3-50.7 15.9 0.780-31 14.2 72.0 
 All ages 388.6 293.8-483.4 71.3 20.7-121.9 -317.2 196.7 147.6-
245.7 
147.1 132-162.2 -49.6 267.6 
Concentration 
Index 
<5yrs 
5-14yrs 
>=15yrs 
All ages 
0.0107 
-0.0570 
-0.0462 
-0.0925 
-0.032-0.05 
-0.5-0.382 
-0.467-0.74 
-0.994-1.17 
-0.0046 
0.1662 
-0.531 
-0.369 
-0.24- 0.23 
-0.63 -0.96 
-.72-(-0.34) 
-1.36-0.85 
 -0.0412 
-0.0511 
0.2540 
0.1617 
-0.20-0.120 
-0.36-0.261 
-0.29-0.802 
-0.85-1.183 
-0.131 
0.216 
-0.056 
0.029 
-0.32-.054 
-0.094-.53 
-0.272-.16 
-0.686-.74 
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Discussion 
Results in this study revealed that intermittent mass test and treat for malaria infection resulted in 
equity gains in the general population and amongst the poor households. After 2 years of 
implementation and six rounds of MTAT, there was no difference in the prevalence of malaria 
between the poorest and less poor individuals as both socioeconomic groups experienced a 
reduction in the overall prevalence of malaria. Results further showed that overall there was a 
significant decline in the proportion of individuals using medication between the surveys. 
However, such a decline in medication use was no different comparing the poorest and less poor 
individuals. The proportion of individuals seeking care for fever was not significantly different 
between the poorest and less poor although the poor had an increase of about 10% such increase 
was no significant in the multivariate analyses.  The result showed a significant reduction in 
DALYs lost due to malaria in the general population and no significant difference in DALYs lost 
between the poorest and less poor. Although the poor had the highest burden of DALYs at 
baseline, they gained DALYs towards the end of the study for both male and females persons 
Some studies had demonstrated that MTAT can reduce transmission of malaria,but  none had  
demonstrated any equity effect of MTAT [71-73, 76] Since most parts of DALYs were malaria-
specific deaths, the results show that more deaths were prevented over time. Further, households 
reported significant cost saving in expenditure on malaria treatment and there was cost-saving 
for poor and less poor households. There was a significant increase in care-seeking amongst the 
poor households compared to the less poor. These results demonstrated that MTAT is an 
important approach towards the reduction of socioeconomic inequalities and increase access to 
medication and treatment, especially amongst the poor individuals.  
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and possible elimination of Malaria among poor Individuals. The insignificant prevalence ratio 
results between the poor and less poor reveal equity in malaria prevalence between the two 
groups. This concurs with the evidence obtained from a study in Tanzania where malaria 
incidence did not differ across the wealth quintiles.[6] 
The percentage of households that sought care was higher in the poor households in both 
baseline and endline. The finding is inconsistent with that conducted in Tanzania where the 
percentage of the households who sought care was higher in richer households. The six rounds of 
MTAT conducted in the community resulted in care available to the poor households located in 
the rural villages, observed through the significant increase in the prevalence ratio, reinforcing 
their understanding leading them to accept that early identification and treatment of malaria 
increases medication effectiveness. The identification, testing, and treatment of Malaria cases by 
health care providers during the community case management of malaria lead to an increase in 
access to care.[68, 77, 86]. We observed that the increase in care-seeking has a positive effect on 
the decline in malaria cases. 
Mass drug administration is beneficial to poor individuals because it could results in cost savings 
especially if individuals do not have to travel long distances to receive medications[87, 88]. 
Although there was no statistical significance, the intervention led to a decrease in medication 
uptake and affordability in the poor and the less poor households. This is contrary to other 
studies that involved testing and treatment like community care management, proactive testing, 
and treatment where free medication was administered to patients with uncomplicated malaria 
leading to an increase in medication uptake.[73] The insignificant prevalence rates among the 
poor and the less poor revealed that there was an equal rate of taking medication and the 
affordability of that medication among different socioeconomic statuses.[80] 
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Children under five years of age had the highest YLD across the wealth quintiles which led to 
the highest number of DALYs. Children have a high mortality rate as compared to other age 
groups and are also vulnerable to infections. This is similar to a study conducted in Sudan to find 
out the burden on malaria focusing on the incidence, mortality, and DALYs lost. The study 
revealed that children <5 years of age had the highest burden of malaria which emphasized the 
fact that burden is highest in this age group[82]. Irrespective of gender, the poorest households 
had the highest gap between the ideal and current health status and after the intervention, a 
general decline in DALYs can be observed with the poorest households showing the highest 
decrease.[89] The average DALYSs reduction was more in the males compared to their female 
counterparts. Our results slightly differed with the same study conducted in Sudan where it was 
found out that females lost more DALYs than males due to their higher life expectancy than 
males.[82]  
The study found some positive results. However, the study was conducted in the lake endemic 
region where malaria prevalence is very high and thus cannot be translated to other regions. 
Results from this study can be used to inform policy in order to establish precise estimates in 
places with low malaria transmission. 
 
Conclusion  
The results from this study suggest that although MTAT only reduced malaria burden by a very 
small margin after two years of implementing three rounds of MTAT. However, the intervention 
achieved equity in malaria prevalence, uptake of medication for malaria between the rich and 
poor. Care seeking improved and cost of treatment reduced after the intervention to favour the 
poor households. The benefits achieved in the two years' intervention are encouraging despite the 
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low impact of malaria prevalence.  Equity effect contributes to the global goal of eliminating 
socioeconomic inequalities and monitoring equity effect of malaria interventions   
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Chapter 5:  Socioeconomic inequalities in population burden of malaria: Analyses of 
disability-adjusted life years in a health and demographic surveillance, 2006-2014, western 
Kenya 
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Abstract: 
Background. Malaria is a major contributor to the high disease burden in Kenya, especially 
among the economically and socially disadvantaged populations. This study assesses 
socioeconomic inequalities in relation to malaria burden measured in terms of Disability 
Adjusted Life Years (DALYs) between 2006 and2014 in western Kenya.  
 
Methods. Malaria mortality data were obtained from the health and demographic 
surveillance system (HDSS), and malaria prevalence data were collected from annual cross-
sectional surveys from 2006-2014 in Siaya County. Malaria deaths were determined using 
verbal autopsy, replaced by an inter-VA computer algorithm from 2010 onwards. Absolute 
DALYs were calculated as the sum of Years of Life Lost due to premature death (YLL) and 
Years lived and Disability (YLD) for all age groups using the Kenyan life table. Wealth 
quintiles were calculated using the Multiple Correspondence Analysis Model (MCA) using 
the household asset as a proxy for socioeconomic status (SES). The concentrated index was 
used together with the MCA model to test for the overall socioeconomic related inequalities. 
 
Results. A total of 3504 malaria-related deaths occurred in the communities from 2006-2014, 
the highest deaths occurred in 2008  
(n=788) and the least in 2014(n=170). A total of 835 deaths occurred in the poorest 
households and 616 in the least poor households. DALYs lost amongst the poorest 
households were more than twice that for the least poor households (35,197 against 14,254 
DALYs).The total absolute DALYs between the poorest and least poor quintiles reduced by 
15% from16, 742 to 14,221.Poorest children aged <5 years had a higher burden of DALYs 
(11,187; 95%CI=11085.72 -12880.01) compared to children <5 years old from least poor 
households (DALYs 9,987; 95%CI=9885.91 -10,088.20). Females in the poorest households 
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had a higher burden of DALYs compared to those in the least poor households. DALY’s 
estimates for males were similar between the poor and less poor respectively. Children aged 
5-14 years had the highest burden of years lived with disability (YLD) (malaria illness) 
across the wealth quintiles. Trends in DALYs, YLL, and YLD show declining trends from 
2008 to 2014. Concentration index of -0.0283, 95% (CI=-0.0371 -0.0219) for females, 
showed that disability-adjusted life years were more heavily concentrated among poor 
households than the richer ones. 
 
Conclusion:  Poor households, children < 5 years in poor households and women 
disproportionately bore the greatest burden of malaria compared to the least poor households, 
older children or males.  Although socioeconomic inequalities in the burden of malaria still 
exist, a decline was evident suggesting intensification of malaria control interventions over 
time.  Interventions targeting the poor, female and children <5 should be considered to bring 
down overall morbidity and mortality due to malaria in economic perspective.  
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Introduction 
According to the World Health Organization (WHO), an estimated,216 million cases of 
malaria occurred worldwide in 2016 (95% CI=196 million- 263 million), with a high 
proportion of nearly 90% occurring in the African region [33]. In 2016, 455,000 malaria 
deaths (range: 236,000–635,000) were estimated worldwide, of which 90% occurred in the 
African region. Between 2000 and 2016, malaria incidence rates fell by 18% globally and by 
20% in Africa, and malaria mortality rates fell by 25% globally and by 66% in Africa [33]. 
In the global disease burden (GBD)  study 2015, malaria was ranked 18th in the list of 
diseases accounting for the global disease burden at 1.4%;  in Africa malaria ranked fourth 
accounting for an estimated 5.7% of the disease burden and caused approximately 35 million 
disability-adjusted life years (DALYs)[90]. The WHO defines disability-adjusted life years 
(DALYs) as the sum of the Years of Life Lost (YLL) due to premature mortality in the 
population and the Years lived with Disability (YLD) for people living with the health 
condition or its consequence. The sum of DALYs across the population, which is a measure 
of the burden of disease, is a measurement of the gap between the current health status and 
ideal health status in which the entire population lives to an advanced age, free of disease and 
disability [81, 91-94]. In the DALY philosophy, every person is born with a certain number 
of life-years potentially lived in optimal health. People may lose these healthy life years 
through living with illness and/or through dying before a reference life expectancy. These 
losses in healthy life years are exactly what is measured by the DALY metric. Ten DALYs, 
for instance, correspond to ten lost years of a healthy life, attributable to morbidity, mortality, 
or both. On a population level, diseases with a higher public health impact will thus account 
for more DALYs than those with a lesser impact [81]. 
In the DALYs approach, a disability weighted zero indicates perfect health and the one 
weighted 1 indicates death [81, 91-94][56]. The calculation of YLD which is one of the 
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components of a DALY can be performed using the prevalence of disease based approach 
recommended by the GBD study 2010[95, 96]. A study from Malawi showed that households 
with a very low income bore a disproportionate share of the economic burden of malaria, 
with 32% of their annual household income being lost as a result of the direct  and indirect 
costs of malaria, compared to only 4.2% for  households in the low- to high-income 
categories1[97]. Estimating the costs of health interventions and the impact or reduction in 
the burden of disease has tremendous potential for maximizing the use of available health 
resources [93]. Estimating the burden of disease and cost-effectiveness of interventions can 
assist governments in deciding which interventions to finance, intervention subsidy levels and 
populations to target[98]. Equitable distribution of health outcomes or interventions is a 
principle advocated for in most national policy documents. Equity can either be horizontal or 
vertical. Horizontal equity means unequal treatment of individuals with equal medical needs, 
regardless of socioeconomic related characteristics while vertical equity is defined as an 
appropriate unequal treatment of individuals with unequal medical needs based on 
socioeconomic related characteristics of the population. 
A study conducted in Gambia between 2010 -2011 to assess the link between malaria 
infections and socioeconomic status (SES) showed that children aged between 6 to 59 months 
and 5 to 14 years from the second, third, fourth and richest quintiles were significantly less 
likely to have malaria infections compared to children from the poorest quintiles.[11] 
A multi-cohort study and meta-analysis with individual-level data from 48 independent 
prospective cohort studies with information about socioeconomic status, indexed by 
occupational position, risk factors (high alcohol intake, physical inactivity, current smoking, 
hypertension, diabetes, and obesity), and mortality revealed that participants with low 
socioeconomic status had greater mortality compared with those with high socioeconomic 
status (RR 1·42, 95% CI 1·38–1·45 for men; 1·34, 1·28–1·39 for women).[99] 
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In Kenya for the last 10 years, there has been a downward trend in both malaria morbidity 
and mortality[90].In 2015, reported confirmed malaria cases both at the facility and the 
community levels were estimated at 1,499,027 and 82,141 respectively, while 15,061 deaths 
were reported in the same year.[90]In Kenya, the top three causes of DALYs in 2010 were 
reported as HIV/AIDS, lower respiratory infections, and malaria and out of the 25 diseases 
ranked in the global burden of disease profile for Kenya 2010, malaria accounted for 10% of 
YLL, and was ranked 3rd with 1,550 years of life lost due to malaria deaths.[95] 
The concentration index is a relative measure of inequality that indicates the extent to which 
a health indicator is concentrated among the disadvantaged or the advantaged.[21, 100] Given 
that a population is ranked by increasing socioeconomic status, the concentration index has a 
negative value when the health indicator is concentrated among the disadvantaged and a 
positive value when the health indicator is concentrated among the advantaged[21]. If a 
single individual (the smallest possible population subgroup) accounted for 100% of a health 
indicator in a population (the highest relative inequality that is theoretically possible), this 
would cause the concentration index to approach its maximum absolute value of the either 
negative one or positive one. If the concentration index is greater than zero, implies health 
variable is disproportionately concentrated on the rich while if less than zero implies its 
concentrated amongst the poor[21,100]. When the concentration index is exactly zero it 
implies the health variable is proportionate.15 
Since 2006 in Kenya, there has been a huge scale-up of malaria prevention and control 
interventions including universal coverage with long-lasting insecticidal bednets (ITNs), 
indoor residual spraying of insecticides, intermittent preventive treatment in pregnancy and 
effective case management and as a result there has been decline mortality and mortality over 
time in some groups in Siaya County[40, 54, 101]. However, there has been limited data on 
the empirical and economic burden of malaria and the microeconomic effect of malaria 
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prevention and control interventions over the last decade. Longitudinal data were examined 
on YLL, YLD and DALY burdens using malaria-specific deaths and prevalence stratified by 
household socioeconomic status from 2006–2014 in a malaria-endemic area of western 
Kenya.  
Methods 
Site  
The Kenya Medical Research Institute (KEMRI) and Centres for Disease Control and 
Prevention (CDC) supported health and demographic surveillance system (HDSS) in western 
Kenya HDSS has been described in detail elsewhere[39, 41]. Continuous routine surveillance 
in three data collection rounds each year were conducted within the HDSS. The HDSS area 
covered a population of approximately 223,000 people residing in 393 villages and was 
located in three sub-counties of Siaya County spread over approximately 700 km2 along the 
shores of Lake Victoria. The vast majority of the population earns their living through 
subsistence farming and fishing [39, 41]. Health indicators are poor compared to national 
level;[42, 43, 102]for example, in 2015, the infant mortality rate was 125 per 1,000 live births 
compared to 77 per 1,000 live births nationally, under-5 mortality was 227 per 1,000 live 
births compared to 115 per 1,000 nationally and overall life expectancy at birth was 38 years 
(i.e., 36 years for men and 39 years for women) compared to 48 years nationally[102] 
 
Data collection  
Malaria morbidity and mortality data used in this study were collected between 2006 and 
2014 within KEMRI and CDC HDSS sites, which included Gem and Rarieda Sub-counties. 
Karemo area which is in the third Sub-county of Alego-Usonga was excluded since it only 
joined HDSS in 2007.  An average of16, 000 households were visited every year and the 
number of self-reported malaria cases and deaths by the households were recorded. Verbal 
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autopsy interviews were conducted in every household where deaths occurred to establish the 
probable cause of death and then malaria-specific deaths were recorded[102]. 
Data collection rounds were conducted every 4 months per year, to collect data on births, 
deaths, pregnancies, migrations, morbidity, parent survival status, immunization for children 
aged under 2 years, educational status, religion, marital status and ethnicity from individuals 
in the households located within the HDSS. Data on socio-economic variables were collected 
every two years for each household. In each year malaria prevalence surveys were conducted 
within the HDSS in all age groups[40]. 
Data Analysis 
Various methods have been proposed to calculate DALYs [81, 94] However, in this study we 
have calculated the number of DALYs using the basic DALY calculation methodology. The 
method was not based on age weighting and time discounting (social preferences). Malaria 
prevalence-specific data from 2006 to 2014 by age groups and gender were used to calculate 
YLD and YLL parameters. The formula adopted from the GBD study of 2010 was used to 
calculate these two parameters.[93, 94] The GBD 2010, deviated from the earlier years’ 
global burden of disease studies in that their analysts chose to use disease prevalence instead 
of incidence to calculate YLDs [6].The YLDs were computed by multiplying the prevalence 
of malaria, by DW associated with the disease. Data on malaria prevalence, number of 
malaria deaths, life expectancy at the age of death and Disability weights were entered into 
programmed excel spreadsheets which automatically produced outputs in the form of YLL, 
YDL, and DALYs. The YLDs in this paper were calculated for three age categories (<5 
years, 5–14 years and >15years) based on the malaria prevalence from the cross-sectional 
surveys conducted from2006-2014 and classified by wealth quintiles (SES) and gender. The 
YLLs were computed using the number of malaria/anaemia deaths per year(2006-2014)for 
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each age category, using life expectancy estimates extracted from the local WHO life tables 
[81].YLDs, YLLs, and DALYs were calculated for each age category and stratified by gender 
and household socioeconomic status (SES).  
 
Calculation of DALYs using a prevalence-based approach 
DALYs, which is the sum of YLD and YLL, were calculated using the prevalence-based 
approach as described in the GBD study[94]. This approach was first used in 2014 by 
Wagner et al [94]to analyze the burden of epilepsy among a rural population in South Africa 
in the absence of incidence data but has not been used to analyze malaria data in endemic 
areas and comparing outcomes by SES. 
 
Years lived with Disability (YLD) 
YLD was computed by multiplying the malaria prevalence for each age category, by 
socioeconomic status (SES) and by gender using a constant disability weight (DW) for 
malaria of 0.191 extracted from the WHO updates.[9, 103] 
YLDp = Prevalence * DW 
Years of Life Lost due to premature death due to malaria (YLL) 
The YLL was calculated as the product of the number of deaths due to malaria occurring in 
each age category, gender and SES per year and the average local standard life expectancy at 
the mean age of death extracted from WHO life tables for Kenya.  
YLL = number of deaths per year * Local life expectancy at age of death 
 
Disability Adjusted Life Years (DALYs) 
 DALYs were calculated by summing up the YLDs with YLL for each age category and 
stratified by household socioeconomic status (SES) and gender. 
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DALYs = YLDp +YLL 
 
Socioeconomic status (SES) 
Different methodologies for assessing SES employing broad quantitative and qualitative 
aspects of poverty have been recommended including PCA, Polychoric PCA, and multiple 
component analysis (MCA) [33].SES indices were generated using MCA. The model inputs 
included; the occupation of household head, (categorized as; doing business, commercial 
,farming, housewife, salaried worker, Skilled labor, unskilled labor and subsistence farming), 
primary source of drinking water, type of cooking fuel, ownership of household assets 
(categorized as; lantern lamp, radio, television, bicycle) and ownership of livestock 
(categorized as; cattle, chicken, pigs, donkey). The households were categorized into  five 
socioeconomic quintiles, which were then aggregated into a binary variable with the first 
three SES quintiles classified as the ‘poor’ and the fourth and fifth quintiles classified as the 
‘less-poor’[22, 23, 62]A study from rural western Kenya compared the three methods of 
ranking households into SES quintiles and established that although the methods produced 
similar results, MCA gave the highest percentage of the total variation for the household asset 
variables and thus the largest weights for the variables[21].In this study household assets and 
characteristics, the approach was adopted because collecting data on household assets is 
much easier and more convenient. Unlike income or expenditure which is not easy to collect 
and when it is collected the data may not be accurate due to under-reporting, seasonality, 
recall bias and imputation of values[104].The magnitude of socioeconomic related 
inequalities was measured using the concentration index recommended by the WHO and 
World Bank guidelines.[100, 105]. Concentration index lies between (-1, 1) and when the 
value is negative implies the health outcome is concentrated amongst the poor and when 
positive implies the health value is concentrated amongst less poor[100, 105]. 
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Results 
Socio-demographic characteristics of the study population 
From 2006 to 2014, a total of 3504 individual deaths were reported in all age groups across 
all quintiles. These ranged from 586 malaria-related deaths in 2006 to 788 in 2008 and down 
from 835 malaria deaths amongst the poorest quintile compared to 616 in the least poor 
quintile. Overall, a total of 2075 children under5 years died of malaria, 275 amongst 5-14 
years and 1154 amongst the adults aged ≥15 years (Table 1). The distribution of malaria-
related deaths amongst males and females by age groups, by year and wealth quintiles are 
described in Tables 2 and 3. 
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Table 1 Total malaria-related deaths in KEMRI HDSS from 2006-2014, Siaya County 
Socioeconomic status Age Category 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total 
n/N (n=deaths, N=Population)  n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N 
Poorest <5years 69/118 49/122 93/147 65/147 36/142 29/142 18/1750 13/1750 21/3177 393/7495 
 5 -14 years 9/30 6/34 4/51 7/51 5/66 1/66 3/1591 4/1591 4/3218 43/6698 
 >=15 years 104/71 97/113 78/143 47/143 22/129 10/129 11/3355 15/3355 15/6364 399/13802 
  All ages 182/219 152/269 175/341 119/341 63/337 40/337 32/6696 32/6696 40/12759 835/27995 
2nd poor <5years 76/96 55/144 113/209 82/209 58/168 26/168 27/2536 30/2536 24/4547 491/10613 
 5 -14 years 5/38 4/58 4/79 8/79 6/103 4/103 5/2461 7/2461 3/5055 46/10437 
 >=15 years 42/84 55/116 36/161 16/161 13/157 2/157 5/3966 9/3966 7/8361 185/17129 
  All ages 123/218 114/318 153/449 106/449 77/428 32/428 37/8963 46/8963 34/17963 722/38179 
3rd poor <5years 69/129 52/151 115/172 71/172 34/178 28/178 25/2895 23/2895 15/4966 432/11736 
 5 -14 years 7/33 9/66 10/88 9/88 10/135 2/135 7/3083 6/3083 4/6471 64/13182 
 >=15 years 28/99 37/110 36/151 15/151 17/183 4/183 14/5010 14/5010 8/10125 173/21022 
  All ages 104/261 98/327 161/411 95/411 61/496 34/496 46/10988 43/10988 27/21562 669/45940 
4th poor <5years 49/99 51/183 99/187 59/187 49/171 28/171 19/3341 23/3341 19/5422 396/13102 
 5 -14 years 7/50 6/81 5/100 6/100 10/97 4/97 6/3874 4/3874 6/7449 54/15722 
 >=15 years 47/69 49/149 39/167 25/167 13/143 9/143 8/6440 10/6440 12/12085 212/25803 
  All ages 103/218 106/413 143/454 90/454 72/411 41/411 33/13655 37/13655 37/24956 662/54627 
Least poor <5years 32/95 35/202 110/193 65/193 40/181 22/181 19/3644 25/3644 15/5527 363/13860 
 5 -14 years 9/45 6/119 7/120 12/120 7/121 5/121 10/4684 7/4684 5/8990 68/19004 
 >=15 years 33/78 37/177 39/158 27/158 13/171 7/171 10/8130 7/8130 12/15498 185/32671 
  All ages 74/218 78/498 156/471 104/471 60/473 34/473 39/16458 39/16458 32/30015 616/65535 
 Overall 586/1134 548/1825 788/2126 514/2126 333/4290 181/4290 187/56760 197/56760 170/107255 3504/236566 
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Table 2 Total female malaria deaths by year, age groups and by wealth quintiles, in Siaya County western Kenya 
SES Age Category 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total 
n/N [n=deaths N=Population] n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N 
Poorest <5years 37/60 21/64 51/57 26/57 15/78 13/78 9/873 6/873 8/1608 186/3748 
 5 -14 years 8/16 3/13 1/26 3/26 1/20 1/20 0/801 1/801 2/1602 20/3325 
 >=15 years 76/43 66/62 53/85 30/85 12/68 6/68 7/2291 11/2291 9/4169 270/9162 
  All ages 121/119 90/139 105/168 59/168 28/166 20/166 16/3965 18/3965 19/7379 476/16235 
2nd poor <5years 33/42 33/70 66/102 36/102 23/77 14/77 11/1279 14/1279 12/2273 242/5301 
 5 -14 years 4/19 1/31 2/37 3/37 5/58 0/58 3/1264 5/1264 0/2575 23/5343 
 >=15 years 24/50 24/68 17/95 8/95 7/83 0/83 2/2643 6/2643 4/5249 92/11009 
  All ages 61/111 58/169 85/234 47/234 35/218 14/218 16/5186 25/5186 16/10097 357/21653 
3rd poor <5years 37/68 24/76 52/75 36/75 15/95 15/95 13/1459 11/1459 7/2514 210/5916 
 5 -14 years 2/15 3/34 5/47 6/47 2/75 1/75 4/1613 3/1613 3/3313 29/6832 
 >=15 years 16/61 19/73 22/80 10/80 10/104 1/104 8/3127 8/3127 5/6128 99/12884 
  All ages 55/144 46/183 79/202 52/202 27/274 17/274 25/6199 22/6199 15/11955 338/25632 
4th poor <5years 26/51 24/87 50/108 30/108 23/70 12/70 9/1678 13/1678 13/2702 200/6552 
 5 -14 years 3/23 2/46 3/56 5/56 7/49 1/49 3/1973 1/1973 2/3746 27/7971 
 >=15 years 26/48 27/83 16/94 15/94 6/78 6/78 3/3868 5/3868 5/7148 109/15359 
  All ages 55/122 53/216 69/258 50/258 36/197 19/197 15/7519 19/7519 20/13596 336/29882 
Least poor <5years 12/43 18/104 59/87 27/87 16/81 10/81 6/1817 12/1817 5/2708 165/6825 
 5 -14 years 2/31 3/67 2/68 5/68 4/62 3/62 7/2398 4/2398 1/4605 31/9759 
 >=15 years 12/40 21/100 17/95 13/95 5/93 2/93 6/4617 3/4617 2/8540 81/18290 
  All ages 26/114 42/271 78/250 45/250 25/236 15/236 19/8832 19/8832 8/15853 277/34874 
Overall  318/610 289/978 416/1112 253/1112 151/2182 85/2182 91/31701 103/31701 78/58880 1784/130458 
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YLD, YLL, and DALYs for males and females  
Overall, among the females, total number of years lived with disability (YLD) due to malaria 
illness irrespective of age category was 61.9 (95%CI=61.7-62.1) amongst the individuals in 
poorest households compared to 99.9 (95%CI=99.7-100.1) in the least poor households 
while, YLL irrespective of age was 16,680 (95% CI=16,574 -16,686) and 14,122(CI=14,016-
14,227) amongst the poorest and richest households respectively. The DALYs amongst 
females, irrespective of age group were 15% higher amongst individuals in the poorest 
households than in the least poor households (see table4). Among males in the poorest 
households, YDLs was 68 (95%CI= 67.4-67.8), while in the least poor households the figure 
stood at 94 (95%CI=93.7-94.2). The YLL and DALYs for males in the poorest and richest 
households did not show any significant difference (Table 5). Among all age categories 
regardless of gender and socio-economic status, children under 5yrs of age disproportionately 
bear a higher burden of malaria in terms of DALYs (Table 4&5). Among all age categories 
irrespective of gender, years lived with disability (YLD) was in favour of the least 
disadvantaged quintiles as indicated by a positive concentration index of 0.0633(95%CI= (-
0.0078 -0.1344), 0.6947(CI=0.275 -0.1114) while the Disability-adjusted life years (DALYs) 
was in favour of the poorest households with a negative concentration index of -
0.0283(95%CI=-0.07363 -0. 0169) and -0. 0112 (95%CI=-0.041 -0.0125) for females and 
males respectively. 
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Table 3  Total male deaths by year, age and SES  in the KEMRI CDC HDSS, Western Kenya 2006-2014 
socioeconomic 
status 
Age Category 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total 
Poorest <5years 32/60 28/64 42/57 39/57 21/78 16/78 9/873 7/873 13/1608 207/3748 
 5 -14 years 1/16 3/13 3/26 4/26 4/20 0/20 3/801 3/801 2/1602 23/3325 
 >=15 years 28/43 31/62 25/85 17/85 10/68 4/68 4/2291 4/2291 6/4169 129/9162 
  All ages 61/119 62/139 70/168 60/168 35/166 20/166 16/3965 14/3965 21/7379 359/16235 
2nd poor <5years 43/42 22/70 47/102 46/102 35/77 12/77 16/1279 16/1279 12/2273 249/5301 
 5 -14 years 1/19 3/31 2/37 5/37 1/58 4/58 2/1264 2/1264 3/2575 23/5343 
 >=15 years 18/50 31/68 19/95 8/95 6/83 2/83 3/2643 3/2643 3/5249 93/11009 
  All ages 62/111 56/169 68/234 59/234 42/218 18/218 21/5186 21/5186 18/10097 365/21653 
3rd poor <5years 32/68 28/76 63/75 35/75 19/95 13/95 12/1459 12/1459 8/2514 222/5916 
 5 -14 years 5/15 6/34 5/47 3/47 8/75 1/75 3/1613 3/1613 1/3313 35/6832 
 >=15 years 12/61 18/73 14/80 5/80 7/104 3/104 6/3127 6/3127 3/6128 74/12884 
  All ages 49/144 52/183 82/202 43/202 34/274 17/274 21/6199 21/6199 12/11955 331/25632 
4th poor <5years 23/51 27/87 49/108 29/108 26/70 16/70 10/1678 10/1678 6/2702 196/6552 
 5 -14 years 4/23 4/46 2/56 1/56 3/49 3/49 3/1973 3/1973 4/3746 27/7971 
 >=15 years 21/48 22/83 23/94 10/94 7/78 3/78 5/3868 5/3868 7/7148 103/15359 
  All ages 48/122 53/216 74/258 40/258 36/197 22/197 18/7519 18/7519 17/13596 326/29882 
Least poor <5years 20/43 17/104 51/87 38/87 24/81 12/81 13/1817 13/1817 10/2708 198/6825 
 5 -14 years 7/31 3/67 5/68 7/68 3/62 2/62 3/2398 3/2398 4/4605 37/9759 
 >=15 years 21/40 16/100 22/95 14/95 8/93 5/93 4/4617 4/4617 10/8540 104/18290 
  All ages 48/114 36/271 78/250 59/250 35/236 19/236 20/8832 20/8832 24/15853 339/34874 
Overall Total 268/610 259/978 372/1112 261/1112 182/2182 96/2182 96/31701 94/31701 92/58880 1720/130458 
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Table 4. Absolute Malaria-related YLDs, YLLs, and DALYs amongst Females in Siaya County, Kenya 
Socioeconomic 
status 
 
 
 
Age 
Category 
Years 
lived 
with 
disability 
(YLD) 
 
 
95% CI 
Lower     Upper 
Years lost 
due to 
premature 
death 
 
 
95% CI  
Lower         Upper 
Disability 
Adjusted 
Life 
Years 
(DALYs) 
 
 
95% CI  
Lower         upper            
Poorest <5years 19.9 19.7 20.02 11,167 11,066 11,268 11,187 11,086 11,288 
 5 -14 years 24 24 25 1,166 1,065 1,267 1,191 1,089 1,292 
 >=15 years 18 17 18 4,347 4,246 4,448 4,364 4,263 4,465 
  All ages 62 62 62 16,680 16,574 16,686 16,742 16,636 16,847 
2nd poor <5years 33 33 34 14,593 14,491 14,694 14,626 14,525 14,727 
 5 -14 years 30 30 31 1,369 1,267 1,470 1,399 1,298 1,500 
 >=15 years 21 21 21 2,409 2,308 2,511 2,431 2,329 2,532 
  All ages 85 85 85 18,371 18,265 18,476 18,455 18,350 18,561 
3rd poor <5years 36 36 36 12,605 12,503 12,706 12,640 12,539 12,742 
 5 -14 years 38 38 39 1,734 1,633 1,836 1,773 1,672 1,874 
 >=15 years 22 21 22 2,736 2,634 2,837 2,757 2,656 2,858 
  All ages 96 96 96 17,074 16,969 17,180 17,170 17,065 17,276 
4th poor <5years 36 36 37 12,117 12,016 12,218 12,154 12,052 12,255 
 5 -14 years 38 38 38 1,578 1,477 1,679 1,616 1,515 1,717 
 >=15 years 23 23 23 3,206 3,105 3,307 3,229 3,128 3,330 
  All ages 97 97 97 16,902 16,796 17,007 16,999 16,893 17,104 
Least poor <5years 33 33 33 9,954 9,853 10,055 9,987 9,886 10,088 
 5 -14 years 41 41 41 1,868 1,767 1,969 1,909 1,808 2,010 
 >=15 years 26 26 26 2,299 2,198 2,400 2,325 2,224 2,426 
  All ages 100 100 100 14,122 14,016 14,227 14,221 14,116 14,327 
Concentration Index          
 <5 years 0.0633 -0.0078 0.1344 -0.0289 -0.07419 0.01643 -0.0283 -0.07362 0.0169 
 5-14 years 0.06623 -0.0080 0.1405 -0.0377 -0.0782 0.0027 -0.03713 -0.07750 0.0032 
 15 + years 0.07170 -.00151 0.14490 -0.0224 -0.06657 0.02172 -0.0219 -0.0658 0.0220 
 
 
 
 
 
 
 
 
 132 
  
Table 5. Absolute Malaria-related YLDs, YLLs, and DALYs amongst males in Siaya 
County, Kenya 
Socioeconomic 
status 
Age 
Category 
Years 
lived 
with 
disability 
 
 
95% CI  
Lower  upper 
Years lost 
due to 
premature 
death 
 
 
95%CI 
Lower        Upper 
Disability 
Adjusted 
Life 
Years 
 
 
95% CI  
Lower  Upper 
Poorest <5years 25.8 25.6 26.0 11,965 11,859 12,070 11,990 11,884    12,096  
 5 -14 years 31.7 31.5 31.9 1,111 1,005 1,216 1,142 1,037      1,248  
 >=15 years 10.1 9.9 10.4 2,622 2,516 2,727 2,632 2,526      2,737  
  All ages 67.6 67.4 67.8 15,697 15,591 15,703 15,764 15,658   15,870  
2nd poor <5years 29.2 29.0 29.5 14,600 14,494 14,705 14,629 14,523    14,735  
 5 -14 years 27.7 27.5 27.9 1,259 1,153 1,365 1,287 1,181      1,393  
 >=15 years 12.4 12.2 12.7 2,348 2,243 2,454 2,361 2,255      2,466  
  All ages 69.3 69.1 69.6 18,207 18,101 18,313 18,276 18,171   18,382  
3rd poor <5years 34.0 33.8 34.2 12,925 12,820 13,031 12,959 12,853    13,065  
 5 -14 years 44.3 44.1 44.5 2,051 1,945 2,156 2,095 1,989      2,201  
 >=15 years 13.9 13.7 14.2 1,656 1,550 1,761 1,670 1,564      1,775  
  All ages 92.3 92 92.5 16,631 16,526 16,737 16,724 16,618   16,829  
4th poor <5years 36.1 35.9 36.3 11,988 11,883 12,094 12,024 11,919    12,130  
 5 -14 years 41.6 41.4 41.9 1,480 1,374 1,585 1,521 1,415      1,627  
 >=15 years 15.3 15.1 15.5 2,395 2,289 2,500 2,410 2,304      2,516  
  All ages 93.0 92.8 93.3 15,863 15,757 15,968 15,956 15,850   16,061  
Least poor <5years 28.1 27.8 28.3 11,014 10,908 11,120 11,042 10,936    11,148  
 5 -14 years 45.1 44.8 45.3 2,193 2,087 2,298 2,238 2,132      2,343  
 >=15 years 20.8 20.6 21.1 2,545 2,439 2,651 2,566 2,460      2,672  
  All ages 94.0 93.7 94.2 15,752 15,646 15,857 15,845 15,740   15,951  
Concentration Index          
 <5 years 0.06947 0.0275 0.1114 -0.0116 -0.04285 0.01967 -0.0112 -0.042 0.0200 
 5-14 years 0.06478 0.0146 0.1149 -0.0148 -0.0416 0.0121 -0.01430 -0.041 0.0125 
 15 + years 0.06455 0.01441 0.11468 -0.0094 -0.03823 0.01953 -0.0090 -0.038 0.0198 
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Trends in Socio economic inequalities in DALYs. 
Over the 9 years under surveillance, DALYs reduced nearly 3-fold, from 11,283 in 2006 to 
4,026 in 2014. In each socioeconomic group, the trend remains the same between 2006 and 
2014 (see table 6). The poorest 60% of the households, accounts for more than 60% of 
malaria burden in terms of DALYs (52,364) while the least poor 40% of the households 
accounted for only 38% of the total DALYs (31,220).In all the socioeconomic groups, 99% 
of the total DALYs were due to YLL and only one per cent was accounted for by YLD. 
Disability-adjusted life years were higher amongst poor households for all the 3 age 
categories with negative concentration indexes of -0.0283, 95% (CI=-0.0371 -0.0219) for 
females and -0.0112, 95% (CI= -0.0143, - 0.0090) for males (tables 4&5). 
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Table 6 Distribution of DALYs amongst males, 2006 – 2014 in Siaya County, Kenya. 
Socioeconomic status Age Category 2006 2007 2008 2009 2010 2011 2012 2013 2014  Total 
Poorest <5years 1216 2081 3009 1570 952 836 594 393 536  11,187 
 5 -14 years 174 448 59 181 67 64 2 66 130  1,191 
 >=15 years 1122 1294 902 411 257 84 78 119 97  4,364 
  All ages 2,512 3,822 3,970 2,161 1,276 983 674 578 763  16,739 
 
2nd poor <5years 1913 1857 3895 2174 1459 883 728 915 801  14,625 
 5 -14 years 59 225 117 182 312 2 179 319 3  1,398 
 >=15 years 584 662 477 230 207 2 52 131 86  2,431 
  All ages 2,556 2,743 4,489 2,586 1,978 887 959 1366 891  18,455 
 
3rd poor <5years 1391 2081 3069 2175 956 946 842 721 460  12,641 
 5 -14 years 161 120 292 361 133 64 254 194 194  1,773 
 >=15 years 529 486 617 286 254 28 203 206 149  2,758 
  All ages 2,080 2,687 3,978 2,821 1,343 1,038 1,299 1,121 803  17,170 
 
4th poor <5years 1391 1462 2950 1813 1459 757 600 853 869  12,154 
 5 -14 years 109 169 176 282 434 64 193 69 122  1,618 
 >=15 years 833 790 449 426 155 152 90 205 129  3,229 
  All ages 2,333 2,421 3,574 2,522 2,047 974 882 1,127 1,119  16,999 
 
Least poor <5years 1043 697 3481 1630 994 631 393 786 331  9,986 
 5 -14 years 175 105 118 303 254 187 442 258 67  1,909 
 >=15 years 585 365 530 371 130 44 155 92 52  2,324 
  All ages 1,803 1,167 4,129 2,305 1,378 862 991 1,136 450  14,221 
 
 Overall 11,283 12,841 20,141 12,396 8,022 4,744 4,806 5,328 4,026  83,587 
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Discussion. 
This study shows that the malaria burden in terms of DALYs has significantly fallen over the 
9 years of surveillance. This suggests that the malaria control program implemented within 
Siaya County and across the country are working and able to keep down malaria morbidity 
and mortality. The results have also revealed that poorer households generally bear a higher 
burden of malaria in terms of disability-adjusted life years compared to richer households. 
Richer households due to their high purchasing power, are able to easily afford malaria 
control and treatment commodities and therefore, can easily control, manage and treat 
malaria cases. Our results are consistent with a study done in Malawian which he analyzed 
the relationship between household income and economic burden of malaria; they concluded 
that households with low- income disproportionately bear the economic burden of malaria 
compared to higher-income households[97]. This study had demonstrated more 
comprehensively the huge economic burden of malaria illness being borne by poor 
households in developing countries and especially those who are economically disadvantaged 
and it has added weight to international calls for more investment in disease prevention and 
pro-poor curative health services[97]. A South African national burden of disease study in the 
year 2000 estimated that HIV accounts for 39% of YLL, trauma (violence and road traffic 
accidents) for 10.5%, tuberculosis for 4.7% and diarrheal diseases for 4.2% of YLL[106]. 
These were the leading causes of premature mortality in South Africa then and together made 
up over 58% of YLL. Of the diseases included in the study, HIV and other communicable 
diseases were found to be more heavily concentrated among poor socioeconomic groups than 
richer socioeconomic groups[106]. The South African study investigated socio-economic 
related health inequality for self-reported ill health and disability in the country and reported 
that ill health and disability were more in favour of poor households than the rich ones.1The 
study further demonstrated that the trend in the magnitude of socioeconomic related 
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inequalities tended to decline overtime[107]. Our results further showed an unexpected 
increase in years of life lived with disability across socioeconomic groups, with the least poor 
households bearing the highest-burden in terms of years lived with disability, the cause of 
this is unclear but it could have been driven by one age category (5-14years) which has not 
been targeted by most malaria control interventions and has consistently maintained a high 
number of years lived with disability in all quintiles. Of all the age categories, children under 
5years of age have the highest number of years of life lost due to premature death (YLLs) in 
all quintiles. The use of DALY philosophy is key in assisting governments to set health 
service priorities; identifying disadvantaged groups and targeting of health interventions; and 
providing a comparable measure of output for intervention, program and sector evaluation 
and planning[92]. WHO technical strategy set an ambitious but achievable goal for 2030, of 
reducing malaria case incidence and malaria-related mortality by at least 90%.[33]. To do this 
there is still a need to monitor the socioeconomic effect of malaria control intervention on 
equity in terms of years lost due to disability. There will still be a need to understand how 
malaria case incidence and mortality are distributed among various socioeconomic groups in 
guiding pro-poor interventions to achieve equity in the fight against malaria infection and 
mortality in endemic areas. 
 
Limitations 
Since our DALYs have been expressed as absolute estimates, we can only provide an idea 
about the total population but not the relative health status of the population. Given the 
absolute numbers, we might not be able to make direct comparisons of health status for 
different population groups (e.g. 200 per 10,000 population). Since DALYs have not been 
expressed relative to the number of cases, it is not easy to make a comparison of the disease 
impact at patient –level (e.g. 50 per 1000 cases). Second limitation; since in the calculation of 
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DALYs we have not applied age weighting and time discounting, it will not be easy for the 
DALY estimates to be compared with other similar estimates. KEMRI HDSS is situated 
largely a rural setting, therefore it was not easy to clearly distinguish between the poor and 
least poor population groups using socioeconomic indices. For example, the DALY estimates 
for the males in this study did not show any significant difference between the poorest and 
least poor households. This may cause a bias in favour of either the poor or the rich. This 
coupled with the fact that asset index methodology does not consider the quantity and quality 
of the assets possessed by the households, the difference among various socioeconomic 
groups could become even more obscure. A study from rural western Kenya compared the 
three methods of ranking households into SES quintiles and established that although the 
methods produced similar results, MCA gave the highest percentage of the total variation for 
the household asset variables and thus the largest weights for the variables. The study 
concluded that MCA was a better model for generating asset weights than PCA or Polychoric 
PCA.21 The study further conducted comparison between ordinary PCA and MCA and 
established that 93% of households were placed in the same quintile by both methods, 87% of 
the households by ordinary PCA and Polychoric, and 91% by Polychoric and MCA and that 
ordinary PCA asset index was statistically significantly correlated with the index based on 
MCA (r = 0.997, p < 0.01[27].  The use of MCA could not have resulted in any significant 
bias given that it was the best amongst all the methods tested. 
 
Conclusion. 
Poor households, children < 5 years in poor households and women disproportionately bore 
the higher burden of malaria compared to the least poor households, older children or males.  
Although socioeconomic inequalities in the economic and population burden of malaria still 
exist, the decline may be due to increased intensification of malaria control over time.  
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Interventions targeting the poor, female and children <5 should be considered to bring down 
overall morbidity and mortality due to malaria in economic perspective. Although children 5-
14 years have the highest burden of morbidity, children <5 had the highest years lost due to 
premature deaths hence the highest DALYs. 
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Abstract 
Introduction: Historically, Kenya has used various distribution models for long-lasting 
insecticide-treated nets (LLINs) with variable results in population coverage.  The models 
presently vary widely in scale, target population, and strategy. There is limited information to 
determine the best combination of distribution models, which will lead to sustained high 
coverage and is operationally efficient and cost-effective. Standardized cost information is 
needed in combination with program effectiveness estimates to judge the efficiency of LLIN 
distribution models and options for improvement in implementing malaria control 
programmes. The study aims to address the information gap, estimating distribution cost and 
the effectiveness of different LLINs distribution models, and comparing them in an economic 
evaluation.  
 
Methods: Evaluation of cost and coverage will be determined for five different distribution 
models in Busia County, an area of perennial malaria transmission in western Kenya.  Cost 
data will be collected retrospectively from health facilities, Ministry of Health, donors and 
distributors. Program-effectiveness data, defined as the number of people with access to an 
LLIN per 1,000 population, will be collected through a triangulation of data from a nationally-
representative, cross-sectional malaria survey, a cross-sectional survey administered to a sub-
sample of beneficiaries in Busia County and LLIN distributors’ records. Descriptive statistics 
and regression analysis will be used for the evaluation. A cost-effectiveness analysis will be 
performed from a health-systems perspective, and cost-effectiveness ratios will be calculated 
using bootstrapping techniques. 
 
Ethics and Dissemination: The study has been evaluated and approved by the Kenya 
Medical Research Institute, Scientific and Ethical Review Board (SERU No. 2997).All 
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participants will provide written informed consent. The findings of this economic evaluation 
will be disseminated through peer-reviewed publications.  
 
Keywords: Economic evaluation, Insecticide-treated bed nets, supply, and distribution, Cost 
analysis  
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Strengths and limitations of this study 
- The main strength of our study is that it is the first to look at the cost-effectiveness of 
parallel net distribution channels and coverage results that can be expected from each 
channel based on financial inputs.  
- The main weakness of the study is that it localized in one county of western Kenya and 
therefore, the results might not be representative or generalizable to all of Kenya or 
other countries.  
 
Background 
In Kenya, five channels of distributing long-lasting insecticide-treated bed nets (LLINs) have 
been used historically in the implementation of malaria control programmes with variable 
results in population coverage [1–6]. In 2004, when LLINs were distributed through the 
commercial retail sector and heavily-subsidized social-marketing schemes in rural shops and 
public health facilities, LLIN coverage was estimated at 7.1% [5 and 6]. By 2005, coverage 
with LLINs increased to 23.5% with the provision of free LLINs in antenatal care and child 
health clinics in public health facilities [7]. In 2011, LLIN coverage dramatically increased to 
67% after the free distribution of LLINs in a Ministry of Health (MoH) mass distribution 
campaign with the goal of universal coverage, defined as one LLIN per two people in each 
household [1–4]. In addition, since 2001, heavily-subsidized LLINs have been distributed 
through social-marketing outlets in rural areas (i.e., approximately 600,000–800,000 nets 
annually) [1&3]. In 2012, the National Malaria Control Program (NMCP)/MoH, began a 
concerted effort to scale up malaria community case management. Using community health 
volunteers to distribute nets, a continuous LLIN distribution pilot project was implemented in 
2014–15, in Samia, an administrative location in Funyula division of Busia County in western 
Kenya.  
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Post-campaign surveys after the rolling 2011–2012 universal coverage mass distribution 
demonstrated low LLIN usage among all age groups [8]. For children less than 5 years old, 
usage ranged from 28–59% across the different malaria epidemiological zones and 31–50% in 
the general population across zones [5, 9 and 10]. The proportion of persons using LLINs did 
not increase significantly after the year 2011–2012 mass campaign compared to the 2010 
Kenya Malaria Indicator Survey (KMIS), which showed that the proportions of children under 
5 years of age and general population who slept under an LLIN the previous night were 42% 
and 39%, respectively [5, 9 and 10].  
By mid-2014, only 34% of households nationally met the universal coverage indicator of one 
LLIN per two people [11]. Access to nets, defined by attaining universal coverage at the 
household level, is directly associated with the use of nets by both children under 5 years of 
age and all household members. In households that met universal coverage (i.e., having at least 
one LLIN for every two people), 87% of children under 5 years of age slept under a net the 
previous night compared to 49% in households without universal coverage [7]. Thus, a major 
part of the solution to increasing net use in Kenya is to increase the number of nets within a 
household to ensure universal coverage. Despite multiple functional distribution channels and 
massive investments, LLIN coverage still remains well below the Kenya National Malaria 
Strategy 2009─2017 (NMS) and World Health Organization goals of having at least 80% of 
people living in malaria-risk areas using LLINs  [2, 5 and 9].  
Studies from various parts of Africa indicate that the use of LLINs has a beneficial effect on 
malaria transmission, severe malaria and mortality [12 and 13]. Similarly, there are numerous 
studies demonstrating the cost-effectiveness of LLINs in different parts of the world and in 
various contexts [14, 15, 16, 17 and 18]. However, information is limited to the actual costs of 
parallel distribution channels in the same context and coverage results that can realistically be 
achieved from each channel based on financial inputs [19]. In 2013, Kenya devolved 
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responsibility for health service delivery from the central government to 47 county 
governments as mandated in the 2010 Constitution of Kenya. This major restructuring 
potentially creates challenges due to inconsistencies in practice, duplicate structures, and may 
hamper malaria control. 
In this new and evolving health services delivery context in Kenya, the NMCP/MoH, counties, 
donors and stakeholders require evidence-based, cost-effectiveness data on LLIN distribution 
channels to make informed, rational decisions for program implementation and targets. This 
study is intended to help provide the evidence required for decision making.  The goals of this 
economic evaluation are, therefore, to determine the actual cost of delivering a net to the end-
user in each channel and the coverage levels that can be achieved given a financial input. The 
economic evaluation results will help inform both policy and program implementation by 
establishing the costs and outcomes for each LLIN distribution channel in Kenya.   
 
Objectives 
The main objective of the economic evaluation is to assess the allocative efficiency of a limited 
budget to support the implementation of LLINs as a prevention strategy and determine the most 
cost-effective mix of LLIN distribution channels that would maximize coverage for 
beneficiaries. 
Specific objectives  
Determine and compare the unit cost associated with distributing an LLIN to a beneficiary 
through the following distribution channels: 
a. Universal coverage mass distribution campaigns 
b. Routine distribution through  antenatal and child health clinics 
c. Continuous community distribution by community health volunteers  
d. Social marketing by community-based organizations through rural outlets 
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e. Commercial retail outlets  
Determine and compare the proportion of coverage defined as the following: 
a. Universal coverage (i.e., one LLIN per two people per household) 
b. At least one LLIN per household  
The principal health economic research question is: Do the current LLINs distribution 
channels represent an efficient allocation of scarce resources?  
Therefore, specific research questions were as follows: 
a. What is the impact of the current LLINs distribution channels on health-systems 
costs? 
b. What are the costs and outcomes of the five different LLINs distribution channels? 
c. What are the main cost drivers in the distribution of LLINs? 
 
Methods and design 
Ethical approval 
The study has received ethical approval from Kenya Medical Research Institute, Scientific 
and Ethical Review Board (SERU No. 2997). 
 
Costing Study design. 
The study is a retrospective economic evaluation from the provider’s perspective involving 
five arms to compare the costs and effectiveness of the LLIN distribution channels in Busia 
County, western Kenya.  The arms of the study are shown in Figure 1. 
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Description of LLINs distribution channels (comparators) 
The five different LLIN distribution channels that will be evaluated are briefly described here 
and illustrated in Figure 1. 
1. Universal coverage mass distribution campaigns which entail the distribution of LLINs 
to all households in endemic and epidemic-prone areas (i.e., 23 counties) every 3 years. 
The campaign is planned and implemented by the NMCP/MoH with financial support 
from donors. The LLINs are procured by the NMCP/MoH and donors and distributed 
to health facilities in the 23 counties as part of the procurement contract.  Prior to 
distribution, a household registration is undertaken whereby small teams of local MoH 
staff and community leaders register all households and the number of persons per 
household in a given geopolitical location or catchment area. The LLINs are distributed 
to health facilities and central storage points in each county based on the household 
registration. The head of the household or designated person comes to the designated 
health facility during the campaign time frame, which is generally 3–5 days, to collect 
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the number of LLINs based on the number of persons registered in their household. 
One LLIN per two persons per household is provided free of charge to beneficiaries. In 
Kenya, there is no household distribution of LLINs during the campaign or after. 
Registered persons who do not come to the health facilities to collect LLINs do not 
receive nets. Households receive communications for both the household registration 
and campaign distribution dates through community meetings, local radio 
announcements, health facilities, and other communication channels. The local MoH 
and county government leadership comprise the majority of staff for mass LLIN 
distribution campaigns. In the rolling 2014–2015 universal coverage mass distribution 
campaign, approximately 12.6 million LLINs will be distributed in 23 counties [5].     
2. Routine distribution of one free LLIN to every pregnant woman at the first antenatal 
clinic visit and to every child less than 1 year of age at first immunization visit in public 
and not-for-profit health facilities in endemic, epidemic-prone and seasonal 
transmission areas (i.e., 36 counties). The distribution of LLINs via antenatal care and 
child health clinics is implemented by a non-governmental organization (NGO) in 
coordination with the NMCP/MoH and with financial support from donors. All routine 
LLINs are procured through one NGO partner. All routine LLINs are transported, 
stored in regional warehouses and distributed to health facilities by a second NGO 
partner. The second NGO partner manages all aspects of the supply chain for LLINs in 
accordance with national policy and in coordination with the NMCP/MoH. In 2015, 
approximately 3 million LLINs will be distributed to meet NMCP/MoH targets for 
routine antenatal care and child health clinic distribution. 
3. Pilot continuous LLIN distribution project using community health volunteers to 
distribute vouchers for nets to community members in a portion of one county. The 
community health volunteers confirm the need for new LLINs at the household level, 
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either because the household does not have enough LLINs for universal coverage or to 
replace worn-out or non-protective nets. The voucher is taken by the community 
member to a designated community health facility and redeemed for free LLINs. The 
pilot project was implemented in three sub-counties in Busia County, western Kenya. 
The pilot was implemented by an NGO partner in coordination with the NMCP/MoH 
and with financial support from donors. All LLINs were procured, transported, stored, 
and distributed to health facilities by the NGO partner. The NGO partner managed all 
aspects of the voucher process and LLIN supply chain in coordination with the 
NMCP/MoH. The community health volunteers are each assigned approximately 50 
households in a village and are linked to health dispensaries or health centres for 
reporting purposes, commodity supply (e.g., malaria rapid diagnostic tests and 
medications for case management) and supervision by the community health extension 
worker.  The community health volunteers do not get a formal salary but receive a 
modest stipend from the county government or NGO partners [3].  Approximately 
100,000 nets were intended for the continuous community distribution pilot project 
from October 2014 to March 2015. 
4. Social marketing of heavily-subsidized LLINs in rural shops and by community-based 
organizations in endemic, epidemic-prone and seasonal transmission areas, including 
Busia County. The distribution of socially-marketed LLINs is a partnership between a 
primary NGO partner, multiple community-based organizations, rural outlets and the 
NMCP/MoH and with financial support from donors. All socially-marketed LLINs are 
procured, transported, stored and distributed to the sellers by one NGO partner. The 
NGO partner manages all aspects of the supply chain for LLINs in coordination with 
the NMCP/MOH.  The rural shops and community-based organizations use 
communications mechanisms such as community gatherings, local radio, and TV shows 
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and advertisements, competitions, drama, and theatre to attract customers. In 2015, the 
target price for a socially-marketed LLIN was approximately 1.50 USD to the customer. 
Approximately 600,000–800,000 LLINs are sold via social-marketing channels 
annually.   
5. Commercial, for-profit-sector retailers stock and sell LLINs at market prices 
throughout Kenya. Prices vary widely based on geographic location, target market, 
manufacturer, brand, size, material and other factors.     
 
Study design 
Cost data will be collected retrospectively from a provider’s perspective from health facilities, 
NMCP/MoH, NGO partners, donors, stakeholders, distributors and the Kenya Medical Supply 
Agency (KEMSA). KEMSA is the central medical store and provides supply chain 
management of malaria commodities from the national to facility levels. Data on outcomes will 
be triangulated from a nationally-representative cross-sectional survey of over 6,300 
households, a cross-sectional survey administered to a sub-sample of beneficiaries in Busia 
County, and distributor’s records. The evaluation will involve comparing the costs of 
distribution and outcomes for each distribution channel. For cost estimates, we will use a 
bottom-up approach, combining activity-based costing (ABC), ingredient approach and budget 
expenditure data [20 and 22]. The bottom-up approach is an established micro-costing 
technique that has been successfully applied to diverse settings in corporate and healthcare 
sectors [20, 21, 22, 23 and 24]. In contrast to traditional costing systems, in which direct, 
indirect and overhead costs are aggregated and assigned proportionally based on unit volume 
produced or services delivered, micro-costing assigns costs more accurately by delineating 
specific services or processes responsible for actual resource consumption. Resources will be 
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organized into cost categories as summarized in Table 1. Cost drivers from each cost category 
will be quantified and unit cost per net distributed will be calculated.  
 
Table 1: Description of key categories of costs and sources 
Cost category                            Information Source 
Labor 
Disaggregated into cadre and type         MOH, sub-county health 
offices, Partner records, and staff interviews                                                                                                                                                                            
                                                                                                
Transport               MOH, sub-county health 
offices, Vehicles       
Motorbikes partner records, retailers 
and staff interviews 
Bicycles 
Fuel 
Maintenance 
Hired vehicles 
Equipment       MOH, sub-county health offices, 
partner records and staff interviews 
Personal protective       
Mobile phones 
Laptops 
Other equipment 
 
Supplies       MOH, sub-county health offices, 
partner records, donor records and staff   interviews                                                                         
Mobile phone and talk time                                                                 
Other supplies 
Other inputs  
Print and radio advertisements          MOH, county health offices, 
partner records, donor records and staff   interviews 
Community mobilization                                                                                                                                                                                                                                  
Meeting space      
Warehousing 
Security  
Waste management 
Overhead costs of partners, retailers 
 Other inputs 
 
MOH=Ministry of Health 
 
Cost data will be obtained from financial reports and budgets of NGO partners, NMCP/MoH, 
KEMSA, and Busia County Directorate of Health, community-based organizations, Ministry 
of Finance/National Treasury and other available sources. To ease understanding and facilitate 
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comparisons, costs in Kenya shillings will be converted into U.S. dollars (USD) depending on 
the currency of the original expenditure and the average Kenya Central Bank exchange rate for 
the period of the expenditure.  
Sample size calculations 
For outcome data, a cross-sectional survey will be conducted in randomly selected households 
in Busia County to collect data on coverage and source of nets. A list of households will be 
obtained from the community unit registers. The sample size was calculated assuming a 
universal coverage of 40% (defined as two persons per one LLIN per house). The least effect 
size in LLIN coverage levels expected from the distribution channels is 15%.  This will result 
in a minimum sample size of 456 households to be surveyed assuming a 5% margin of error 
and 80% power to detect differences in coverall levels. An additional 30% to account for 
refusals and absentees during the survey will be added to obtain a target sample size of 592 
households.  
Interviewers will explain to all participants that involvement in the study is voluntary and that 
they have the right to withdrawal at any point in time and ask any questions. Information about 
the study will be read to all participants and provided in a hard copy. All consenting participants 
will be asked to sign two standard consent forms (that is one for the interviewee and one 
retained by the interviewer). 
Effectiveness measures 
The main effectiveness measure is the percentage of persons using an LLIN for malaria 
prevention in at-risk areas; the NMCP/MoH and WHO target for this indicator is at least 80% 
of the population [5]. Two additional effectiveness measures will based on WHO and the Roll 
Back Malaria Monitoring and Evaluation Reference Group (RBM MERG) indicators used for 
monitoring achievement of universal coverage: percentage of households with universal 
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coverage with LLINs (i.e., one LLIN per two persons per household) and percentage of 
households with at least one LLIN  [5].  
The main health economics-related outcomes are the total and unit cost of distributing an LLIN 
through each of the five current distribution channels. Additional outcomes are the mean and 
median cost by distribution channel categorized by quartiles and household outcome, the total 
and mean cost by distribution channel and by cost category and the incremental cost of the 
distribution channel compared with other channels.  Savings will be recorded as negative 
incremental costs. 
Economic evaluation 
The cost and effectiveness of the outcomes of the five distribution channels will be compared 
with each other and analyzed using cost-effectiveness methods [15, 16, 17, 18 and 19]. To 
analyze the effectiveness of the distribution channel with regards to the cost and outcome 
measures, descriptive statistics and a generalized linear regression model were used because 
cost data is usually not normally distributed [15, 16, 17 and 18]. The analysis will include a 
comparison of the different distribution channels as well as a multi-level analysis focusing on 
cost categories. 
Cost-effectiveness ratios will be calculated based on the primary outcome measure in relation 
to a range of health economics outcomes (e.g., total, mean, median and incremental costs) for 
each LLIN distribution channel. Financial costs will be adjusted to obtain economic costs and 
assign costs to donated items as well as the time of volunteers included in some of the 
distribution channels. The LLIN distribution channels are generally expected to perform for 
more than one year and the capital items purchased to deliver the LLINs have a life expectancy 
in excess of 1 year. Similarly, LLINs are intended to last for 3 years in field conditions [19, 25 
and 26]. Therefore, capital costs will be expressed as an annual equivalent. Capital inputs that 
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will be annualized are LLINs, vehicles, and equipment using 3.5% as a discounting rate [15, 
16, 17, 18 and 19]. 
Cost-effectiveness will be calculated for each comparison and will be expressed as incremental 
cost-effectiveness ratios (ICERs). Mass campaigns are by far the largest channel by volume 
and assumed to be the least expensive and most efficient channel for distributing LLINs in 
Kenya; therefore, the campaign distribution channel will be used as a baseline for the 
comparative analysis. Due to time and resource constraints, the economic evaluation (i.e., cost-
effectiveness component) will be performed from a health-systems perspective (i.e., 
distributors and donors). Incremental cost-effectiveness ratios will be estimated using 
bootstrapping techniques and graphically presented on cost-effectiveness planes [21, 22, 23 
and 24]. For comparisons and ease of understanding, costs will generally be quoted in U.S. 
dollars.  
Cost estimates inevitably involve assumptions and uncertainty. Therefore, we will carefully 
identify critical assumptions and areas of uncertainty and re-estimate the results using different 
assumptions to test the sensitivity of the results and conclusions due to such change. We will 
perform both one-way and multi-way sensitivity analysis in order to assess the robustness of 
the results and examine the effect of common assumptions and uncertain variables on the 
evaluation findings [27 and 28]. An a priori analysis plan was developed and agreed upon prior 
to the initiation of data collection and analysis. 
 
Discussion and conclusion 
Although there is a robust literature around LLINs as the main malaria prevention and control 
strategy, there is very limited data on the cost-effectiveness of LLIN distribution channels in 
field settings. Therefore, national malaria control programmes, stakeholders and donors have 
limited information upon which to base policy and plan programmatic implementation to meet 
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national and international LLIN coverage target indicators. This economic evaluation is 
intended to provide the NMCP/MoH, partners, stakeholders and donor with evidence on the 
costs and resources required to deliver LLINs using current distribution channels and to assist 
in determining the efficient allocation of resources to meet target outcome measures.  
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Chapter 7: Universal household coverage with insecticide-treated bed nets - efficiency 
and equity outcomes in malaria-endemic western Kenya. 
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Abstract 
Background  
In malaria-endemic countries, long-lasting insecticide-treated bed nets (LLINs) have been 
distributed through various delivery channels. In Kenya, eight channels of distributing LLINS 
have been used in the implementation of malaria control programmes with variable results in 
population coverage. However, the is no sufficient data on the cost-effectiveness of various 
channels, assessing efficiency and equity effect of the interventions to aid decision-making on 
optimal distribution strategies to reach national/subnational targets. 
Methods 
We conducted a retrospective economic analysis from the provider perspective, comparing two 
combinations of five LLIN distribution channels: intervention arm where the channels were 
community health volunteers (CHV), ante-natal and child clinics (ANC), social marketing 
(SM) and commercial outlets (CO) and control arm where the channels were as above, yet 
instead of CHV distributing nets, nets were distributed via a mass distribution campaign (MD). 
We assessed coverage through cross-sectional surveys and interviewed program officers on 
costs, expenditures, and the number of nets distributed. We estimated cost per LLIN distributed 
from the demand and supply sides and assessed the equity effect. 
Findings 
The proportion of households with universal coverage (UC) was high for the pooled data (0.80; 
95% confidence interval CI= [0.77-0.83]. Overall, in the pooled data, 31.1% of nets were 
obtained from CHVs, 51.3% in the intervention arm and 15.4% in the control arm. Most nets 
overall were obtained from MD (51.7%), 28.1% in the intervention arm and 70.0% in the 
control arm.  MD channel was the most important source of nets overall and in all households 
followed by ANC while SM being the least important. MD had the lowest cost per net 
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distributed ($3·13) and CHV has the second-lowest ($10·84). SM had the highest cost ($92·41).  
Wealthier households owned more nets (CIn = 0.024). Of the nets obtained from CHVs, 33.4% 
were acquired by poorest households and 28.2% by wealthiest households. CHV followed by 
MD appeared to be the least inequitable channels and ANC most inequitable. 
Discussion 
A concerted effort with multiple distribution channels can achieve policy goals of universal 
LLIN coverage. Mass distribution campaigns plus other channels are the most cost-effective 
way to achieve universal coverage. None of the channels is pro-poor, however, community-
level distribution appears to be more equitable than the other channels, but the difference is not 
statistically robust. The study shows that combinations of multiple channels are required to 
reach and maintain high levels of LLIN use and achieve equitable LLIN ownership and use.  
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Introduction 
Long-lasting Insecticide-treated nets (LLINs) have played an important role in reducing the 
global malaria burden since 2000 [1] and the world health organization (WHO) Global 
Technical Strategy for Malaria 2016-2030 recommends universal coverage (UC) for all people 
at risk of malaria with either LLINs or indoor residual spraying (IRS) [108]. Throughout 
malaria-endemic countries, including Kenya, LLINs have been distributed through various 
channels [30, 109] and have been shown to be a cost-effective malaria control tool [110-114]. 
To achieve and maintain UC (defined as one LLIN per two persons per household), WHO 
recommends that countries develop and implement a single national LLIN plan and policy that 
includes both continuous and campaign distribution strategies through multiple channels based 
on identification of a combination of distribution channels with which to achieve universal 
coverage and minimize gaps in universal coverage[108]  
. 
In 2009, Kenya adopted a policy of LLIN UC in endemic and epidemic-prone areas with a 
targeted goal of achieving 80% of people living in malaria-risk areas using LLINs [31].  
Aggressive malaria control over the last decade has led to a decline in the overall burden of 
malaria nationally to 8% among children <15 years of age in 2014 [4, 53, 115]. Despite 
substantial progress, moderate-to-high levels of malaria transmission persist in some areas, 
including the endemic area around Lake Victoria in western Kenya where malaria parasite 
prevalence is 27% in children <15 years of age [4]. Like most malaria-endemic countries, 
Kenya has numerous channels to distribute nets including mass distribution campaigns, routine 
distribution through antenatal and child health clinics, continuous community distribution by 
community health volunteers, social marketing by community-based organizations through 
rural outlets, school-based distribution and via commercial retail outlets[112, 115-118]. 
However, evidence on the actual household coverage and delivery costs (i.e., cost-
 181 
  
effectiveness) of these channels is lacking, particularly for multi-channel distribution strategies 
in real operational settings [119]. This study reports household coverage and use levels for 
LLINs, the costs of delivering nets to the end-user for each distribution channel and compares 
the primary outcomes of universal coverage and equity for combinations of channels. The 
findings of this study will help to inform the Kenya LLIN policy, strategy and program 
implementation and help other malaria-endemic countries to develop strategies to meet UC 
goals for LLINs and reduce the malaria burden. Its findings are particularly relevant in the 
context of devolution and decreasing donor resources which makes it imperative to ensure that 
limited resources are used most effectively to reach the most at-risk populations.  
Methods 
 
Study design  
The study design, which is described elsewhere[30], compared the household coverage and 
delivery costs (i.e., total and unit cost per net distributed by channel) of the five distribution 
channels used in combination in one real-life intervention and one control setting. The channels 
evaluated were the following: 1) mass distribution campaign (MD), 2) routine continuous 
distribution via ante-natal clinic and child clinics (ANC), 3) a pilot of continuous net 
distribution using community health volunteers (CHV) to distribute LLIN vouchers to 
community members for redemption at health facilities (CHV), 4) continuous distribution via 
social marketing of subsidized LLINs in selected rural shops and commercial business outlets 
(SM), and 5) continuous distribution via commercial for-profit outlets that stock and sell LLINs 
at market prices (CO). Additional details of each distribution channel are provided in Table 1 
and (2). The school-based program was not used during this period. 
 
Two operational factors resulted in modifications to the published study design. First, the CHV 
pilot was initially planned to start directly after the MD to address gaps in UC and maintain 
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high coverage following the MD with the evaluation planned for 12 months following the MD. 
However, delays in the MD resulted in the pilot CHV distribution starting prior to the MD. The 
CHV pilot involved two phases: a 12-month top-up phase where CHVs distributed vouchers to 
households with the aim of achieving UC, and a 6-month continuous distribution phase where 
CHVs were responsible for monitoring coverage and distributing vouchers to maintain UC. In 
both phases of the CHV pilot, community members were responsible for travelling to health 
facilities to exchange vouchers for LLINs. Second, due to insufficient LLINs for the overall 
MD, the National Malaria Control Program (NMCP) made an operational decision to exclude 
from the MD the areas in Samia where the CHV distribution was piloted, hence the areas in 
Samia that were part of the CHV pilot distribution did not receive nets during the 2014-2015 
UC MD campaign. 
 
Study Site 
The study took place in Samia Sub-county, Busia County located in western Kenya. Samia is 
largely rural with some peri-urban pockets and has a population of approximately 120,000 
people living in 29 sub-locations, the smallest administrative unit in Kenya [120]. Samia is a 
malaria-endemic area with a prevalence of 27% in children <15 years of age, has a functioning 
health system including 12 public health facilities and an active community health volunteer 
(CHV) programme[4]. The 2011-2012 UC LLIN mass distribution campaign included Busia 
County; LLINs were distributed in Samia in 2011[118]. In 2014, 48.3% of households in Busia 
County had at least one LLIN for every two people [121]. 
 
Population, sampling strategy, and sample size 
The modified two-arm study design therefore consisted of an intervention arm with a 
combination of CHV, ANC, SM, and CO channels which was implemented in 18 sub-locations 
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with an estimated population of 63,772 and a control arm with a combination of MD, ANC, 
SM, and CO channels which was implemented in 11 sub-locations in Samia with a population 
of 55,474. Using probability proportional to size sampling, a total of 1000 (500 in each ram) 
were targeted and 879 households were finally interviewed. This was higher than the 592 
estimated in the protocol [30]. Households were selected randomly for the control and 
intervention sub-locations, from the list of households in the community unit register of the 
sub county[30]. 
 
Data Collection 
Costs and household survey data were collected retrospectively from the provider’s perspective 
(i.e. excluding community costs) from both the sites where intervention was implemented (use 
of CHVs) and areas where MD was used without CHVs (control). Therefore, the study design 
can be described as quasi-experimental and conducted in a real-life setting. A standardized 
post-intervention household survey tool was adapted to capture demographic and 
socioeconomic data and quantity, source and use of nets in the two arms after obtaining the  
consent from the head of household per protocol[30] 
 
Data Management and Analysis 
Household survey data were double entered, cleaned and analyzed in Stata and R. The cost 
data were calculated and analyzed in Ms excel spreadsheets.  The detailed analysis is as 
described below 
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Table 1a. Description of MD and ANC Channels being implemented and evaluated in Samia Sub-County, Busia County, Kenya 
Channel Scale/Location Timeframe Responsibility for 
Planning, Financing, 
and Procurement  
Responsibility for and Description of Distribution Activities 
Mass distribution 
campaign (MD) 
Nationwide programme: 23 
counties. In Samia, MD was 
carried out in 11 sub-locations 
referred to as control sub-
locations. 
Multi-phased UC campaign, 
2014-2015. 
Mass distribution in Busia 
County took place during 
October 2015 and completed in 
Samia Sub-County in 1 week. 
Planning, Coordination 
and Management 
NMCP/MoH 
Donor Financing 
Global Fund 
PMI 
Procurement  
Global Fund procured 
LLINs included 
distribution by the 
supplier to sub-county 
level 
PMI procured LLINs that 
were delivered to the 
Kenya Port. 
Enumeration 
Small teams of local MoH staff and community leaders registered all 
households and the number of persons per household in each area to quantify 
nets required and alert households to the campaign.  
IEC 
Community meetings, local radio announcements, health facilities and other 
communication channels used to inform the population about household 
registration and campaign distribution dates. 
Distribution 
PSK transported PMI procured nets from port to Samia. The household head 
(or a representative) came to the designated health facility during the 
campaign time frame (usually three to five days), to collect their LLINs. One 
LLIN per two persons per household was provided free of charge. There was 
no household-level distribution of LLINs during or after the MD. Registered 
persons who did not come to the health facilities to collect LLINs did not 
receive nets. NMCP staff supervised and managed the distribution 
Distribution via 
antenatal and 
child health 
clinics (ANC) 
National: 36 of 47 counties (all 
except counties in low-risk 
transmission zone) including 
Busia County.  
Ongoing since 2004, when free 
ITN distribution to pregnant 
women and children <5 years 
of age at maternal and child 
health (MCH) clinics started.  
Planning, Coordination 
and Management 
NMCP/MoH 
Donor Financing 
DFID 
PMI 
Procurement  
JSI and PSK procured 
LLINs delivered to 
Kenya Port 
Distribution 
PSK transported LLINs to the regional warehouse for storage. Nets were then 
distributed to health facilities by PSK who also managed the supply chain, in 
coordination with the NMCP/MoH. Pregnant women and children less than 1 
year of age were given one free LLIN at the first antenatal clinic appointment 
or on first immunization at child health clinics in public and not-for-profit 
health facilities. All 12 public sector health facilities in Busia were involved 
in the distribution, but two privately run ANC clinics were not used. 
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Table 2b Description of CHV, SM and CO implemented and evaluated in Samia Sub-County, Busia County, Kenya 
Channel Scale/Location Timeframe Responsibility for 
Planning, Financing, 
and Procurement  
Responsibility for and Description of Distribution Activities 
Distribution via 
community health 
workers (CHV) 
Pilot in Samia sub-county. 18 
intervention and 11 control sub-
locations (control sub-locations 
received MD).  
Top up Phase 
January - December 2014  
Continuous distribution phase 
January - May 2015 
Planning, 
Coordination and 
Management 
NMCP/MoH 
Donor Financing 
PMI 
Procurement  
PSK procured LLINs 
delivered to Kenya 
Port 
CHV recruitment and training 
PSK recruited and trained CHVs to assess the need for LLINs at the household level. CHVs are 
linked via health dispensaries or health centres for reporting purposes, commodity supply, and 
supervision by the community health extension worker (CHEW). CHVs do not get a formal salary 
but receive a modest stipend from the County government or NGO partners [3]. There are multiple 
CHVs in a village and each was assigned approximately 50 households for LLIN distribution. 
Net/Voucher Distribution  
PSK transported, stored, and distributed LLINs to health facilities and managed the voucher 
process. LLIN supply chain was managed by PSK in coordination with the NMCP/MoH. During 
the Top-up phase, CHVs visited households to assess how to achieve UC. Damaged nets were 
repaired with patch kits. Vouchers for new nets were given for additional or replacement (for worn 
out) nets. 
Community members took their voucher to a designated health facility and exchanged it for free 
LLIN/s. During the continuous distribution phase, CHV monitored households to ensure coverage 
of new householders and maintain UC.  
Social Marketing 
(SM) 
Operating in 14 Counties 
including all Sub-Counties in 
Busia County 
2004 to March 2016 Funding 
officially ended in March 2015, but 
the program continued through 
March 2016 to exhaust all nets and 
financial pipeline. 
Planning, 
Coordination and 
Management 
NMCP/MoH 
Donor Financing 
PMI 
DFID 
Procurement  
PSK procured LLINs 
delivered to Kenya 
Port 
Distribution 
LLINs were procured, transported, stored and distributed to the sellers by an NGO partner who 
managed the supply chain in coordination with the NMCP/MOH. Sellers included selected rural 
shops and by community-based organizations. In 2015, the target price for a socially-marketed 
LLIN was approximately 1.50 USD to the customer. Rural shops and community-based 
organizations used community gatherings, local radio and TV shows and advertisements, 
competitions, drama, and theatre to attract customers.  
 
Commercial 
outlets (CO) 
Assumed to operate throughout 
Kenya. 
Ongoing Private commercial retail and wholesalers finance and manage the entire process. There is no public-sector involvement in 
this distribution system other than via communication campaigns to promote LLIN use. Commercial for-profit retail outlets 
stock and sell LLINs at market prices. Prices vary widely based on geographic location, target market, manufacturer, brand, 
size, material and other factors. Householders visit retail outlets to purchase nets.  
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Effects 
As per the protocol, the main effectiveness measure is the (self-reported) proportion of the 
population that slept under an ITN the previous night. We also conducted a subgroup analysis 
on the proportion of children under five and pregnant women sleeping under a net the previous 
night. Next, we analysed the data from individual households and calculated the number and 
proportion of households with at least one LLIN and the number and proportion of households 
with and at least one net for two people (UC). Two additional (standard) indicators were also 
calculated: the proportion of the population with access to an ITN in their household and the 
proportion of existing LLINs use the previous night. These seven effect indicators were 
calculated for the whole sample (pooled data), control and intervention arms. Chi-squared or 
Fisher's exact test was used to test for association with study arm for each indicator. The 
difference in proportion between the control and intervention arm was calculated along with 
the confidence interval which was used to interpret the significance of any difference observed 
between the two arms. 
The overall number and percentage of nets observed in households by channel were calculated 
for the pooled, control and intervention arms. Data on the number of nets and the net source 
could give an unclear picture if a lot of the nets were concentrated in a few households, 
therefore, the source of nets in individual households was also examined. Households were 
stratified by net coverage level (a. any net, b. at least one net but not universal coverage and c. 
universal coverage) and the number and percentage of households with a net from each source 
were calculated.  
 
Costs 
Cost data were collected retrospectively, per protocol, using questionnaires, reviews of 
expenditure data and meetings with implementing partners. Cost data were entered into Excel 
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spreadsheets, costs in Kenyan Shillings were converted to United States Dollars (USD) using 
the average annual exchange rate for 2015 (3). Costs incurred for activities in more than one 
county (e.g. Central level support) which could not be assigned using the micro-costing 
(bottom-up) approach, were allocated to Samia using a suitable proxy. To facilitate comparison 
of costs across the different distribution methods, a set of standard activities were developed 
that could be used to capture key activities for all distribution methods (e.g. administration, 
coordination, and management; communication and mobilisation; net storage and distribution; 
training). All costs were then allocated to one of these categories independently by two authors 
(EW and VW) with each discrepancy discussed and resolved. Likewise, each item was 
categorised by the level at which the cost was incurred (national, regional, sub-County or sub-
Location) independently by EW and VW and discrepancies resolved.  
As per protocol the total cost and cost by the channel are presented as financial and economic 
costs. In addition, annualised (total and unit) costs are also presented. Annualised financial 
costs are calculated by dividing capital costs (those with a useful life of more than one year) 
by their useful life, annualised economic costs were calculated alike and discounted at 3%. All 
costs are presented by channel, activity and health system level with costs are expressed as 
number and percentage of total costs to identify cost drivers and differences between channels. 
The purchase price, brand, and quantity of nets purchased by channel is presented, however, 
since the analysis is focussed on distribution costs of LLINs and the cost of LLINs procured 
differed between channels, LLIN costs were excluded from the analysis. A sub-analysis to 
estimate the percentage of turnover accounted for by net sales, which would lead to a break-
even point given the cost of sales for the CO channel is presented.  
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Cost and Cost-effectiveness 
As per protocol, the two main health economics outcomes are total and unit cost of distributing 
an LLIN through each channel (unit cost per channel). The total economic and financial costs 
for each channel were calculated by summing all costs for each channel, and are reported by 
activity, cost category, and level in USD. Annualised economic and financial costs are also 
presented. 
Unit cost per channel was calculated separately from the supply side and demand-side 
perspectives. For the supply side, implementing agencies were asked to self-report the number 
of nets or (for the CHV channel) vouchers distributed, which was used to calculate the potential 
(supply side) unit cost per net or voucher delivered for each distribution channel. Since nets 
available for distribution may not have been distributed, and vouchers distributed may not have 
been exchanged for a net, household survey (demand side) data on reported net source was 
used to estimate the total number of nets from each channel. An estimate of the number of nets 
from each channel in the entire sub-County was obtained by multiplying the number of 
observed nets by channel by the sample proportion (879 households out of a total of 23,081 
households). Total cost was divided by the estimate of nets delivered by each channel to give 
a demand-side estimate of unit cost per net distributed from each channel.  
Mean cost per house achieving UC was calculated by dividing the total estimated costs of all 
channels by the estimated number of households with UC in the control, intervention and 
pooled households. Incremental cost per house achieving UC (cost per UC house) was 
calculated by dividing total estimated costs of all channels by the estimated change in the 
number of households with UC pre- and post-intervention, in the control, intervention and 
pooled households. The number of households achieving UC in each arm was estimated by 
multiplying the proportion of households in each arm with UC by the estimated number of 
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households in that arm. The change in UC in each arm was calculated by subtracting the post-
intervention UC percentage from that at baseline according to the 2014 Kenya DHS survey 
data for Busia County (this is the lowest admin-level available from the DHS). This analysis 
was conducted excluding CO channel costs, representing the public-sector provider perspective 
(and repeated including the unadjusted CO costs obtained from a sample of CO). Uncertainty 
estimates on the cost-effectiveness were obtained by re-running the analysis using the 95% 
confidence interval range on the proportion of households with UC [122].  
 
Equity effects 
Household-level socio-economic data and asset ownership were used to construct a wealth 
index using principal components analysis. Each household was assigned to a wealth quintile 
(1 poor – 5 least poor). We calculated and plotted the number of nets observed in households 
in each quintile by source (channel) of nets, and the number of nets from each channel by 
wealth quintile of the household in which the nets were observed. To quantify in/equity, we 
calculated the concentration index (CI) for all nets, and for nets by channel. The CI measures 
the degree to which a characteristic, in this case, the destination of nets from each channel is 
concentrated in richer (or poorer) households, across all quintiles. A CI of 0 indicates perfect 
quality, –1 the highest degree of pro-poor inequalities, and +1 the highest degree of pro-rich 
inequality. The CI provides a measure of equity across all five quintiles that is relatively 
independent of the overall level of coverage. We also calculated the absolute and relative 
contribution of the different channels to the overall CI as a way of assessing which channel 
contributed most to the overall in/equity in net ownership by source observed in the sample 
population.  
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Estimating confidence intervals of the costs and effects  
The confidence intervals for effects was estimated through bootstrapping techniques. This is 
a non-parametric method that involves repetitive computations of resampled data to estimate 
the shape of a statistic’s sampling distributions. Using a bootstrap resamples, the procedure 
was repeated 1000 times to estimate cost or effects. Bootstrap standard error methods used in 
a bootstrap distribution to determine the limits of the confidence intervals [1]. The formula 
used for bootstrapping was done using Ms excel Visual Basic software. The classic formula 
is 
         θ ±  tα/2 σ θ B 
Where θ is the estimate, σθ is the standard error of θ and tα/2 is the critical value of the test 
statistic and B is the number of bootstrap replications.  
The lower and upper confidence interval of the bootstrap samples is given by  
 [θ - tα/2 σ θ B, θ + tα/2 σ θ B] 
 
Results 
Household coverage 
A total of 879 respondents (52% control and 48% intervention) similar in sex, age, household 
head occupation and education level, with most being either self or unemployed with low levels 
of education, completed the household survey. Pooled analysis showed high and increased 
LLIN use the previous night (87%), UC in 80% of households and 97% of households having 
at least one net compared with 42%, 32%, and 59% respectively in 2014. Reported LLIN use 
by under-fives was also high (92%, compared with 54% in 2014) although reported use by 
another priority vulnerable group pregnant woman lags at 78% (compared with 51% in 2014). 
Statistical comparison of the control versus intervention arm. 
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Significantly more effective at increasing the number of households with UC, than the 
combination of channels used in the intervention arm. This translated into significantly higher 
net use (the night before the survey) in the control arm than in the intervention arm, in the 
overall population and in children under five (sig 95% level), use was also higher in pregnant 
women, but this difference was not significant. These findings are consistent with previous 
studies which have shown that the main barrier to net use within households is the insufficient 
number of nets available within households (access). The combination of channels used in the 
intervention arm resulted in significantly higher levels of nets being used than in the control 
arm. Overall, we conclude that the control arm (including MDC) is effective at increasing 
universal coverage and access and that this translates into higher net use at the household level. 
However, nets delivered by the combination of channels in the control arm (including MDC), 
are less likely to be used than those delivered by the combination of channels used in the 
intervention arm (including CHV).  
MD was the most important source of nets overall and in all households, regardless of net 
coverage status in the pooled, and control arms, whereas CHV was the most important source 
in intervention households for all indicators and the second most important source of net overall 
in the pooled and control arms. ANC was the third most important net source overall, and for 
all household net coverage strata in the pooled and intervention arms. In the control arm, ANC 
was the second most important net source after MD. CO was the fourth most important net 
source overall and for all household net coverage strata, with SM being the least important net 
source overall and for all strata. The high proportion of nets from the MD found in the 
intervention arm, and CHV nets found in the control arm also imply contamination (leakage of 
nets) between arms and challenges with recall and differentiation on the source of nets. There 
may be a particular challenge for households differentiating between CO and SM nets.  
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Table 3 Indicators of ITN coverage, access, and use, for all households, control households, and intervention households 
¥Small number of counts could lead to errors in P-value, therefore used Fisher's exact test.  
* Significant at 95%  
Indicators explicitly mentioned in the protocol in bold, main per-protocol indictor bold underlined, other standard indicators included but were 
not specifically mentioned in the protocol 
 
Indicator Pooled data 
(n=879)  
Control arm  
(n=459)) 
Intervention arm 
 (n=420)) 
 (Chi squared 
except¥) 
Difference in 
Proportions (Control 
– Intervention) 
[95% confidence 
interval on 
Difference] 
N Proportion 
[95% CI] 
n Control  
95% CI 
 n Intervention (n=420) 
95% confidence interval 
Proportion of households 
with at least one ITN 
852 0.969 [0.956—0.979] 448 0.976 [0.957-0.987] 404 0.962 [0.939-0.977] 0.225 0.014 [-0.009-0.037] 
Proportion of households 
with at least one ITN for 
every two people 
(universal coverage) 
682 0.801 [0.773-0.827] 375 0.839 [0.802-0.870] 307 0.760 [0.716-0.799] 0.004* 0.079 [0.025-0.131] 
Proportion of population 
with access to an ITN in 
their household 
3276 0.879 [0.868-0.889] 1842 0.898 [0.984-0.910] 1434 0.856 [0.838-0.872] <0.001* 0.042 [0.021-0.063] 
Proportion of the 
population that slept 
under an ITN the 
previous night 
3251 0.872 [0.861-0.883] 1830 0.892 [0.878-0.905] 1421 0.848 [0.830-0.865] <0.001* 0.044 [0.022-0.0665] 
Proportion of children 
under five years old who 
slept under an ITN the 
previous night 
475 0.983 [0.968-0.993] 275 0.958 [0.928-0.978] 170 0.876 [0.821-0.919] <0.001* 0.082 [0.030-0.134] 
Proportion of pregnant 
women who slept under 
an ITN the previous night 
29 0.906 [0.750-0.980] 13 0.929 [0.661-0.998] 16 0.889 [0.653-0.986] 1¥ 0.040 [-0.219-0.270] 
Proportion of existing 
ITNs used the previous 
night 
2081 0.862 [0.847—0.875] 1111 0.808 [0.786-0.829] 970 0.933 [0.916-0.947] <0.001* -0.125 [-0.150-0.099] 
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Table 4 Source of nets overall (1) and by household net coverage status (2a-c) for all (pooled), control and intervention households  
Shading indicates % contribution of each channel from highest (darkest) to lowest lightest/white) 
Underlined text indicates this channel is operating in this arm according to study design 
n/a Not applicable 
*percentages add up to more than 100% because households can have at least one net from more than one source 
Channel MD CHV ANC SM CO Other Total 
1. Overall source of nets observed in households 
Pooled 1268  
51·7% 
762  
31·1% 
265  
10·8% 
10  
0·4% 
90  
3·7% 
57  
2·3% 
2452  
100% 
Control 967  
70·0% 
213  
15·4% 
122  
8·8% 
10  
0·7% 
36  
2·6% 
34  
2·5% 
1382  
100% 
Intervention 301  
28·1% 
549  
51·3% 
143  
13·4% 
0 
0% 
54  
5·0% 
23  
2·1% 
1070 
100% 
2. Source of nets within households stratified by household net coverage 
a. Any nets 
Pooled 490  
57·6% 
315 
37·0% 
162 
19·0% 
9 
1·1% 
63 
7·4% 
n/a 851 
122·1%* 
Control 352 
78·7% 
74 
16·6% 
81 
18·1% 
8 
1·8% 
27 
6·0*% 
n/a 307 
121·3%* 
Intervention 138 
45·0% 
241 
78·5% 
81 
26·4% 
1 
0·0% 
36 
11·7% 
n/a 307 
161·9% 
b. At least one net but not universal coverage3 
Pooled 86 
50·9% 
63 
37·3% 
38 
22·5% 
1 
0·6% 
6 
3·6% 
n/a 114·8%* 
Control 51 
70·8% 
14 
19·4% 
14 
19·4% 
0 
0·0% 
3 
4·2% 
n/a 72 
113·9%* 
Intervention 35 
36·1% 
49 
50·5% 
24 
24·7% 
1 
1·0% 
3 
3·1% 
n/a 97 
115·5%* 
c. Universal coverage 
Pooled 404 
59·2% 
252 
37·0% 
124 
18·2% 
8 
1·2% 
57 
8·4% 
n/a 682 
123·9%* 
Control 301 
67·3% 
60 
13·4% 
67 
15·0% 
8 
1·8% 
24 
5·4% 
n/a 447 
102·9%* 
Intervention 138 
45·0% 
192 
62·5% 
57 
18·6% 
0 
0·0% 
33 
10·7% 
n/a 307 
136·8%* 
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Costs and cost-effectiveness 
The results of the cost analysis by cost activity category and health system level are shown in 
Table S1 and Table S2. Excluding LLIN commodity costs (Table S3), CHV was the most 
expensive channel ($208,979), followed by ANC ($188,447) and MD ($104,115). SM had the 
lowest total cost ($$21,878). Reported number and cost per LLIN/voucher distributed (supply-
side indicator) and estimated number and cost of LLINs (demand-side indicator) for all 
channels (except CO where aggregate data was not obtained) are shown in Table 5. MD 
distributed the most nets at the lowest cost per net distributed according to the supply and 
demand-side data. SM distributed the fewest vouchers at the second-lowest-cost according to 
the supply-side data, however, demand-side estimates put SM at the highest cost per LLIN is 
found in the household. CHV had the second-lowest-cost per LLIN in households followed by 
ANC (demand side). The cost of all channels, except MD, is higher according to demand-side 
estimates, with the SM channel being almost 18 times higher due to the low number of nets 
identified from this channel.  
 
Results of the marginal cost estimates to achieve universal coverage are shown in table 6. The 
total average and marginal annualised economic cost per UC house in the pooled analysis are 
US$ 29.26 [95%CI=$28.34 - $30.32] and the US $73.71 [95%CI=$73.71 -$80.82] 
respectively. The average and marginal annualised economic cost per UC house was USD 
$28.31 [$27.42 - $29.34] and $71.31 [$71.31 - $78.2] respectively,  and are higher in the 
intervention arm (US $27.5 [95%CI=$26.52 - $28.77] vs US $27.5 [95%CI=$26.52 - $28.77]  
than control arm (US $27.5 [95%CI=$26.52 - $28.77]and US $64.81 [95%CI=$64.81 - 
$72.32]). However, there isn’t much difference in terms of the final cost of UC per HH between 
the two channels but the significant difference in marginal economic costs of distribution 
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per UC household table 5. By activity (Table S1) personnel costs were the highest contribution 
to costs in ANC and CO, whereas distribution and transport were the biggest drivers in MD 
and SM. Training and meeting costs were the biggest cost driver in the CHV channel. By level, 
(Table S2) the majority of costs are incurred at the sub-Location level in the MD, ANC and 
CHV channels. All costs are incurred at the sub-Location level (i.e. individual shop) for the 
CO channel. SM costs are heavily skewed (80%) to the national level. Annualised economic 
(and financial) costs are very similar to total costs due to the low proportion of capital costs on 
all channels. Economic and financial costs are also very similar and because no donated 
resources were identified in the cost the difference is entirely down to discounting of capital 
costs in the economic analysis.  
CO data on total costs are not comparable with other channels as they only represent a sample 
of providers’ costs. Cost per net distributed by CO can only be calculated at an individual shop 
level using supply-side data (Table S4) where the costs per net sold range from US$10-221·4. 
These results are highly sensitive to the proportion of the outlets business that is attributed to 
bednet sales. This was estimated at 10%, 1%, and 0·1%. Even at 1%, it appears that it would 
be difficult for retail outlets to cover the costs of LLIN sales. Sellers reported a mark-up of 
between KSH50-150 on each net, or US$0·51-1·52, which even if LLINs only made up 1% of 
their business turnover, would not cover the cost of sales. Only when LLINs sales account for 
0·1% of turnover, might they break even/make a small profit on net sales. 
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Table 5 Annualised economic cost per LLIN or voucher distributed by channel using 
supply (a) and demand-side (b) estimates (US$2015) 
Channel MD CHV ANC SM CO Other 
Total 
number of 
nets/vouche
rs and cost 
a. LLINs/Vouchers distributed (Supply-side indicator) 
Reported number  28,870  29,972 8,400  4,704  
No 
data  
No data 71,946  
Economic/Financial 
cost (per 
LLIN/voucher) 
3·61 7·23 23·31 5·16 ‡ ‡ 
7·78 
 
Annualized financial 
cost§ (per 
LLIN/voucher) 
3·61 6·97 22·43 4·65 ‡ ‡ 7·41 
b. LLINs in the household (Demand-Side indicator) 
Estimated number 33,295 20,009 6,958 263 2,363 1,497 64,385 
Economic/Financial 
cost (per LLIN) 
3·13 10·84 28·14 92·41 ‡ ‡ 8·70 
Annualized financial 
cost† (per LLIN) 
3·13 10·44 27·06 83·12 ‡ ‡ 8·27 
 
Shading indicates lowest cost (darkest) to highest (lightest) cost per net/voucher distributed/in 
household and highest (darkest) to lowest (lightest) number of nets/vouchers 
distributed/estimated in households  
‡Cannot be computed as no estimate of LLINs distributed and/or total cost 
§ Annualised economic costs exactly equal to annualised financial costs for all channels 
† Annualised economic costs exactly equal to annualised financial costs except for ANC 
27·08, SM 83·32 and average  
 
Costs by channel and cost per additional house with universal coverage, including and 
excluding commercial outlet costs 
Total economic costs (excluding LLIN commodity costs), were highest for CHV ($216,821), 
and followed by ANCC ($195,776), MC ($104,114), and SM ($24,266). Costs were lowest 
for CO ($19,070), which represented eight outlets (seven retail and one wholesale) identified 
as selling LLINs. CHVs distributed more vouchers (29,972) than LLINs distributed by the 
other channels (MC=28,870, ANCC=8,400, SM=8,400) according to supply-side data. 
Supply-side estimated unit costs were highest for ANCC ($23·31), followed by CHV ($7·23), 
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SM ($5·16), and MC ($3·61). Demand-side estimates were highest for SM ($92·41), followed 
by ANCC ($27·92), CHV ($10·81), and MC ($3·10) 
 
  
Table 6 Costs by channel and cost per additional house with universal coverage including and excluding 
commercial outlet costs 
 Mass 
Campaign 
(MC) 
Community 
Health 
Volunteer 
(CHV) 
Antenatal 
and child 
health 
clinic 
(ANC) 
Social 
Marketing 
(SM) 
Commercial 
Outlets 
(CO) 
The marginal cost per additional house with 
universal coverage 
Total Economic Cost¤ 
Intervention 
24,502·53  156,088·67  104,854·04  -  11,441·79 {0} 86·44 [75·77 - 102·77] {83·11 [72·85 - 98·81]} 
Control 
79,612·88  60,732·68  90,922·39  24,266·12  7,627·86 {0} 69·20 [63·66 - 77·23] {67·20 [61·81 - 74·99]} 
Pooled 
104,115·41  216,821·35  195,776·43  24,266·12  19,069·65 {0} 76·30 [70·54 - 83·67] {73·71 [68·13 - 80·82]} 
Annualised Financial Cost 
Intervention 
24,502·53  150,327·40  100,848·39  -  5,555·44 {0} 81·88 [71·78 - 97·35] {80·27 [70·36 - 95·42]} 
Control 
79,612·88  58,491·03  87,448·95  21,826·34  3,703·63 {0} 66·03 [60·74 - 73·68] {65·05 [59·84 - 72·6]} 
Pooled 
104,115·41  208,818·43  188,297·34  21,826·34  9,259·07 {0} 72·53 [67·04 - 79·53] {71·26 [65·88 - 78·14]} 
Annualised Economic Cost 
Intervention 
24,502·53  150,442·71  100,928·40  -  5,662·31 {0} 67·30 [58·99 - 80·01] {80·32 [70·41 - 95·49]} 
Control 
79,612·88  58,535·89  87,518·33  21,877·59  3,774·87 {0} 79·34 [72·98 - 88·54] {65·10 [59·88 - 72·65]} 
Pooled 
104,115·41  208,978·60  188,446·73  21,877·59  9,437·18 {0} 72·60 [67·11 - 79·61] {71·31 [65·92 - 78·2]} 
¤Total financial cost equals the total economic cost 
Cost and cost-effectiveness excluding commercial outlet costs shown in { } 
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Lower and upper bounds of cost-effectiveness calculated using the upper and lower confidence  
Table 7 Average and marginal unit cost per house with UC for all (pooled), control and 
intervention households 
 
Proxy for Cost allocation by arm 
(Intervention) 
Average Cost per house 
with UC (USD) 
Marginal Cost per house with UC 
(USD) 
Excluding CO costs   
Total Economic/Financial Costs by 
distribution system: Intervention $30.41 [$28.93 - $32.28]  $83.44 [$83.44 - $99.2] 
Total Economic/Financial Costs by 
distribution system: Control $28.39 [$27.37 - $29.7]  $66.9 [$66.9 - $74.66] 
 
Total Economic/Financial Costs by 
distribution system: Pooled $29.26 [$28.34 - $30.32]  $73.71 [$73.71 - $80.82] 
Annualised Financial Costs by distribution 
system: Intervention $29.37 [$27.94 - $31.18]  $80.59 [$80.59 - $95.8] 
Annualised Financial Costs by distribution 
system: Control $27.48 [$26.5 - $28.75]  $64.76 [$64.76 - $72.28] 
 
Annualised Financial Costs by 
distribution system: Pooled $28.29 [$27.4 - $29.32]  $71.26 [$71.26 - $78.14] 
Annualised Economic Costs by distribution 
system: Intervention $29.39 [$27.96 - $31.2]  $80.64 [$80.64 - $95.87] 
Annualised Economic Costs by distribution 
system: Control $27.5 [$26.52 - $28.77]  $64.81 [$64.81 - $72.32] 
Annualised Economic Costs by 
distribution system: Pooled $28.31 [$27.42 - $29.34]  $71.31 [$71.31 - $78.2] 
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Table S1 Total financial/economic cost (a), the annualised financial cost (b) and annualised economic cost (c) by channel and activity 
(2015USD), excluding LLIN commodity cost 
Cost category Admin, 
Coordination, 
and 
Management 
Buildings Communication 
and Mobilisation 
Distribution and 
Transport 
Monitoring 
and 
Evaluation 
Storage Training Total  Cost 
a. Total financial/economic cost and % 
MD 31,252 30·0% 0 0% 6,576 6·3% 51,402 49·4% 0 0% 7,501 7·2% 7,385 7·1% 104,115 
CHV 14,818 6·8% 0 0% 23,121 10·7% 30,110 13·9% 0 0% 4,889 2·3% 143,884 66·4% 216,821 
ANC 97,154 49·6% 0 0% 0 0% 81,822 41·8% 11,819 6·0% 4,981 2·5% 0 0% 195,776 
SM 5,740 23·7% 0 0% 6,481 26·7% 9,545 39·3% 0 0% 2,369 9·8% 130 0·5% 24,266 
CO* 6,009 31·5% 10,219 53·6% 70 0·4% 1,840 9·6% 0 0% 931 4·9% 0 0% 19,070 
Grand Total 154,973 27·7% 10,219 1·8% 36,248 6·5% 174,719 31·2% 11,819 2·1% 20,671 3·7% 151,399 27·0% 560,049 
b. Annualised financial cost and % 
MD 31,252 30·0% 0 0% 6,576 6·3% 51,402 49·4% 0 0% 7,501 7·2% 7,385 7·1% 104,115 
CHV 13,944 6·7% 0 0% 23,121 11·1% 22,980 11·0% 0 0% 4,889 2·3% 143,884 68·9% 208,818 
ANC 96,805 51·4% 0 0% 0 0% 74,693 39·7% 11,819 6·3% 4,981 2·6% 0 0% 188,297 
SM 5,402 24·7% 0 0% 6,481 29·7% 7,444 34·1% 0 0% 2,369 10·9% 130 0·6% 21,826 
CO* 6,009 64·9% 409 4·4% 70 0·8% 1,840 19·9% 0 0% 931 10·1% 0 0% 9,259 
Grand Total 153,413 28·8% 409 0·1% 36,248 6·8% 158,358 29·7% 11,819 2·2% 20,671 3·9% 151,399 28·4% 532,317 
c. Annualised economic cost and % 
MD 31,252 30·0% 0 0% 6,576 6·3% 51,402 49·4% 0 0% 7,501 7·2% 7,385 7·1% 104,115 
CHV 13,962 6·7% 0 0% 23,121 11·1% 23,122 11·1% 0 0% 4,889 2·3% 143,884 68·9% 208,979 
ANC 96,812 51·4% 0 0% 0 0% 74,835 39·7% 11,819 6·3% 4,981 2·6% 0 0% 188,447 
SM 5,411 24·7% 0 0% 6,481 29·6% 7,486 34·2% 0 0% 2,369 10·8% 130 0·6% 21,878 
CO* 6,009 63·7% 587 6·2% 70 0·7% 1,840 19·5% 0 0% 931 9·9% 0 0% 9,437 
Grand Total 153,447 28·8% 587 0·1% 36,248 6·8% 158,684 29·8% 11,819 2·2% 20,671 3·9% 151,399 28·4% 532,856 
*CO costs are a sample, not full costs therefore not comparable with other channels 
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Table S2 Total financial/economic cost (a), the annualised financial cost (b) and, 
annualised economic cost (c) by channel and level (2015USD), excluding LLIN 
commodity cost 
 
*CO costs are a sample, not full costs therefore not comparable with other channels 
 
Health system level where the cost incurred National Regional Sub-County Sub-Location 
Total 
Cost 
a. Total financial/economic cost and % 
MD 27,331 26·3% 7,405 7·1% 27,297 26·2% 42,083 40·4% 104,115 
ANC 55,704 28·5% 0 0% 67,987 34·7% 72,085 36·8% 195,776 
CHV 43,410 20·0% 23,848 11·0% 10,846 5·0% 138,717 64·0% 216,821 
SM 19,547 80·6% 3 0·0% 3,307 13·6% 1,409 5·8% 24,266 
CO* 0 0·0% 0 0% 0 0% 19,070 100·0% 19,070 
Grand Total 145,992 26·1% 31,256 5·6% 109,437 19·5% 273,364 48·8% 560,049 
b. annualized financial cost and % 
MD 27,331 26·3% 7,405 7·1% 27,297 26·2% 42,083 40·4% 104,115 
ANC 48,225 25·6% 0 0% 67,987 36·1% 72,085 38·3% 188,297 
CHV 36,280 17·4% 22,975 11·0% 10,846 5·2% 138,717 66·4% 208,818 
SM 17,495 80·2% 3 0·0% 2,920 13·4% 1,409 6·5% 21,826 
CO* 0 0% 0 0% 0 0% 9,259 100·0% 9,259 
Grand Total 129,331 24·3% 30,383 5·7% 109,050 20·5% 263,553 49·5% 532,317 
c. Annualized economic cost and % 
MD 27,331 26·3% 7,405 7·1% 27,297 26·2% 42,083 40·4% 104,115 
ANC 48,374 25·7% 0 0% 67,987 36·1% 72,085 38·3% 188,447 
CHV 36,422 17·4% 22,993 11·0% 10,846 5·2% 138,717 66·4% 208,979 
SM 17,536 80·2% 3 0·0% 2,930 13·4% 1,409 6·4% 21,878 
CO* 0 0% 0 0% 0 0% 9,437 100·0% 9,437 
Grand Total 129,663 24·3% 30,401 5·7% 109,060 20·5% 263,731 49·5% 532,856 
Table S3 Purchase price and quantity of nets by channel and acquisition year, KSH and 2015 USD 
 
Distribution strategy Net Brand Number purchased Price in KSH Price in 2015 USD  
MD Permanet 29000 400 4.07 
CHV Permanet 30480 400 4.07 
ANC Unstated 7826 400 4.07 
SM Supernet extra power 22000 90 0.92* 
CO 
Meng Mei 12 250 2.55 
Romantic house 72 350 3.56 
SafiNet 
10 150 1.53 
16 450 4.58 
20 150 1.53 
30 300 3.06 
Supernet 20 250 2.55 
SupernetExtra 28 100 1.02 
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Table S4 Cost per net sold by a shop in CO channel (excluding the cost of nets) 
Individual 
Shop 
Annualised 
Economic 
Cost 
Nets sold in 
2015 
Cost per net sold if LLIN sales represent x% 
of the annual turnover of each shop 
X = 10% X = 1% X = 0·1% 
Shop 1 722 72 10·0 1·0 0·10 
Shop 2 1,328 6 221·4 22·14 2·214 
Shop 3 971 30 32·4 3·24 0·324 
Shop 4 1,053 14 75·2 7·52 0·752 
Shop 5 864 10 86·4 8·64 0·864 
Shop 6 655 20 32·7 3·27 0·327 
Shop 7 (w) 2,858 20 142·9 14·29 1·429 
Shop 8 987 28 35·3 3·53 0·353 
Total  9,437 200 47·2 4·72 0·472 
 Data, as reported by shop owners (w) wholesaler, other shops, are retail 
 
Equity effects of the LLIN distribution channels 
Most nets in all households came from the MD channel and the CHV channel, with the share 
of nets from these two channels being highest in the lowest wealth quintiles, demonstrating 
the importance of these two channels in ensuring access to LLINs in the poorest households 
(Figure 1, Panel B and Table S5). All distribution channels resulted in pro-wealthy 
inequitable net distribution, however, the CI for CHV and MD channels were close to zero 
(perfect equity). CHV was the least inequitable distribution channel (CI = 0·035) with MD 
being the second most equitable channel (CI = 0·039), however, as the 95% confidence 
interval for these channels overlaps, the difference is not statistically significant. The results 
showed that CHV and MD channels contributed most to the overall equity in LLIN 
ownership (Table 9). 
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Table 9 Nets categorised by channel and wealth quintile of the house where they were 
observed and concentration index for each channel 
Channel 
Wealth quintile 
Concentration Index  
[95% confidence interval] 
Q1 
[Poor
est] 
Q2 Q3 Q4 
Q5 
[Rich
est] 
MD 218 251 254 280 272 0·039 [0·008 to 0·07] 
CHV 130 155 152 164 163 0·035 [0 to 0·071] 
ANC 31 52 51 60 73 0·129 [0·033 to 0·225] 
SM 0 1 5 2 2 0·147 [-0·276 to 0·569] 
CO 4 11 3 19 53 0·460 [0·326 to 0·594] 
Other 6 12 14 12 15 0·107 [-0·03 to 0·243] 
All 
Channels 
389 482 479 537 578 0·067 [0·024 to 0·109] 
 
Figure 1 Panel: A Source channel of nets by household wealth quintile, Panel B: 
destination of nets by channel and wealth quintile 
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  Source data provided in Supplementary Table S5 
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Table S5a Equity data: Number and % of nets observed in the household survey by reported source and wealth quintile 
(Supplementary table) 
Reported source 
of nets observed 
in the household 
survey 
Indicator Q1 Q2 Q3 Q4 Q5 Total 
Channel  
MD Number acquired 218 251 254 280 272 1,279 
% acquired by channel 17·04% 19·62% 19·86% 21·89% 21·27% 100% 
% of nets in this quintile from this channel 56·04% 52·07% 53·03% 52·14% 47·06% 51·89% 
SM Number acquired 0 1 5 2 2 10 
% acquired by channel 0·00% 10·00% 50·00% 20·00% 20·00% 100% 
% of nets in this quintile from this channel 0·00% 0·21% 1·04% 0·37% 0·35% 0·41% 
ANC Number acquired 31 52 51 60 73 267 
% acquired by channel 11·61% 19·48% 19·10% 22·47% 27·34% 100% 
% of nets in this quintile from this channel 7·97% 10·79% 10·65% 11·17% 12·63% 10·83% 
CHV Number acquired 130 155 152 164 163 764 
% acquired by channel 17·02% 20·29% 19·90% 21·47% 21·34% 100% 
% of nets in this quintile from this channel 33·42% 32·16% 31·73% 30·54% 28·20% 30·99% 
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Table S5b Equity data: Number and % of nets observed in the household survey by reported source and wealth quintile 
(Supplementary table) 
 
 Indicator Q1 
 
Q2 Q3 Q4 Q5 Total 
CO Number acquired 4 11 3 19 53 90 
% acquired by channel 4·44% 12·22% 3·33% 21·11% 58·89% 100% 
% of nets in this quintile from this channel 1·03% 2·28% 0·63% 3·54% 9·17% 3·65% 
others/don't know 
 
Number acquired 1 2 2 5 0 10 
% acquired by channel 10·00% 20·00% 20·00% 50·00% 0·00% 100% 
% of nets in this quintile from this channel 0·26% 0·41% 0·42% 0·93% 0·00% 0·41% 
relative/friend 
 
Number acquired 5 10 12 7 15 49 
% acquired by channel 10·20% 20·41% 24·49% 14·29% 30·61% 100% 
% of nets in this quintile from this channel 1·29% 2·07% 2·51% 1·30% 2·60% 1·99% 
Total 
 
Number acquired 389 482 479 537 578 2,465 
% acquired by channel 15·78% 19·55% 19·43% 21·78% 23·45% 100% 
% of nets in this quintile from this channel 100% 100% 100% 100% 100% 100% 
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Discussion 
Universal coverage and use targets of long-lasting insecticide nets were achieved in both arms 
through the simultaneous use of multiple channels. However, UC and use were higher in the 
control arm where mass distribution was used suggesting that MD are the most effective way 
to achieve high coverage. MD has the lowest cost per net distributed, regardless of how this is 
measured or estimated (SS vs D side). CHV appears to be the next lowest-cost way of 
distributing nets when estimated from the household survey, however, SM was the second-
lowest-cost when using supplier reported data. We observed very few SM nets in the household 
survey which makes this the most expensive channel when estimating cost per net distributed 
from these data. Cost-effectiveness analysis showed the average annualized marginal costs per 
house with universal were significantly higher in the intervention arm (the US $ 80.64) where 
the CHV model was used compared to the control arm (the US $ 64.81) with MD. The study 
concludes that mass campaigns done together with other continuous distribution channels can 
be the most effective and cost-effective way to achieve universal coverage while community-
based distribution channels like the use of CHVs are best in addressing equity concerns around 
ITN distribution, ownership and use. The study findings support the results by a study 
conducted in Ghana which analyzed the cost of three continuous distribution channels and 
established that the channels which target specific population with vulnerabilities are more 
likely to incur higher distribution costs than those that are intended for everybody [123]. The 
results of this study while reinforcing the important role in reducing the global malaria burden 
since 2000 [1] and global target of LLIN distribution to achieve 80% universal coverage for all 
people at risk of malaria with either LLINs or indoor residual spraying (IRS) by 2030 [108]. 
Concerted efforts with multichannel distribution can achieve a high level of ownership and 
contribute towards achieving a universal coverage policy goal.   
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ANC is an important source of nets, and although it is a relatively higher cost than the other 
channels, it allows targeting of key vulnerable groups and therefore should not be neglected. 
Equity analysis revealed that net distribution is still inequitable, with higher ownership in 
wealthier households. The CHV appeared to be the most equitable channel, closely followed 
by MD, however, these results are not statistically robust, implying weak evidence for an equity 
efficiency trade-off between the alternative channels with the MD being more efficient but less 
equitable than the CHV channel. It is notable that the ANC channel was less equitable than 
both the MD and CHV channel (with overlapping confidence interval) suggesting that more 
work needs to be done to increase access to ANC services for the poorest women and children. 
Cost per net distributed by the CO could not be calculated and the nets from this channel were 
the most inequitably distributed, however, since this channel operates without any public-
sector investment its contribution is highly efficient from the (public) provider perspective and 
may represent a viable keep up, particularly for the upper wealth quintiles. The SM channel 
appears to be a poor investment when compared with other publicly financed channels, 
however, the poor performance of SM would be attributed to political factors rather than 
efficiency and economic concerns.  
There is likely some recall issues with the source of net among households and this may be a 
particular challenge when being asked to differentiate between nets from CO and those via the 
SM channel. This reveals the importance of measuring outcomes of net distribution channels, 
rather than relying simply on supply-side data on quantity distributed as is often done in net 
distribution campaigns. 
Studies reveal that the cost of LLIN distribution varies between locations and that economies 
of scale exist [124]. However, relatively little is known about the cost of alternative channels 
in the same setting. In spite of a large number of studies on the cost-effectiveness of LLINs 
[29, 110, 113, 114, 124], there have only been two other studies that compare alternative LLIN 
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distribution channels in the same setting. In Uganda Kolaczinski et. al compared a targeted 
LLIN campaign with ANC delivery and found that costs were broadly the same for campaign 
and ANC delivery in the same area, but that outcomes (nets retained and used) were better for 
the campaign [124]. In Burkina Faso, De Allegri et. al found that the economic costs of 
subsidised social marketing sales and free distribution to PW through ANC were the same, but 
they did not examine other outcomes [125]. Our study revealed that costs do differ between 
channels, in the same setting, however in our study, some of this variation may be due to 
limitations on the number of nets available to be distributed via each channel, which may have 
limited economies of scale for some channels. The potential of each channel to handle a higher 
volume of nets would improve both the efficiency and coverage outcomes, however, this was 
beyond our scope.  
To our knowledge, this is the first study to look at the cost-effectiveness of achieving universal 
LLIN coverage. Yet this is the primary policy goal [1, 108, 126]. We found the marginal cost 
of each additional household achieving one net between two people (UC) is around $74¸ 
revealing the need for significant financial resources to reach and maintain universal LLIN 
coverage in populations. Challenge is to keep this up – sustainability and upscaling.  
Study limitations include the fact that conducting evaluation alongside implementation is 
challenging and we had to deal with changes to the implementation. However, this type of 
study is more representative of real-world problems, therefore, we have to do it. Cost data may 
be incomplete and problems of recall and accuracy are inherent with this type of study. To 
address this we triangulated our results with details from donors on the finances provided to 
support LLIN distribution via MD and CHV channels. This is complex since donor financing 
agreements are not aligned with economic evaluation methods.  The incremental cost-
effectiveness ratio was not used as per the protocol since we did not a clear counter-factual 
comparator. We computed costs per outcome in each channel with 95% confidence intervals. 
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Universal coverage may be reached incomparable rural settings through a mix of multiple 
delivery channels. Long term upkeep of coverage is a separate challenge requiring long term 
financial and political commitment. Many countries grappling with this policy question· 
Transferability of results to other settings is not guaranteed therefore we recommend a repeat 
of similar analysis in other settings.  
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Chapter 8: Discussion and conclusion 
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Relationship between malaria infection and socioeconomic status  
The study has established that the poorest individuals bore the highest burden of malaria 
infection compared to less poor individuals and remained most at risk. The findings from this 
study provide evidence on the existence of the relationship between malaria and poverty 
status and contribute to the evidence that socioeconomic inequalities still exist in malaria 
infection at the household level in Kenya. We confirmed our hypothesis that malaria infection 
disproportional occurs amongst the poorest individuals. A previous study by Somi et al. had 
also reported a large variation in parasitaemia rates between socioeconomic groups, where 
individuals with the lowest SES were significantly more likely to have malaria parasites than 
less-poor individuals [10]. However, this finding contrasted with those of de Castro and 
Fisher who found that SES had no association with malaria infection [8]. The de Castro study 
was limited to children aged 6–59 months, compared to the study by Somi et al. which did 
not restrict the analysis to a specific age group [8]. 
Persons from the poorest households spent significantly more money to purchase medications 
that are not recommended for malaria treatment. These medicines are likely to have less 
clinical efficacy and lead to unnecessary risk of adverse effects and complications of taking 
inappropriate medications. These findings from our study further illustrate existing 
socioeconomic inequalities in expenditures on non-recommended malaria medication in this 
rural western Kenya setting and provide further evidence that SES is still an important risk 
factor for malaria infection and treatment and contributes to higher burden amongst the 
poorest individuals. 
However, the lack of a significant association between an individual’s SES and care-seeking 
or between SES and ITN ownership demonstrate the progress towards achieving equity in 
accessing preventive interventions. This is in line with the principle of the Kenya Health 
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Policy 2014–2030 which aims to achieve equity in the distribution of health services and 
interventions by 2030 [49]. 
 
Application of the MCA model and its contribution  
In response to previous concerns of inconsistency in findings comparing SES and malaria due 
to different methods of establishing household or individual SES, we aimed to apply Multiple 
Correspondence Analysis (MCA) to establish wealth quintiles using household assets, 
utilities, and characteristics. Although there was extensive literature on health inequalities 
and health outcomes more generally, no previous study had evaluated the relationships 
between malaria indicators and SES using MCA to analyse microeconomic data.  
Malaria remains an important public health concern with approximately 3.2 million people at 
risk of infections globally [1]. The World Health Organization (WHO) estimated that a total 
of 216 million malaria cases occurred globally between 2010 – 2016. Sub-Saharan Africa 
(SSA) is disproportionally affected with over  90% (445,000 ) of malaria deaths reported in 
2016 [33]. Malaria has a significant economic impact on national economies and to 
individual households [35, 62]. Total funding for malaria control and elimination efforts was 
estimated at US$2.9 billion globally in 2015, with governments in malaria-endemic countries 
providing 32% of the total funding, of which 65% or US$612 million was expenditure by 
national malaria control programs for program implementation and 35% or US$332 million 
was expenditure on health service delivery [33]. It is estimated that 3.1% of all disability-
adjusted life-years (DALYs) were lost to malaria in 2002 [2] while 35 million disability-
adjusted life years lost were 2015 [90]. The global sustainable development goal is to achieve 
a reduction in malaria mortality rates by 90%, reduce case incidence by 90%, eliminate 
malaria from 35 countries in which malaria was transmitted, and to prevent re-establishment 
of malaria in all countries that are malaria-free by the year 2030 compared to 2015 [127].   
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In Kenya, despite remarkable achievements in malaria prevention and control over the last 10 
years, malaria remains a leading cause of morbidity and mortality with more than 70 per cent 
of the population at risk [3].  Malaria has been described as a disease of the poor and the 
relationship between malaria and poverty has often been described as a vicious cycle [12, 14] 
in the sense that poor individuals  are more at risk of infection due to many factors including 
low economic power to purchase care and recommended treatment, and similarly, the  
disease can lead to poverty due to catastrophic expenditure and disability [8, 13]. 
 
Monitoring socioeconomic inequalities in malaria-related indices  
We aimed to assess the trends in socioeconomic inequalities in malaria indicators at the 
household level in a malaria-endemic region of western Kenya between 2006 and 201. We 
had hypothesized that over time, malaria occurrence, ITN use, drug use, and related 
expenditure would disproportionally occur among lower economic strata in the population 
over time. The study established that indeed overtime, poor individuals have had a higher 
burden of malaria infections compared to less-poor individuals confirming our hypothesis. 
These results were consistent across all age groups (<5years, 5-14 years and at least 15 years) 
between 2006 and 2013. However, contrary to our hypothesis, the results showed reduced 
inequalities in care-seeking behaviour across socioeconomic groups. Similarly, over time, 
poor individuals were less likely to use effective antimalarial medications. In the pooled 
analysis, the use of ITN for malaria prevention was slightly lower amongst the poorest 
individuals compared to the less poor but the differences were small which suggests that 
ITNs are equitably used among these relatively poor rural communities. 
 
Results showed that over time there were no socioeconomic inequalities in care-seeking for 
fever or use of any medications but poor individuals were still less likely to use the 
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recommended first-line antimalarial medications such as  AL for uncomplicated malaria and 
quinine for complicated malaria infection or for pregnant women [44, 55, 57]. This supports 
our hypothesis that the use of malaria prevention and treatment disproportionately occur 
amongst those in low SES. A previous study had also established that the use of AL was 
higher in children from the lowest wealth quintile compared to those in the highest wealth 
quintile because of policies that systematically affected access to malaria treatment for 
children[31]. Prior to the 2010 introduction of the Affordable Medicine Facility– malaria 
(AMFm) in Kenya, AL was significantly more expensive than other non-recommended 
antimalarial medicines in the private sector[63]. Evidence from a similar area of rural western 
Kenya showed that when adults are uncertain that fever is due to malaria, they tend to choose 
the lowest-priced antimalarial medicine from private-sector pharmacies and retail outlets 
[47]. Therefore, when antimalarial medications were not available in public health facilities 
during the study period, individuals from poor households might have preferentially 
purchased non-recommended antimalarial medications in the private sector due to lower 
prices [40]. But despite equity in care-seeking, there still existed inequalities in ITN use and 
the use of effective malaria treatment. The existence of socioeconomic inequalities is a 
hindrance to attaining universal coverage. However, even perfectly equitable access to 
interventions could have an inequitable impact since the risk is strongly linked to poverty.   
The study examined the existence of socioeconomic inequalities or equity effects of 
intermittent mass screen and test for malaria treatment using data from a two-year 
community-based cluster-randomized trial in rural western Kenya. The results showed that 
after two years of implementation of six rounds of the MTAT intervention, there was no 
significant difference in the prevalence of malaria between the poorest and less poor 
individuals, implying equity in the burden of malaria had been achieved. There was also 
equity in care-seeking for fever and the use of medication between the poorest and the less. 
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These results confirm our hypothesis that MTAT intervention resulted in reduced 
socioeconomic inequalities in access and use of medicines and ITNs. This could be attributed 
to the availability of malaria medication to the participating households within their close 
proximity. Similarly, MTAT implementation resulted in a reduction in DALYs in the general 
population and non-significant differences (equity) in DALYs lost between the poorest and 
less poor. Even though the poor had the highest burden of DALYs at baseline (2013), they 
had more DALYs at the end of the study in 2015. Some studies have shown that the use of 
MTAT can reduce transmission of malaria, however, none to date have assessed the equity 
effect of MTAT on malaria indices through an economic perspective rather than purely 
epidemiological standpoint [71, 73, 76]. This study is perhaps the first one to demonstrate the 
equity effect of MTAT intervention on malaria mortality and morbidity despite over overall 
non-significant effect on reducing malaria burden. The above findings, demonstrate that 
MTAT can be an important strategy towards malaria reduction, elimination and addressing 
equity concerns about malaria burden between different population groups and especially at 
the microeconomic level. A community-based intervention would still have economic 
benefits to individuals in low socioeconomic status in terms of access to free medications 
which was readily available and they did not have to seek care as often.  The MTAT provided 
LLINs to the target households before the start of the study with an aimed of achieving at 
least 80% coverage. This also resulted in equity in access to LLINs between individuals in 
low and high SES. The MTAT study targeted about only 30,000 individuals within the HDSS 
which has about 220,000 individuals [5, 41] 
 
The study further evaluated the economic and population burden of malaria using 
longitudinal data collected from a health and surveillance system for nine years (Chapter 5).  
The HDSS had an approximate population of 220,000 individuals. The main advantage of the 
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surveillance data was documentation of malaria-specific deaths not only from the households 
that participated in previous surveys, including MTAT study but in the general population in 
the study area[41]. The results of the study also indicated that malaria-related mortality 
progressively reduced over the nine-year period of evaluation. Poorest individuals, children < 
5 years and women disproportionately bore the greatest burden of malaria compared to the 
least poor individuals, older children or males. This finding provided evidence that 
socioeconomic inequalities in the burden of malaria still existed in the overall population 
confirming our hypothesis but there was an overall decline over time suggesting that the 
intensification of malaria control interventions over time resulted in reducing socioeconomic 
inequalities in the study area over time (2006 to 2014). A study conducted in South Africa 
established that socio-economic related health inequality for self-reported ill health and 
disability were in favour of poor households than the rich ones. However, the trend in the 
magnitude of socioeconomic related inequalities tended to decline over time, showing 
progress toward attaining SDG on reducing inequalities [107]. 
 
Monitoring socioeconomic and equity effects of malaria control programs contribute to the 
global agenda and have implications for five Sustainable Development Goals (SDGs). The 
specific SDGs relate to the reduction of health inequalities nationally and worldwide which 
includes poverty reduction, health, and wellbeing for all, equitable education, gender 
equality, and reduction of inequalities within and between countries [26, 60]. Despite 
intensified malaria control program in Africa and in Kenya, there was inadequate data on the 
impact on economic burden at the household level and on progress towards achieving equity. 
Socioeconomic inequalities are known barriers to achieve universal health coverage and 
SDGs goals by 2030 [50]. In this thesis, we hypothesized that the malaria burden and related 
indices are disproportionately higher amongst the poorest households compared to wealthier 
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ones. Data on socioeconomic are often collected but seldom utilized in analyses hindering 
monitoring of health-related inequalities and economic impact of the control interventions at 
the household level [60]. The need for such monitoring is in line with the Kenya National 
Malaria Strategy 2009-2017 objectives, whose aim was to reduce mortality for children less 
than five years by two-thirds by 2015 and eradication of malaria in Kenya by 2017. While 
these were not achieved [31] it highlighted the importance of monitoring epidemiological and 
economic benefits of control programs, as proposed in Kenya Health Policy 2014-2030 [49]. 
In the context of intensification of malaria control programs and due to scarce and competing 
resources in the health sector, policymakers increasingly request the economic impact of 
interventions before decisions to adopt a new intervention are taken [60]. At the same time,  
the effects of malaria interventions may have economic benefits or losses to households 
especially the need to promote equity or reduce inequality between the poor or less poor 
households [128].  
The World Bank and WHO have recommended methods and strategies for monitoring 
inequality and equity in health outcomes in developing countries, but there is a need for a 
continuous evaluation of these methods aimed at evaluating socioeconomic inequalities and 
the relationship between malaria and poverty [21]. However, the lack of adequate data has 
hindered this monitoring consistently. In western Kenya, availability of longitudinal data or 
clinical trial data collected from a well-established health and demographic surveillance 
provide an opportunity to measure the existence of socioeconomic inequalities or equity 
effect and cost-effectiveness of malaria control programs at the household. 
In order to comprehensively evaluate the socioeconomic inequalities, equity effects and cost-
effectiveness of control programs we used data from longitudinal repeated cross-sectional 
surveys collected from 2006 to 2013, malaria deaths from surveillance data from 2006 to 
2014 which was used to estimate DALYs lost/gains, data from a cluster-randomized trial 
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collected in 2013 to 2015 and costing data collected in 2015 to assesses costs and effects of 
LLIN distribution channels.  
 
Relationship between malaria and socioeconomic status  
We aimed to establish the existence of socioeconomic inequalities and the relationship 
between household socioeconomic status and malaria-related health outcomes such as ITN 
use, medication use and expenditure on treatment using data from a cross-sectional survey 
conducted in 2012. We had hypothesized that the risk of malaria-related outcomes such as 
malaria prevalence, care-seeking, ITN use, and expenditures disproportionately occur 
amongst the poorest individuals. For this analysis, we applied a multiple correspondence 
analysis to gauge the relative socio-economic status (SES) of the population at the household 
level. This model had not been used before to assess the relationship between SES and 
malaria indices and its application contributes to methods for assessing SES. The results have 
shown that individuals in the poorest households had a higher burden of malaria infection 
compared to those from the least poor households. Persons from the poorest households also 
spent significantly more money to purchase medications that are not recommended for 
malaria treatment. These medicines are likely to have less clinical efficacy and lead to 
unnecessary risk of adverse effects and complications of taking inappropriate medications. 
There were no significant associations between SES and care-seeking or between SES uses of 
ITNs.   
 
In 2015, while the prevalence of microscopically-confirmed malaria was 8% amongst 
children less than 15 years (13% by malaria rapid diagnostic test nationally, it was 27% (43% 
by malaria RDT) in the lake-endemic region of western Kenya [4]. There has been scale-up 
of malaria control interventions including long-lasting insecticide nets (LLINs), indoor 
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residual spraying (IRS), improved case management with rapid diagnostic tests (RDTs), 
Artemisinin-based combination therapy (ACT) and intermittent preventive treatment (IPT) 
for high-risk groups[1] and most recently the use of mass test and treat MTAT has been 
suggested for evaluation[5]. It is known that individuals with asymptomatic parasitemia play 
an important role in sustaining malaria transmission during the dry season when the 
population of Anopheles mosquitoes has decreased, and provide a parasite reservoir at the 
beginning of the wet season when anopheles populations rebound [70]. Asymptomatic 
Plasmodium infections may occur between 12 and 39% of the population and systematic 
identification and treatment of individuals with asymptomatic infections could reduce 
transmission of malaria [71, 72]. Mathematical simulations have shown that MTAT can have 
a significant impact on malaria transmission, particularly in areas with the hypoendemic 
transmission or low to moderate transmission achieved through vector control [71, 73]. 
Empirical studies of who benefits from the distribution of public goods (whether drugs or bed nets) 
suggest that such programs tend to favour those who are better off, yet there are no studies to show 
equity effect of MTAT in malaria-endemic areas.  
Chapter 3 presents findings related to the second objective of this thesis which showed that  
although there was equity in care-seeking behaviour for fever between individuals from poor 
compared to less-poor households, poor individuals were less likely to use the recommended 
first-line antimalarial medications, AL and quinine for pregnant women [44, 55, 57]. A 
previous study had suggested that the use of AL was higher in children from the lowest 
wealth quintile compared to the highest wealth quintile because of policies that systematically 
affected access to malaria treatment for children[31]. Prior to the 2010 introduction of the 
Affordable Medicine Facility– malaria (AMFm) in Kenya, AL was significantly more 
expensive than other non-recommended antimalarial medicines in the private sector[63]. 
Evidence from a similar area of rural western Kenya showed that when adults are uncertain 
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that fever is due to malaria, they tend to choose the lowest-priced antimalarial medicine from 
private-sector pharmacies and retail outlets [47]. Therefore, when antimalarial medications 
were not available in public health facilities during the study period, individuals from poor 
households might have preferentially purchased non-recommended antimalarial medications 
in the private sector due to lower prices [40]. But despite equity in care-seeking, there still 
existed inequalities in ITN use and the use of effective malaria treatment. The existence of 
socioeconomic inequalities is a hindrance to attaining universal coverage.  
 
In chapter 4 the study examined the equity effect of the MTAT using data from a two-year 
community-based cluster-randomized trial in rural western Kenya. The results showed that 
after two years of implementation of six rounds of the MTAT intervention, there was no 
significant difference in the prevalence of malaria between the poorest and less poor 
households, implying equity in the burden of malaria had been achieved. There was also 
equity in care-seeking for fever and use of medication as results showed the non-significant 
difference between the poorest and the less. This could be attributed to the availability of 
malaria medication to the participating households within their close proximity. Similarly, 
MTAT implementation resulted in a reduction in DALYs in the general population and there 
was equity in terms of no notable differences in DALYs lost between the poorest and less 
poor. Even though the poor had the highest burden of DALYs at baseline, they gained more 
DALYs towards the end of the study. Some studies have shown that the use of MTAT can 
reduce transmission of malaria, however, none to date have demonstrated any equity impact 
of MTAT on malaria outcome through an economic perspective rather than purely 
epidemiological standpoint [71, 73, 76]. This study is perhaps, the first study to demonstrate 
the equity impact of MTAT intervention on malaria mortality and morbidity despite over 
overall non-significant effect on reducing malaria burden. The above findings, demonstrate 
 223 
 
that MTAT can be an important strategy towards malaria reduction, elimination and 
addressing equity concerns about malaria burden between different population groups and 
especially at the microeconomic level.  
 
The most notable finding was that poor household was made to unfairly bear a higher burden 
of malaria mortality compared to the least poor households, and this was observed across the 
socioeconomic groups and over this time. As it has been demonstrated in the previous 
chapters, care-seeking behaviour, access to malaria medications and ITNs use are all in 
favour of the least poor, the same has been reflected in malaria burden in terms of disability-
adjusted life years. The rich are mostly favoured by their strong purchasing power which 
allows them to afford malaria treatment and prevention commodities with minimal hindrance. 
Our results are consistent with a study conducted in Malawi, in which the author analysed the 
relationship between household income and the economic burden of malaria and found out 
that households with low- income disproportionately bear the economic burden of malaria 
compared to higher-income households [97]. The study also demonstrated more 
comprehensively the huge economic burden of malaria illness being borne by households in 
developing countries and especially those who are economically disadvantaged [97]. Our 
finding is also in line with that of a South African national burden of disease study in 2000, in 
which the burden of various diseases was estimated and the disease burden apportioned based 
on the socioeconomic status it was established that concentrated among poor socioeconomic 
groups compared to the least poor socioeconomic groups [6]. Also, a study by Ataguba et al 
investigating socio-economic related health inequalities in self-reported ill health and 
disability revealed that poor people reported more ill health and disability than the least poor 
[107]. It further demonstrated that the trend in the magnitude of socioeconomic related 
inequalities tends to decline over time. 
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Effectiveness of interventions to control malaria and their effects on equity 
Studies from various parts of Africa have indicated that the use of LLINs has a beneficial 
effect on malaria transmission, severe malaria and mortality [27, 28]. Similarly, there are 
numerous studies demonstrating the cost-effectiveness of LLINs in different parts of the 
world and in various contexts [29]. However, while there has been the application of various 
LLIN distribution methods, information is limited on the actual costs of parallel distribution 
channels in the same context and coverage results that can realistically be achieved from each 
channel based on financial inputs [30]. Similarly, there were no studies which had evaluated 
the cost, effects of various ITN distribution channels in a malaria-endemic area of western 
Kenya.  
 
Cost-effectiveness and equity impact of LLIN distribution channels  
We aimed to study cost-effectiveness and equity effects of distributing LLINs using five 
different channels namely; Mass distribution (MD), ANC, Social marketing (SM), CHVs and 
commercial outlets (CO). The findings showed that mass distribution was the most cost-
effective from both provider and consumer perspectives. CHV was the next lowest costly 
way of distributing nets when estimated from the household survey. However, SM had the 
second-lowest-cost when using supplier reported data. All channels were pro- richer 
households. CHV approach was the least inequitable/possibly neutral, followed by MD.  CO 
was the least equitable. ANC and SM were in between. Mass campaigns might have 
benefited from the economies of scale owing to a large volume of nets distributed through 
this channel thus lowering the cost per net distributed. The study findings support the results 
by a study conducted in Ghana which analysed the cost of three continuous distribution 
channels and established that the channels which target specific population with 
vulnerabilities are more likely to incur higher distribution costs than those that are intended 
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for everybody [123]. Concerted efforts with multichannel distribution can achieve a high 
level of ownership and contribute towards achieving a universal coverage policy goal.  The 
study concludes that mass campaigns done together with other continuous distribution 
channels can be the most effective and cost-effective way to achieve universal coverage 
while community-based distribution channels like the use of CHVs are best in addressing 
equity concerns around ITN distribution, ownership and use.  
 
Relationship between malaria infection and socioeconomic status  
The study has established that the poorest individuals bore the highest burden of malaria 
infection compared to wealthier individuals and remained most at risk. The findings from this 
study provide evidence on the existence of a relationship between malaria and poverty status 
and contribute to the evidence that socioeconomic inequalities still exist in malaria infection 
at the household level in Kenya. We confirmed our hypothesis that malaria infection 
disproportionately occurs amongst the poorest individuals. A previous study by Somi et al. 
had also reported a large variation in parasitaemia rates between socioeconomic groups, 
where individuals with the lowest SES were significantly more likely to have malaria 
parasites than less-poor individuals [10]. However, this finding contrasted with those of de 
Castro and Fisher who found that SES had no association with malaria infection [8]. The de 
Castro study was limited to children aged 6–59 months, compared to the study by Somi et al. 
which did not restrict the analysis to a specific age group [8]. 
Persons from the poorest households spent significantly more money to purchase medications 
that are not recommended for malaria treatment. These medicines are likely to have less 
clinical efficacy and lead to unnecessary risk of adverse effects and complications of taking 
inappropriate medications. These findings from our study further illustrate existing 
socioeconomic inequalities in expenditures on non-recommended malaria medication in this 
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rural western Kenya setting and provide further evidence that SES is still an important risk 
factor for malaria infection and treatment and contributes to higher burden amongst the 
poorest individuals. 
However, the lack of a significant association between an individual’s SES and care-seeking 
or between SES and ITN ownership suggest progress towards achieving equity in accessing 
preventive interventions. This is in line with the principle of the Kenya Health Policy 2014–
2030 which aims to achieve equity in the distribution of health services and interventions by 
2030 [49]. 
 
Application of the MCA SES model and its contribution  
In response to previous concerns of inconsistency in findings comparing SES and malaria due 
to different methods of establishing household or individual SES [7], we aimed to apply 
Multiple Correspondence Analysis (MCA) to establish wealth quintiles using household 
assets, utilities and characteristics to mitigate these problems. Although there is extensive 
literature on health inequalities and health outcomes more generally, no previous study had 
evaluated the relationships between malaria indicators and SES using MCA to analyse 
microeconomic data.  
 
Malaria remains an important public health concern with approximately 3.2 million people at 
risk of infections globally [1]. The World Health Organization (WHO) estimated that a total 
of 216 million malaria cases occurred globally between 2010 – 2016. Sub-Saharan Africa 
(SSA) is disproportionally affected with over  90% (445,000 ) of malaria deaths reported in 
2016 [33]. Malaria has a significant economic impact on national economies and to 
individual households [35, 62]. Total funding for malaria control and elimination efforts was 
estimated at US$2.9 billion globally in 2015, with governments in malaria-endemic countries 
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providing 32% of the total funding, of which 65% or US$612 million was expenditure by 
national malaria control programs for program implementation and 35% or US$332 million 
was expenditure on health service delivery [33]. It is estimated that 3.1% of all disability-
adjusted life-years (DALYs) were lost to malaria in 2002 [2] while 35 million disability-
adjusted life years lost were 2015 [90]. The global sustainable development goal is to achieve 
a reduction in malaria mortality rates by 90%, reduce case incidence by 90%, eliminate 
malaria from 35 countries in which malaria was transmitted, and to prevent re-establishment 
of malaria in all countries that are malaria-free by the year 2030 compared to 2015 [127].   
In Kenya, despite remarkable achievements in malaria prevention and control over the last 10 
years, malaria remains a leading cause of morbidity and mortality with more than 70 per cent 
of the population at risk [3]. Malaria has been described as a disease of the poor and the 
relationship between malaria and poverty has often been described as a vicious cycle [12, 14] 
in the sense that poor individuals  are more at risk of infection due to many factors including 
low economic power to purchase care and recommended treatment, and similarly, the  
disease can lead to poverty due to catastrophic expenditure and disability [8, 13]. 
 
Monitoring socioeconomic inequalities in malaria-related indices  
We aimed to assess the trends in socioeconomic inequalities in malaria indicators at the 
household level in a malaria-endemic region of western Kenya between 2006 and 201. We 
had hypothesized that over time, malaria occurrence, ITN use, drug use, and related 
expenditure would disproportionally occur among lower economic strata in the population 
over time. The study established that indeed overtime, poor individuals have had a higher 
burden of malaria infections compared to less-poor individuals confirming our hypothesis. 
These results were consistent across all age groups (<5years, 5-14 years and at least 15 years) 
between 2006 and 2013. However, contrary to our hypothesis, the results showed reduced 
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inequalities in care-seeking behaviour across socioeconomic groups. Similarly, over time, 
poor individuals were less likely to use effective antimalarial medications. In the pooled 
analysis, the use of ITN for malaria prevention was slightly lower amongst the poorest 
individuals compared to the less poor but the differences were small which suggests that 
ITNs are equitably used among these relatively poor rural communities. 
 
Results showed that over time there were no socioeconomic inequalities in care-seeking for 
fever or use of any medications but poor individuals were still less likely to use the 
recommended first-line antimalarial medications such as  AL for uncomplicated malaria and 
quinine for complicated malaria infection or for pregnant women [44, 55, 57]. This supports 
our hypothesis that the use of malaria prevention and treatment disproportionately occur 
amongst those in low SES.  A previous study had also established that the use of AL was 
higher in children from the lowest wealth quintile compared to those in the highest wealth 
quintile because of policies that systematically affected access to malaria treatment for 
children[31]. Prior to the 2010 introduction of the Affordable Medicine Facility– malaria 
(AMFm) in Kenya, AL was significantly more expensive than other non-recommended 
antimalarial medicines in the private sector[63]. Evidence from a similar area of rural western 
Kenya showed that when adults are uncertain that fever is due to malaria, they tend to choose 
the lowest-priced antimalarial medicine from private-sector pharmacies and retail outlets 
[47]. Therefore, when antimalarial medications were not available in public health facilities 
during the study period, individuals from poor households might have preferentially 
purchased non-recommended antimalarial medications in the private sector due to lower 
prices [40]. But despite equity in care-seeking, there still existed inequalities in ITN use and 
the use of effective malaria treatment. The existence of socioeconomic inequalities is a 
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hindrance to attaining universal coverage. However, even perfectly equitable access to 
interventions could have an inequitable impact since the risk is strongly linked to poverty.  
The study examined the existence of socioeconomic inequalities or equity effects of 
intermittent mass screen and test for malaria treatment using data from a two-year 
community-based cluster-randomized trial in rural western Kenya. The results showed that 
after two years of implementation of six rounds of the MTAT intervention, there was no 
significant difference in the prevalence of malaria between the poorest and less poor 
individuals, implying equity in the burden of malaria had been achieved. There was also 
equity in care-seeking for fever and the use of medication between the poorest and the less. 
These results confirm our hypothesis that MTAT intervention resulted in reduced 
socioeconomic inequalities in access and use of medicines and ITNs. This could be attributed 
to the availability of malaria medication to the participating households within their close 
proximity. Similarly, MTAT implementation resulted in a reduction in DALYs in the general 
population and non-significance differences (equity) in DALYs lost between the poorest and 
less poor. Even though the poor had the highest burden of DALYs at baseline (2013), they 
had more DALYs at the end of the study in 2015. Some studies have shown that the use of 
MTAT can reduce transmission of malaria, however, none to date have assessed the equity 
effect of MTAT on malaria indices through an economic perspective rather than purely 
epidemiological standpoint [71, 73, 76].  This study is perhaps the first one to demonstrate 
the equity effect of MTAT intervention on malaria mortality and morbidity despite over 
overall non-significant effect on reducing malaria burden. The above findings demonstrate 
that MTAT can be an important strategy towards malaria reduction, elimination and 
addressing equity concerns about malaria burden between different population groups and 
especially at the microeconomic level. A community-based intervention would still have 
economic benefits to individuals in low socioeconomic status in terms of access to free 
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medications which was readily available and they did not have to seek care as often.  The 
MTAT provided LLINs to the target households before the start of the study with an aimed of 
achieving at least 80% coverage. This also resulted in equity in access to LLINs between 
individuals in low and high SES.  The MTAT study targeted about only 30,000 individuals 
within the HDSS which has about 220,000 individuals [5, 41] 
 
The study further evaluated the economic and population burden of malaria using 
longitudinal data collected from a health and surveillance system for nine years (Chapter 5).  
The HDSS had a population of approximate 220,000. The main advantage of the surveillance 
data was documentation of malaria-specific deaths not only from the households that 
participated in previous surveys, including MTAT study but also in the general population in 
the study area[41]. The results of the study also indicated that malaria-related mortality 
progressively reduced over the nine-year period of evaluation. Poorest individuals, children < 
5 years and women disproportionately bore the greatest burden of malaria compared to the 
least poor individuals, older children or males.  This finding provided evidence that 
socioeconomic inequalities in the burden of malaria still existed in the overall population 
confirming our hypothesis but there was an overall decline over time suggesting that the 
intensification of malaria control interventions over time resulted in reducing socioeconomic 
inequalities in the study area over time (2006 to 2014). A study conducted in South Africa 
established that socio-economic related health inequality for self-reported ill health and 
disability were in favour of poor households than the rich ones. However, the trend in the 
magnitude of socioeconomic related inequalities tended to decline over time, showing 
progress toward attaining SDG on reducing inequalities [107]. 
Monitoring socioeconomic and equity effects of malaria control programs contribute to the 
global agenda and have implications for five Sustainable Development Goals (SDGs). The 
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specific SDGs relate to the reduction of health inequalities nationally and worldwide which 
includes poverty reduction, health, and wellbeing for all, equitable education, gender 
equality, and reduction of inequalities within and between countries [26, 60].  Despite 
intensified malaria control program in Africa and in Kenya, there was inadequate data on the 
impact on economic burden at the household level and on progress towards achieving equity. 
Socioeconomic inequalities are known barriers to achieve universal health coverage and 
SDGs goals by 2030 [50].  In this thesis, we hypothesized that the malaria burden and related 
indices are disproportionately higher amongst the poorest households compared to wealthier 
ones. Data on socioeconomic are often collected but seldom utilized in analyses hindering 
monitoring of health-related inequalities and economic impact of the control interventions at 
the household level [60]. The need for such monitoring is in line with the Kenya National 
Malaria Strategy 2009-2017 objectives, whose aim was to reduce mortality for children less 
than five years by two-thirds by 2015 and eradication of malaria in Kenya by 2017. While 
these were not achieved  [31] it highlighted the importance of monitoring epidemiological 
and economic benefits of control programs, as proposed in Kenya Health Policy 2014-2030 
[49]. In the context of intensification of malaria control programs and due to scarce and 
competing resources in the health sector, policymakers increasingly request the economic 
impact of interventions before decisions to adopt a new intervention are taken [60]. At the 
same time,  the effects of malaria interventions may have economic benefits or losses to 
households especially the need to promote equity or reduce inequality between the poor or 
less poor households [128].  
The World Bank and WHO have recommended methods and strategies for monitoring 
inequality and equity in health outcomes in developing countries, but there is a need for a 
continuous evaluation of these methods aimed at evaluating socioeconomic inequalities and 
the relationship between malaria and poverty [21]. However, the lack of adequate data has 
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hindered this monitoring consistently. In western Kenya, availability of longitudinal data or 
clinical trial data collected from a well-established health and demographic surveillance 
provide an opportunity to measure the existence of socioeconomic inequalities or equity 
effect and cost-effectiveness of malaria control programs at the household. 
In order to comprehensively evaluate the socioeconomic inequalities, equity effects and cost-
effectiveness of control programs we used data from longitudinal repeated cross-sectional 
surveys collected from 2006 to 2013, malaria deaths from surveillance data from 2006 to 
2014 which was used to estimate DALYs lost/gains, data from a cluster-randomized trial 
collected in 2013 to 2015 and costing data collected in 2015 to assesses costs and effects of 
LLIN distribution channels.  
 
Relationship between malaria and socioeconomic status  
We aimed to establish the existence of socioeconomic inequalities and the relationship 
between household socioeconomic status and malaria-related health outcomes such as ITN 
use, medication use and expenditure on treatment using data from a cross-sectional survey 
conducted in 2012. We had hypothesized that the risk of malaria-related outcomes such as 
malaria prevalence, care-seeking, ITN use, and expenditures disproportionately occur 
amongst the poorest individuals. In this analysis, we applied a multiple correspondence 
analysis to gauge the relative socio-economic status (SES) of the population at the household 
level. This model had not been used before to assess the relationship between SES and 
malaria indices and its application contributes to methods for assessing SES. The results have 
shown that individuals in the poorest households had a higher burden of malaria infection 
compared to those from the least poor households. Persons from the poorest households also 
spent significantly more money to purchase medications that are not recommended for 
malaria treatment. These medicines are likely to have less clinical efficacy and lead to 
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unnecessary risk of adverse effects and complications of taking inappropriate medications. 
There were no significant associations between SES and care-seeking or between SES uses of 
ITNs. 
 
In 2015, while the prevalence of microscopically-confirmed malaria was 8% amongst 
children less than 15 years (13% by malaria rapid diagnostic test nationally, it was 27% (43% 
by malaria RDT) in the lake-endemic region of western Kenya [4]. There has been scale-up 
of malaria control interventions including long-lasting insecticide nets (LLINs), indoor 
residual spraying (IRS), improved case management with rapid diagnostic tests (RDTs), 
Artemisinin-based combination therapy (ACT) and intermittent preventive treatment (IPT) 
for high-risk groups[1] and most recently the use of mass test and treat MTAT has been 
suggested for evaluation[5]. It is known that individuals with asymptomatic parasitemia play 
an important role in sustaining malaria transmission during the dry season when the 
population of Anopheles mosquitoes has decreased, and provide a parasite reservoir at the 
beginning of the wet season when anopheles populations rebound [70]. Asymptomatic 
Plasmodium infections may occur between 12 and 39% of the population and systematic 
identification and treatment of individuals with asymptomatic infections could reduce 
transmission of malaria [71, 72]. Mathematical simulations have shown that MTAT can have 
a significant impact on malaria transmission, particularly in areas with the hypoendemic 
transmission or low to moderate transmission achieved through vector control [71, 73]. 
Empirical studies of who benefits from the distribution of public goods (whether drugs or bed nets) 
suggest that such programs tend to favour those who are better off, yet there are no studies to show 
equity effect of MTAT in malaria-endemic areas.  
Although there was equity in care-seeking behaviour for fever between individuals from poor 
compared to less-poor households, poor individuals were less likely to use the recommended 
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first-line antimalarial medications, AL and quinine for pregnant women [44, 55, 57]. A 
previous study had suggested that the use of AL was higher in children from the lowest 
wealth quintile compared to the highest wealth quintile because of policies that systematically 
affected access to malaria treatment for children[31]. Prior to the 2010 introduction of the 
Affordable Medicine Facility– malaria (AMFm) in Kenya, AL was significantly more 
expensive than other non-recommended antimalarial medicines in the private sector[63]. 
Evidence from a similar area of rural western Kenya showed that when adults are uncertain 
that fever is due to malaria, they tend to choose the lowest-priced antimalarial medicine from 
private-sector pharmacies and retail outlets [47]. Therefore, when antimalarial medications 
were not available in public health facilities during the study period, individuals from poor 
households might have preferentially purchased non-recommended antimalarial medications 
in the private sector due to lower prices [40]. But despite equity in care-seeking, there still 
existed inequalities in ITN use and the use of effective malaria treatment. The existence of 
socioeconomic inequalities is a hindrance to attaining universal coverage.  
 
This study examined the equity effect MTAT using data col from a two-year community-
based cluster-randomized trial in rural western Kenya. The results showed that after two 
years of implementation of six rounds of the MTAT intervention, there was no significant 
difference in the prevalence of malaria between the poorest and less poor households, 
implying the presence of equity in the burden of malaria had been achieved. There was also 
equity in care-seeking for fever and use of medication as results showed the non-significant 
difference between the poorest and the less. This could be attributed to the availability of 
malaria medication to the participating households within their close proximity. Similarly, 
MTAT implementation resulted in ina reduction in DALYs in the general population and 
there was equity in terms of no notable differences in DALYs lost between the poorest and 
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less poor. Even though the poor had the highest burden of DALYs at baseline, they gained 
more DALYs towards the end of the study. Some studies have shown that the use of MTAT 
can reduce transmission of malaria, however, none to date have demonstrated any equity 
impact of MTAT on malaria outcome through an economic perspective rather than purely 
epidemiological standpoint [71, 73, 76]. This study is perhaps, the first study to demonstrate 
the equity impact of MTAT intervention on malaria mortality and morbidity despite over 
overall non-significant effect on reducing malaria burden. The above findings, demonstrate 
that MTAT can be an important strategy towards malaria reduction, elimination and 
addressing equity concerns about malaria burden between different population groups and 
especially at the microeconomic level.  
 
The most notable finding was that poor household was made to unfairly bear a higher burden 
of malaria mortality compared to the least poor households, and this was observed across the 
socioeconomic groups and over this time.  As it has been demonstrated in the previous 
chapters, care-seeking behaviour, access to malaria medications and ITNs use are all in 
favour of the least poor, the same has been reflected in malaria burden in terms of disability-
adjusted life years. The rich are mostly favoured by their strong purchasing power which 
allows them to afford malaria treatment and prevention commodities with minimal hindrance. 
Our results are consistent with a study conducted in Malawi, in which the author analysed the 
relationship between household income and the economic burden of malaria and found out 
that households with low- income disproportionately bear the economic burden of malaria 
compared to higher-income households [97]. The study also demonstrated more 
comprehensively the huge economic burden of malaria illness being borne by households in 
developing countries and especially those who are economically disadvantaged [97]. Our 
finding is also in line with that of a South African national burden of disease study in 2000, in 
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which the burden of various diseases was estimated and the disease burden apportioned based 
on the socioeconomic status it was established that concentrated among poor socioeconomic 
groups compared to the least poor socioeconomic groups [6]. Also, a study by Ataguba et al 
investigating socio-economic related health inequalities in self-reported ill health and 
disability revealed that poor people reported more ill health and disability than the least poor 
[107]. It further demonstrated that the trend in the magnitude of socioeconomic related 
inequalities tends to decline over time. 
 
Effectiveness of interventions to control malaria and their effects on equity 
Studies from various parts of Africa have indicated that the use of LLINs has a beneficial 
effect on malaria transmission, severe malaria and mortality [27, 28]. Similarly, there are 
numerous studies demonstrating the cost-effectiveness of LLINs in different parts of the 
world and in various contexts [29]. However, while there has been the application of various 
LLIN distribution methods, information is limited on the actual costs of parallel distribution 
channels in the same context and coverage results that can realistically be achieved from each 
channel based on financial inputs [30]. Similarly, there were no studies which had evaluated 
the cost, effects of various ITN distribution channels in a malaria-endemic area of western 
Kenya.  
 
Cost-effectiveness and equity effect of LLIN distribution channels  
We aimed to study cost-effectiveness and equity effects of distributing LLINs using five 
different channels namely; Mass distribution (MD), ANC, Social marketing (SM), CHVs and 
commercial outlets (CO). The findings showed that mass distribution was the most cost-
effective from both provider and consumer perspectives. CHV was the next lowest costly 
way of distributing nets when estimated from the household survey. However, SM had the 
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second-lowest-cost when using supplier reported data. All channels were pro- richer 
households. CHV approach was the least inequitable/possibly neutral, followed by MD.  CO 
was the least equitable. ANC and SM were in between. Mass campaigns might have 
benefited from the economies of scale owing to a large volume of nets distributed through 
this channel thus lowering the cost per net distributed. The study findings support the results 
by a study conducted in Ghana which analyzed the cost of three continuous distribution 
channels and established that the channels which target specific population with 
vulnerabilities are more likely to incur higher distribution costs than those that are intended 
for everybody [123]. Concerted efforts with multichannel distribution can achieve a high 
level of ownership and contribute towards achieving a universal coverage policy goal.  The 
study concludes that mass campaigns done together with other continuous distribution 
channels can be the most effective and cost-effective way to achieve universal coverage 
while community-based distribution channels like the use of CHVs are best in addressing 
equity concerns around ITN distribution, ownership and use.  
 
Strengths and Limitations of studies presented in this Ph.D. thesis 
Strengths  
The strength of the first two papers presenting the data in chapter two and three is the 
application of multiple correspondence analysis to establish wealth quintiles using household 
assets, utilities, and characteristics. Although there is extensive literature on health 
inequalities and health outcomes more generally, no previous study has evaluated the 
relationships between malaria indicators and SES using MCA to analyse microeconomic 
data. The use of eight years of repeated annual cross-sectional pooled data provided more 
power to assess socioeconomic inequalities and equity trends. In that analysis, we have used 
multivariate regression models accounting for clustering to assess the equity effect of 
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enhanced malaria control interventions. However, unlike longitudinal surveys, these studies 
provide results based on the proportionate representation of select socioeconomic groups at 
different time periods. However, the use of longitudinal monitoring provides an opportunity 
to monitor the effectiveness of policy intervention over time. However, because the datasets 
used in chapters two and three are from sectional surveys with limitations of inability to 
establish cause-effect, in chapter four, we used data collected from a cluster-randomized trial 
when MTAT intervention was implemented for two years to establish the effect on reducing 
malaria burden. This was the first study to the best of our knowledge to assess equity effect 
and socioeconomic inequalities using disability-adjusted life years in the MTAT trial and 
provided an opportunity to assess the economic benefits of a clinical trial.  
 
While the studies analysed so far were restricted to participating households, the analyzing in 
chapter 6 applied pooled population-level data from a health and demographic surveillance 
data and assessed the health indicators irrespective of trails and control programs. This is also 
the first study to monitor equity and socioeconomic trends at the household level in western 
Kenya assessing years of life lost and DALYs. In Chapter 7 we compared the cost-
effectiveness of five LLIN distribution channels and the equity effect. The strength of this 
paper is to answer the critical question of whether malaria control methods aimed to achieve 
universal coverage in a cost-effective and equitable manner or not. This is the first study to 
achieve this in western Kenya. The analysis applied both statistical, epidemiological and 
econometric methods and provides future research with approaches to monitor the impact of 
control interventions from economic perspectives.  
 
Limitations 
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The study had a number of limitations. First, some of the findings were based on data from 
cross-sectional surveys preventing any evaluation of cause-and-effect of SES on malaria 
indicators over time. Second, only households with children <5 years were included in the 
surveys based on protocol-specific objectives. Although all children <5 years in a household 
were surveyed annually, only a small proportion of persons ≥5 years were included in the 
survey samples.  Similarly, different sampling techniques were applied over the course of the 
study which may have moderated different potential selection effects, yet, given the sample 
size, the actual differences in the impact will be limited. The analysis of the data, however, 
accounted for stratification and clustering both at study areas and at households. This limits 
the bias of sampling  
 
Although we applied MCA to rank households into SES, we did not present comparison 
results of using other methods such as PCA. This could have provided an opportunity to 
demonstrate that MCA better ranks households than other methods but we relied on evidence 
already provided in a previous analysis in the same study area [22]. This actually promotes 
internal validity, yet external validity might be limited and may need the use of the traditional 
PCA approach.   
 
In the absence of relevant recent data, these studies limited the analysis to the period 2006–
2015. Nevertheless, the findings of these studies would have long-term relevance, as it 
focuses on socioeconomic inequalities, which have persistent influence in the behavioural 
aspects of healthcare services utilization and malaria control efforts. 
 
The DALY estimates have been expressed as absolute estimates, and hence we can only 
provide the idea about the total population burden but not the relative health status of the 
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population. Given the absolute numbers, we might not be able to make direct comparisons of 
health status for different population groups (e.g. 200 per 10,000 population). Since DALYs 
have not been expressed relative to the number of cases, it is not easy to make a comparison 
of the disease impact at patient –level (e.g. 50 per 1000 cases). Secondly, the study sites are 
situated largely in a rural setting, therefore it was not easy to clearly distinguish between the 
poor and least poor population groups using socioeconomic indices, and we describe relative, 
not absolute poverty. For example, the DALY estimates for the males in this study did not 
show any significant difference between the poorest and least poor households. This may 
cause a bias in favour of either the poor or the less poor. This coupled with the fact that asset 
index methodology does not consider the monetary and quality of the assets possessed by the 
households, the difference among various socioeconomic groups could become even more 
obscure. 
 
For the LLIN cost-effectiveness study, the main limitations were that conducting evaluation 
alongside programme implementation was challenging and changes in implementation led to 
redefining the evaluation. Secondly, cost data may be incomplete because of reporting issues 
from the provider perspectives. However, we compared these data against donor information 
before applying them. Complex donor financing agreements make this challenging. Thirdly, 
there are inevitably recall issues regarding household sources of nets (especially in 
differentiating CO and SM channels), transferability of results to other settings is not 
guaranteed therefore we recommend repeating the approach while up-scaling, using similar 
analysis in other (Kenyan) settings. 
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Summary findings of the doctorate study 
The study has established that socioeconomic inequalities still exist between the poor and less 
poor. The burden is highest amongst children under five in terms of DALYs lost to malaria 
deaths and infections. Community-based distribution of interventions such as MTAT resulted 
in equity gains for poor individuals providing access to ITN and medications directly to 
households hence removing the financial hardship. A combination of the community-based 
mass campaign together with a targeted approach such as the use of Community health 
volunteers is the most cost-effective and equitable way of achieving universal coverage. The 
policy will require continuous monitoring of socioeconomic inequalities and identify gaps to 
achieved sustainable development goals. 
 
Methodological considerations  
A previous study assessing the multi-level nature of socioeconomic inequalities in malaria 
disease had shown that socioeconomic factors determine where people live and the 
distribution of risk [129, 130]. By applying a multi-level logistic regression model, a previous 
study was able to address cluster- and district-level variability which helped to explain 
variation in the outcomes than with SES and covariates alone, and also supported the view 
that socio-economic factors influence malaria [131]. This has also been the case in our 
analysis where we included individual, cluster-level covariate in our analyses to strengthen 
the analyses.  The concentration index and Gini coefficient have been used to assess 
socioeconomic inequalities in health outcomes and income. However, its application often 
lacks the statistical and epidemiological rigour required in controlling for confounders, effect 
modifiers, clustering, accurate estimating risks and complex nature of datasets and study 
designs [100, 132]. In this thesis, we improved on these methods by first, applying MCA to 
establish wealth quintiles because it has more statistical power, generates better factor 
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weights making classification of households into quintiles more distinct compared to other 
methods like PCA [22, 60]. Secondly, we applied robust generalized linear modelling 
controlling for confounding factors and clustering at the household level. This approach is 
superior to using multi-level logistic regression which tends to over-estimate the risk of 
health outcomes in a cross-sectional study where the outcomes are common [60]. We also 
used a morbidity approach to complement the calculation of disability-adjusted life years for 
cross-sectional studies where incidence rates are missing. Monitoring socioeconomic 
inequalities in health is a key global and national agenda of public health surveillance [133]  
 
Policy recommendations  
There has been a mass distribution of LLINs in Kenya since 2006, conducted every three 
years which has increased the availability of LLIN in households. Although universal 
coverage has not been achieved, there is progress towards attaining 80% by 2030. The result 
shown in chapter seven indicated that up to 80% [ranging from 77.3% to 82.7%] of 
households achieved universal coverage. The result from this study also showed that half of 
the LLINs observed in households originated from mass distributions (MD), one third from 
the community health volunteer (CHV) approach while one in ten nets were obtained through 
the antenatal care clinic targeting pregnant women and children. These findings demonstrate 
that the MD and CHV approach can achieve both universal coverage and equity when used 
together.  Distribution channels that have cost barriers such subsidized nets through social 
marketing, ANC (travel cost) and the commercial outlets are most inequitable and have the 
least chance of reaching the poorest households. Mass distribution campaigns have been 
shown to influence bednet usage irrespective of household socioeconomic status. The result 
from this study has shown that household socioeconomic status had an influence on LLIN 
ownership, however, once a household has nets, the probability of usage is increased. 
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Ensuring mass distribution of LLINs will achieve universal coverage but strategies to target 
poor households will result in equity by ensuring that the availability of nets in households 
achieves equity and universal coverage [134, 135]. 
Results from these studies have shown that malaria is associated with poverty and previous 
studies had already reported high poverty levels reported in endemic areas of western 
Kenya[61],  the fight against malaria would be compromised. Policy efforts should be geared 
towards reducing socioeconomic inequalities and targeting vulnerable groups like the poorest 
persons, children and women especially in the malaria-endemic area because our data has 
shown the children <5, women and poorest individuals lost most DALYs due to malaria 
infections.  
 
This study has demonstrated that malaria is unfairly concentrated amongst the poorest 
households and hence interventions against malaria should be done simultaneously with 
poverty eradication programs. Targeting at-risk populations is an essential component for 
achieving equity despite the fact that it requires more resources than mass distribution. Since 
malaria is unfairly distributed amongst the poorest individuals, achieving both universal 
coverage and equity by 2030 will be a challenge. However, aiming to universal coverage and 
at the same time documenting any equitable coverage in at-risk populations is still key to the 
control program through monitoring and evaluations[75]. 
 
The study has shown that care-seeking and taking medication is equitable due to non-
significance difference between the poorest and wealthier individuals. However, when the 
poorest individuals seek care for fevers, they purchase non-effective medications unlikely to 
treat malaria. Regulation of quality of medicines sold off-the-counter sale may cushion the 
poor against the adverse effect of poor treatment.  
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Recommendations for specific future research 
The use of cross-sectional data meant that we were unable to assess cause-effect 
relationships, however, a future study could design a longitudinal cohort study that can 
monitor changes in wealth quintiles and health outcomes for specific individuals and 
households over time.  A better defined randomized trial to evaluate the cost-effectiveness 
and equity impact which addresses the limitations experienced in our study can improve the 
study of a cost analysis of LLIN distribution channels and doing these studies in setting with 
urban and rural areas can provide more definitive data on differing subpopulations, allowing 
greater generalizability. A future study could also be done to assess the comparison of 
socioeconomic inequalities using MCA and PCA at the same time, to validate the superiority 
of MCA in SES classifications.  
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